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ABSTRACT 
 
Herd-level Risk Factors Associated with Antimicrobial Susceptibility Patterns and 
Distributions in Fecal Bacteria of Porcine Origin. 
(August 2011) 
Susan Noble Rollo, B.S.; M.S., Texas Tech University; 
D.V.M., Texas A&M University 
Chair of Advisory Committee: Dr. Bo Norby 
 
 The purpose of this dissertation is threefold: to determine the differences in 
apparent prevalence and the antimicrobial susceptibility of Campylobacter spp. between 
antimicrobial-free and conventional swine farms; secondly, to introduce an appropriate 
statistical model to compare the minimum inhibitory concentration distributions of 
Escherichia coli and Campylobacter spp. isolated from both farm types; and thirdly, to 
examine the potential herd level risk factors that may be associated with antimicrobial 
resistance of Campylobacter spp. and E. coli isolates from finishers on antimicrobial-
free and conventional farming systems. In addition, a critical review of studies that have 
compared the levels and patterns of antimicrobial resistance among animals from 
antimicrobial-free and conventional farming practices was performed. 
 Fecal samples from 15 pigs were collected from each of 35 antimicrobial-free 
and 60 conventional farms in the Midwestern U.S. Campylobacter spp. was isolated 
from 464 of 1,422 fecal samples, and each isolate was tested for susceptibility to 6 
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antimicrobials. The apparent prevalence of Campylobacter spp. isolates was 
approximately 33% on both conventional and antimicrobial-free farms. The proportion 
of antimicrobial resistance among Campylobacter was higher for three antimicrobials 
within conventional compared to antimicrobial-free farms. 
 The susceptibilities of populations of bacteria to antimicrobial drugs were 
summarized as minimum inhibitory concentration (MIC) frequency distributions. The 
use of MIC values removed the subjectivity associated with the choice of breakpoints 
which define an isolate as susceptible or resistant. A discrete-time survival analysis 
model was introduced as the recommended statistical model when MICs are the 
outcome. 
A questionnaire was completed by each farm manager on biosecurity, preventive 
medication, vaccines, disease history, and production management. Multivariable 
population-averaged statistical models were used to determine the relationships among 
antimicrobial susceptibility patterns and potential herd-level risk factors. Controlling for 
herd type (antimicrobial-free versus conventional), each antimicrobial-bacterial species 
combination yielded unique combinations of risk factors; however, housing type, history 
of rhinitis, farm ventilation, and history of swine flu were significant in more than one 
model. A variety of herd-level practices were associated with the prevalence of 
antimicrobial resistance on swine farms. Further studies are encouraged when 
considering interventions for antimicrobial resistance on both antimicrobial-free and 
conventional farms. 
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NOMENCLATURE 
 
 
ABF   Antimicrobial-free 
AMR   Antimicrobial resistance 
CI   Confidence interval 
DTSA   Discrete-time survival analysis 
MDR   Multidrug resistance 
MIC   Minimum inhibitory concentration 
MIC50 Minimum inhibitory concentration that inhibits the growth of 50% 
of isolates tested 
MIC90  Minimum inhibitory concentration that inhibits the growth of 90% 
of isolates tested  
m-PCR  Multiplex PCR 
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1. INTRODUCTION AND LITERATURE REVIEW 
1.1. Introduction 
 
For more than 30 years, agricultural animal farming has been oriented toward 
highly structured processes that often involve multiple applications of antimicrobial 
drugs for the prevention, control, and treatment of disease and for the promotion of 
animal growth. However, consumers have become increasingly concerned about the 
presence of antimicrobial-resistant bacteria in foods of animal origin, and during the past 
decade there has been a significant consumer trend toward purchasing natural foods and 
supporting organic farming practices. Due to the rising demand for organic and 
antimicrobial-free animal products, some producers have voluntarily ceased to use 
antimicrobial drugs (Aarestrup et al., 2001a; WHO, 2003). Government agencies in 
some European countries have gone so far as to ban many of the antimicrobial drugs that 
are used for growth promotion (Aarestrup et al., 2001a; Grave et al., 2006). In the U.S., 
because of the rising concern about development, propagation, and accumulation of 
antimicrobial resistance, some drugs that are used for the treatment of disease have been 
withdrawn (examples include enrofloxacin and sarafloxacin for the treatment of disease 
in poultry) (Federal Register, 2001). 
 
 
 
 
 
 
___________ 
This dissertation follows the style of Preventive Veterinary Medicine. 
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Critics have suggested that there may be drawbacks to this trend (Singer et al., 
2006). The voluntary or required cessation of antimicrobial drug use in farms may result 
in an increase in the prevalence of zoonotic pathogens, potentially increasing the risk to 
humans or negatively affecting animal well-being (WHO, 2003). For example, the ban 
on antimicrobial growth promoters in Denmark in the late 1990s was followed by an 
increase in therapeutic antimicrobial use in the treatment of E. coli–related disease 
(WHO, 2003; Grave, 2006). Hence, disease management and infection control are issues 
that antimicrobial-free producers have to address when they decide to avoid 
antimicrobial drugs. It cannot be assumed that simply eliminating antimicrobial drug use 
from an established production system will always result in safer food products. 
There is a great deal of debate about the overall value of organic farming 
practices and the effects of eliminating antimicrobial drug use. Researchers who have 
tackled these issues have run into a morass of methodological problems and, in some 
cases, may have put forward conclusions that were unwarranted by the data. In this study 
we provide an analysis of the existing research literature on the effects of eliminating 
antimicrobial drug use in animal farming. We offer a detailed critique of the 
methodological issues that have plagued this research, and we show that in some cases 
highly suspect conclusions were reached. The result of our analysis is to describe 
protocols that can be used by future researchers to improve the validity of their 
comparative data. 
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1.1.1 Organic animal farming: Definition and debates 
Organic farming is an expansive concept that can mean different things to 
different people. In the United States, the development and administration of organic 
farming standards is organized by the U.S. Department of Agriculture’s National 
Organic Program (NOP). The NOP standards for animal farming specify that the 
production system cannot involve any use of hormones for growth encouragement or for 
antibiotic purposes (though vaccines are allowed and sick animals can be permanently 
removed from the production system for treatment). Additional requirements are also 
included in the NOP standards, such as the use of organic feed and a certain amount of 
outdoor exposure (USDA, 2010). Since the precise definition of organic farming can be 
hard to pin down, some researchers instead focus on the term “antimicrobial-free 
farming” (Baker, 2006). However, even the seemingly straightforward term 
“antimicrobial-free” can be defined in more or less stringent ways, as will be discussed 
below in subsection 1.2.4. While acknowledging that “organic” often has more 
expansive connotations, in this dissertation “organic farming” and “antimicrobial-free 
farming” are used interchangeably to refer to any animal production system in which the 
use of antimicrobial agents is prohibited. What it means to prohibit antimicrobial agents 
is a matter for detailed discussion in the following subsections. 
The reasons for wanting to prohibit antimicrobial agents are relatively 
straightforward. Starting in the 1950s, antibiotics were increasingly used in both human 
and animal medicine (Aarestrup, 2006; Guardabassi and Kruse, 2008). In food animals, 
they were adopted for growth promotion as well as for the treatment, control, and 
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prevention of disease (McEwen and Fedorka-Cray, 2002). However, the broad use of 
antimicrobial drugs in animal farming created conditions in which antimicrobial-
resistant (AMR) bacteria could emerge. Such bacteria were found to be accumulating in 
farm environments and then disseminating among different species and populations 
(Baquero and Canton, 2009). Researchers also found that antimicrobial resistance can 
spread among bacteria via the transmission of resistance determinants (genes) located on 
mobile genetic elements such as plasmids and transposons (O’Brien, 2002; Baquero and 
Canton, 2009). The significance of these mobile genetic units is that resistance can 
develop and spread much faster than would be predicted by basic evolutionary 
dynamics. 
Most researchers assume that a gradual increase in the proportion of AMR 
bacteria is likely to occur after an antimicrobial drug is used for a prolonged period of 
time in an animal population under circumstances that allow for selective and 
evolutionary events to accrue over time. It seems reasonable to suppose that the 
prevalence of AMR bacteria is associated with or proportional to the route in which 
antimicrobial drugs are given, the total volume of antimicrobials used over time, and the 
nature of the treatment program (treatment of individual animals vs. treatment of entire 
populations). With the cessation of antimicrobial use in a population of animals, which is 
what occurs in the shift to organic farming, one would expect to see a decrease or 
possibly an elimination of resistant bacteria. Resistance to antimicrobials may incur a 
fitness cost (a decrease in the ability of a bacterium to compete with other bacteria in the 
environment) that would cause bacteria that acquire additional resistance genes to 
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become less fit (Andersson, 2003). Organic farming organizations, many researchers, 
and many regulatory policymakers have thus claimed that the cessation of antimicrobial 
drug use will (in addition to other benefits) result in more wholesome animal products 
with less chance of resistant bacteria ending up in the food supply. However, this has 
been disputed by many farming organizations and politicians, as well as by some 
researchers. 
As a result of this controversy, a number of studies have been conducted to 
compare the relative proportions of resistant bacteria (from a variety of different 
bacterial species) in conventional farming systems versus organic farming systems. In 
addition, several review papers have been written on this subject (Jacob et al., 2008; 
Wilhelm et al., 2009; Young et al., 2009). However, these reviews have been wholly 
inadequate in reflecting the complexity of the data and in addressing methodological 
inconsistencies. In these reviews, authors failed to discuss the limitations in the existing 
literature that make comparison and summation difficult. (These limitations are 
described in detail in the second part of this section.) The existing reviews involved 
scientifically based, systematic selections of studies, but conclusions were summarized 
across studies in a way that was often improper and unjustified. For example, Jacob et al. 
(2008) acknowledged that the studies they reviewed did not all use the same definition 
(breakpoint) for determining whether bacterial isolates would be classified as resistant or 
susceptible. However, these reviewers did not elaborate on which studies differed in this 
respect or how the differences might affect comparability. Likewise, in Wilhelm and 
colleagues’ (2009) study, the authors specifically pointed out that their objective was to 
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summarize results across studies using systematic review techniques, but they did not 
consider differences in sample sizes, nor did they discuss the different criteria that were 
used in various studies to select and define organic versus conventional farms. 
1.1.2 Purpose of the study 
Our main objective was to provide a rigorous review of previous studies in which 
levels and patterns of bacterial antimicrobial resistance were compared in organic versus 
conventional farming systems. We focus on issues that can make generalizations 
unreliable and that can cause difficulties for comparison and summation across studies. 
A review of this subject matter is very intricate due to the complexity of the data, and 
therefore, a thorough analysis is warranted. The value of this analysis is that it highlights 
problems with the existing research literature such that comparisons should be 
interpreted with caution. Standardization or consensus would be valuable for developing 
more reliable results which will help in making policy decisions, informing consumers, 
and for developing and designing future research. 
1.1.3 Selection of relevant literature 
Relevant literature was identified by searching major electronic bibliographic 
databases in June of 2009 and again in August of 2010. A matrix of key terms was used 
to search for studies in which farms that do not use antimicrobials were compared 
against conventional farms that do use antimicrobials (see Appendix A). The databases 
that were searched included Ovid (CAB, FSTA, AGRIS, and CAB), ISI (Web of 
Science), and PubMed (Medline). The years accessed were 1985 through 2010, and 
selections were restricted to English-language journals. Additionally, references from 
  
7 
review articles and other significant publications were checked and included in the data 
set where relevant. After reviewing the abstracts and titles of more than 200 relevant 
articles, 25 were selected for evaluation. The inclusion criteria were that any included 
study included farm animal populations and involved a comparison of bacterial 
antimicrobial resistance in organic farming systems versus conventional farming systems 
(see Appendix B for article details). We only considered studies that collected samples 
on the farm rather than in harvest or postharvest settings. 
 
1.2. Problems in the Existing Research Literature 
In reviewing the literature, we found that there are significant and systematic 
methodological factors in these studies that limit their usefulness for reaching 
comparative conclusions about levels of AMR bacteria in organic versus conventional 
farms. Some of the problems had to do with the internal validity of the studies, while 
others were related to their generalizability and to the possibility of making cross-study 
comparisons. In the following subsections, we break down these issues into seven 
specific problem areas. First, however, we will provide a brief introduction to the format 
of these studies. The unit of comparison in most of the studies was individual bacterial 
isolates from fecal samples that were collected from individual animals on organic and 
conventional farms. These bacterial isolates were usually analyzed for resistance to a 
group of several antimicrobials (the specific antimicrobials varied among the studies and 
depended on the types of bacteria that were being examined). An isolate may harbor a 
specific phenotype of resistance to a certain antimicrobial. However, not finding a 
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phenotype did not necessarily mean that it was not present in the animal. Also, a farm 
could be said to be “positive” in harboring a specific resistance phenotype if that 
phenotype were isolated from an animal on the farm. However, not finding a phenotype 
did not necessarily mean that it was not present on the farm. The working assumption in 
most of the studies was that the isolate would reveal the most dominant bacterial strain 
within the fecal sample of the animal that was selected. 
1.2.1 Sample size 
 Interpretations concerning the prevalence of AMR bacteria on conventional and 
organic farms have been hampered by the limited number of samples collected and the 
limited number of isolates available for antimicrobial susceptibility testing. One of the 
major limitations for studies of specific resistance phenotypes is the number of the 
samples or animals included in the study. There can be a great deal of variation in the 
prevalence of the target bacteria and in the prevalence of resistant phenotypes among the 
target bacteria in a given animal population. In some studies, researchers investigated 
differences in AMR in commensal bacteria (e.g., E. coli or Enterococcus spp.), which 
will be present in all fecal samples, while in other studies they investigated differences in 
AMR in pathogens that are only present (or cultivable) from some animals (e.g., 
Campylobacter in poultry or E. coli 0157:H7 in cattle) . Furthermore, not all bacterial 
strains (be they commensal or pathogen) within a species will have a specific AMR 
phenotype or pattern. This may result in a very low power to detect differences among 
the populations that are purportedly being studied. 
  
9 
Sample-size determination is thus necessary in order to draw appropriate 
inferences when comparing the proportion of AMR bacteria present on different farms. 
In many studies, however, a priori sample-size calculations were not performed (or, at 
least, were not mentioned in the study reports). In some cases, the sample-size 
calculation might have been based on the estimated true prevalence of a pathogen, but 
since only a fraction of these pathogens carry resistance to specific antimicrobial drugs, 
the power to determine true differences in susceptibility in such studies may be very low. 
Compared to commensal bacteria, many pathogenic bacteria have a low prevalence in 
farm animal populations. These include Listeria monocytogenes (Schwaiger et al., 
2009), Shiga-toxin E. coli (Cho et al., 2006; Cho et al., 2007; Reinstein et al., 2009), and 
Non-Typhi Salmonella (Siemon et al., 2007; Gebreyes et al., 2006; Ray et al., 2006). In 
one study, out of 799 cloacal swabs from chicken farms in Germany, only 12 Listeria 
isolates were obtained (Schwaiger et al., 2009). This small sample makes it difficult to 
meaningfully evaluate whether there are differences in the overall bacterial AMR on 
different farms. It is possible to use a post-hoc statistical technique to analyze the power 
of a study (that is, the likelihood that a difference would have been found if one was 
actually present). However, this was not done in any of the studies in the reviewed 
literature in which no differences were found between organic and conventional farms. 
Therefore, it is hard to know whether the findings of no difference were due to an actual 
lack of difference or were merely a result of having small sample sizes and insufficient 
statistical power. 
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1.2.2 Sampling selection 
A second issue that makes it difficult to assess the results of previous studies is 
the variation in how subjects (animals) were sampled on the farms and how bacterial 
isolates were chosen to undergo antimicrobial susceptibility testing. For example, 
samples of milk were treated in three distinct ways. Some were pooled from a group of 
cows (Sato et al., 2004b), others were pooled from the four milk quarters of individual 
cows (composite milk samples, one sample per animal) (Bombyk et al., 2008), and some 
were taken as quarter samples and not pooled at all (four samples per animal) (Pol and 
Ruegg, 2007). The assumption when using pooled samples to determine pathogen 
prevalence is that if one animal is positive then the entire pool will be positive (Salman, 
2003). Pooled milk samples can be informative when the expected prevalence is low and 
the objective is to determine pathogen endemicity. However, pooled samples are not as 
helpful in determining the relative prevalence of antimicrobial susceptibility on different 
farms, because each farm would normally have unique isolates within different animals 
on the same farm. 
Another sometimes employed sampling method was selecting pathogenic 
bacteria from clinical or subclinical animals, as opposed to obtaining commensal 
bacteria (Docic and Bilkei, 2003; Garmo et al., 2010; Roesch et al., 2006; Bennedsgaard 
et al., 2006). This is a form of targeted sampling since the expected prevalence of the 
bacteria in the selected animals is higher than that in the overall population (Salman, 
2003). One example of this approach is a study by Roesch et al. (2006), in which milk 
quarters from individual cows were sampled based on their reactivity to the California 
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Mastitis Test. This was done to increase the probability that pathogens would be present 
in the samples. While this is not an internal problem for Roesch and colleagues’ study, it 
becomes a problem in research reviews when these results are used as a basis for 
comparison with other studies in which targeted sampling was not used. A comparison 
of data from studies that used targeted sampling against data from studies that did not 
use targeted sampling (Bombyk et al., 2007; Pol and Ruegg, 2007) is clearly 
inappropriate. 
An additional issue that made comparisons of studies difficult was that in many 
of the reviewed studies, multiple colonies were selected from the culture plate of one 
sample/animal to help ensure that an isolate would be available for antimicrobial 
susceptibility testing (e.g., Gebreyes et al., 2006; Ray et al., 2006). In one study, the total 
isolate count actually came out to be greater than the number of animals used to 
determine animal-level prevalence (Ray et al., 2006). Increasing the number of selected 
isolates for susceptibility testing will increase the probability of finding low prevalence 
antimicrobial resistance, and it is a legitimate technique that is conducive to determining 
the presence of antimicrobial resistance (if the goal is to increase the chance of finding 
resistant bacteria, then obtaining many isolates per sample would be preferred). 
However, prevalence estimates from studies that sample more than one isolate per 
sample cannot be compared directly to other studies that sample only one isolate per 
animal. 
In some of the reviewed studies (Heuer et al., 2001; Pol and Ruegg, 2007), only a 
subset of the total number of isolates were selected for susceptibility testing—in other 
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words, not all of the isolates that were obtained were tested. Heuer et al. (2001) sampled 
10 animals from each of 160 flocks on 39 different farms, but selected only 53 of the 
resulting isolates for antimicrobial susceptibility testing. Reinstein et al. (2009) 
randomly selected an equal number of isolates from each production system. When only 
a subset of isolates is selected for testing, the power of the study and the precision of the 
prevalence estimates are decreased. Such studies have an increased chance of resulting 
in a Type II error (concluding there is no difference when there really is one). 
Additionally, the process of choosing a subset of isolates may introduce selection bias 
into the study if the selection is not performed in a random fashion. If the sample 
variance between different animals or within the same animal is not known, it will be 
difficult to determine whether to use frequency sampling to chose the isolates or whether 
to weight the sampling by the number of isolates available per animal. In Heuer’s study, 
one would additionally need to know the partitioning of variance between farm, flock, 
and individual animals in order to determine a truly random sampling design among the 
available isolates. Furthermore, none of the study reports addressed these issues of 
random selection in the hierarchical structure. 
In some of the reviewed studies, samples were collected from a large number of 
animals in order to better characterize antimicrobial susceptibility in herds (e.g., 
Villarroel, et al., 2006). In other studies, however, researchers focused on collecting 
multiple samples from a few animals in order to increase the sensitivity to detect the 
prevalence of rare resistant phenotypes (Dunlop et al., 1999). Sampling multiple animals 
enhances the ability to characterize between-animal and between-group variability. This 
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is particularly helpful since much of the variability in these kinds of studies can be 
attributed to the bacterial diversity within one animal. However, the value of collecting 
samples from a large number of animals is often specifically relative to the antimicrobial 
drug and bacterial species combination being tested and to the distribution of the 
variance within animals as compared to the variance between animals and between 
farms (Villarroel et al., 2006). For example, in looking at variation among cows, there 
may not be much difference in sampling multiple cows versus sampling multiple isolates 
per cow when it comes to determining variability (Villarroel, et al., 2006). Of course, the 
potential for clustering of AMR phenotypes within samples taken from only one animal 
or a few animals can produce additional limitations on the ability to determine the 
bacteria’s overall prevalence (Berge et al., 2003 and Alali et al., 2008). 
When considering many-animal versus few-animal studies, it must be concluded 
that there is no single best method for comparing AMR patterns among groups of 
animals (Wagner et al., 2002). However, the power of a particular study design in a 
particular context can be identified. If most of the variability is between-farms (as 
opposed to within-farm variance), then a study will have more power if more herds are 
sampled. Between-farm and within-farm variances are estimable in all studies where 
multiple animals on multiple farms are sampled. However, very few studies (excluding 
Dunlop et al., 1999, Wagner et al., 2002, and Villarroel et al., 2006) reported this 
breakdown of variance between and within farms. Thus, it can only be assumed that 
when most of the studies were conducted, no knowledge of the variance partitioning 
between and within farms was available to guide the sampling design. 
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The issue of how many farms to sample versus how many samples to select 
within farms is further complicated with the addition of several hierarchical levels within 
a farm. For example, to estimate the most efficient sampling design on a pig farm, one 
would need estimates of variance at the herd-level, the house-level, the pen-level and the 
level of individual pigs within a pen. If several different production groups within a farm 
are sampled, then the variance among the production groups may also need to be 
accounted for. These variances may not always be significant—for example, Dunlop 
(1999) determined that most of the variance in a study on pigs originated from between 
individual animals and not between pens or buildings. Without an analysis of the 
variance, however, it is impossible to know whether or not the variances are significant, 
and thus it is impossible to know the relative power of these studies when it comes to the 
likelihood of finding differences in prevalence of AMR that may exist between organic 
and conventional farms. In some of the studies the power to find differences between 
farms may have been relatively high, and in other studies the power to find differences 
may have been relatively low. These differences should be taken into account when 
comparing and summarizing the findings from various studies; however, given the 
methodological limitations described above, it is simply impossible for us to know with 
any precision which studies had a lower power to find differences and which studies had 
a higher power to find differences. 
Although different sampling methods can be justified under different 
circumstances, a standard format among comparative studies would be highly desirable. 
To maximize the ability to determine variance between farms, it is usually best to sample 
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larger numbers of animals from multiple farms. Of course, this may be difficult to 
accomplish given the relatively small number of organic farms and the logistical 
problems with sampling multiple farms on a large scale. More importantly, to allow for 
comparability, calculations of variability and study power should be conducted. The 
direct quantification of the absolute or relative number of bacteria that are resistant to a 
particular antimicrobial drug (using a medium that incorporates the antimicrobial drug in 
the agar plate) would be a preferable method for determining differences in resistance 
among farm types. This approach is tedious and very costly, however, so it may not be 
possible in many cases. Hence, for the purposes of determining patterns of antimicrobial 
susceptibility, sampling at the individual animal level with ideally one bacterial isolate 
per animal would be the best common protocol for establishing antimicrobial 
susceptibility patterns across studies. 
1.2.3 Farm selection 
A third issue that makes it very difficult to establish generalizations across the 
reviewed studies is that the methods used to select farms for participation varied 
tremendously. In some geographic areas there are relatively few organic farms, leading 
researchers to include a smaller number of organic farms than conventional farms in 
their comparative studies. For example, Nulsen (2008) sampled a total of four farms, but 
only one of them was an organic farm. The length of time that this farm had used 
organic practices was unspecified. In contrast, Garmo et al. (2010) invited all of the 
organic farms in Norway to participate in their study leading to a much better balance 
between conventional and organic farms in the final sample. These researchers also 
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matched conventional farms to organic farms by geography, housing system, breed, and 
herd size, thus removing these factors as potential confounding variables. 
Convenience sampling of farms was a common practice in the reviewed studies 
(Sato et al., 2004a, 2005; Halbert et al., 2006; Ray et al., 2006; Bunner et al., 2007). The 
logistics of selecting organic farms in a random fashion (for example, from a list 
providing by the NOP) are often practically and economically unfeasible. Therefore, 
probability sampling of farms was not used in most of the studies, leading to a greater 
chance that an unrepresentative sample of farms may have been obtained. Convenience 
sampling can lead to a variety of problems—in one study, samples from farms in two 
countries (the U.S. and Denmark) were included for comparison, even though the 
samples from these different farms appear to have been obtained using different 
methodological protocols (Sato et al., 2004b). These are limitations that can lead to bias, 
and they should be mentioned as limitations when reporting comparative results. 
The best practices for comparative studies would be to sample the same number 
of animals on each farm, using the same protocols, and to eliminate as many potential 
confounding variables as possible. Farms should be selected based on their 
representation of the target population and a method of random selection should be used 
if feasible. Since fewer organic farms are available, they should be selected first, and 
then conventional farms can be selected based on geographical proximity to organic 
farms and in such a way that eliminates confounding variables. Although matching by 
herd size would be preferable, this is typically not possible because organic farms in 
general are smaller than conventional farms. Researchers should faithfully record their 
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study limitations; reviews of the literature should reflect these limitations, and caution 
should be exercised when making generalizations and comparisons on the basis of 
studies that may contain sampling bias. 
1.2.4 How an antimicrobial-free population is defined and selected 
In the studies included in this review, the definition of organic and antimicrobial-
free farms varied significantly. In other words, exposure (for both organic and 
conventional) was not comparable between studies. One common difference was 
whether or not organic farms would allow antimicrobial drugs to be given to a sick 
animal, which was then left in the herd while discarding the product (e.g., the milk) for a 
period of time. This is a common practice in Europe—whereas in the U.S. sick animals 
on organic farms are permanently removed from the herd for treatment (IFOAM, 2010; 
USDA, 2010). In one study, antimicrobial use was allowed on an “antimicrobial-free” 
farm in cases of calves with severe diarrhea or pneumonia (Sato et al., 2005). In another 
study, three treatments per year with antimicrobials were allowed for each individual 
cow on an organic farm (Garmo et al., 2010). In addition to this variation in 
antimicrobial usage, products used on particular farms can have an effect on selection 
for certain resistance mechanisms. For example, some of the organic farms that were 
sampled in the reviewed studies allowed the use of phytogenic feed additives. These are 
plant-derived growth promoters that have antimicrobial activity and therefore can co-
select for antimicrobial resistance (Roesch et al., 2006). Some of the organic farms that 
were sampled may have used heavy metals, such as copper or zinc, in feed to help with 
growth promotion; researchers have found that these heavy metals may also have 
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antimicrobial activity (Hasman et al., 2006). Variations in such practices among the 
organic farms in the various studies could reasonably be predicted to cause variations in 
bacterial antimicrobial resistance patterns (Baker-Austin et al., 2006). Furthermore, 
some of the comparative studies defined “antimicrobial-free” farms only on the basis of 
whether or not antimicrobials were used prophylactically, and in one of these studies the 
authors did not specify whether or not antibiotics were used on the farms for other 
reasons (Docic and Bilkei, 2003). These discrepancies in the definition of antimicrobial-
free farms make any comparison across studies very difficult, to say the least. 
In addition, some researchers have used the “organic” label for farms that raise 
animals entirely on pasture (Siemon et al., 2007). Although being raised on pasture is not 
the same as being raised under organic practices, a recent review by Jacob et al. (2008) 
inappropriately categorized farm conditions as “organic” when it involved the exclusive 
use of pasture. One example of why this is problematic is that pasture-raised animals are 
likely to be exposed to significantly greater amounts of environmental Staphylococcus 
aureus (SA), which has been shown to be mostly novobiocin-sensitive, coagulase-
negative Staphylococcus spp. (NSCNS). In contrast, animals in confinement under 
organic practices are more likely to have been exposed to novobiocin-resistant 
Staphylococcus spp. (NRCNS) (Matos et al., 1991). 
One of the research practices that has led to discrepancies in the definitional 
parameters for organic versus conventional farms is the reliance on organic certification 
labeling from co-ops, producers, or government agencies. The farming practices required 
for such labeling vary greatly among different organizations. In most of the studies 
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under review, researchers identified organic farms based on the labeling of a co-op or 
similar regional organization. Even national organic labeling requirements, however, can 
vary between countries. One example of these international differences is the 
requirement for the use of organic feed. The International Federation of Organic 
Agriculture Movements, which is located in Germany and organizes much of the organic 
labeling in Europe, currently requires that 50% of the feed must be produced on an 
organic farm and that 60% of the total diet for ruminants must be roughage (IFOAM, 
2010). This is in contrast to the NOP in the United States, which mandates different 
standards in regards to the origin and proportions of feed (USDA, 2010). 
In recent years the organic industry has made progress in creating consistent 
international standards of practice. However, most of the studies under review were 
conducted in the early 2000s, when there were even greater differences in national and 
local policies for organic labeling requirements. Researchers should not consider these 
definitional inconsistencies to be a thing of the past. As recently as 2009, a review that 
compared organic and conventional dairy farm practices suggested that the standards in 
the United States were more stringent than those in other countries (Ruegg, 2009). For 
the sake of making consistent and legitimate comparisons, researchers should provide a 
specific account of what types of products and practices are included in their definitions 
of organic farms. This should include information concerning the use of ionophores and 
other feed additives. 
The number of years that a farm has used organic practices is another factor that 
should be specified in comparative studies. It is plausible that the resistance levels to at 
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least some antimicrobial agents may be different depending on the number of years that 
antimicrobial agents have not been used in herds. Hence, the number of years that a farm 
has been antimicrobial-free should be investigated as a possible determinant in statistical 
models comparing resistance on organic and conventional farms. In addition, some 
organic farms change to antimicrobial-free practices after using conventional practices 
for a number of years, while other organic farms obtain new genetic stock from a variety 
of sources or exposures. Furthermore, the environments where organic farms are located 
may contain reservoirs of resistance genes. None of these issues were considered in the 
studies included in this review. It is a critical limitation in comparative studies that 
researchers failed to identify and recruit farms at the same number of years of being 
antimicrobial free to ensure that the exposure information pertained to an etiologically 
relevant time period. 
1.2.5 Methods used to determine and report antimicrobial susceptibility 
Phenotypic antimicrobial resistance is most often determined by exposing a 
bacterial isolate to increasing antimicrobial concentrations, by the use of in vitro tests, 
and measuring its survival on a gradient. The in vitro concentrations at which bacteria 
survive are then compared to benchmarks that signify clinical efficacy. In the U.S., these 
benchmarks are set by the Clinical and Laboratory Standards Institute (CLSI) to reflect a 
level of resistance that is likely to compromise the efficacy of antimicrobial treatment in 
an infected animal or human (CLSI, 2010). Based on susceptibility testing, bacteria are 
commonly divided into susceptible, intermediate, and resistant categories (or just 
divided into a susceptible / resistant dichotomy). The susceptible category includes 
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isolates for which the antimicrobial activity is associated with a likelihood of therapeutic 
success when the recommended dosages for a specific antimicrobial agent are used. The 
resistant category includes isolates for which the antimicrobial activity is associated with 
a higher-than-expected likelihood of therapeutic failure (CLSI, 2010; Kahlmeter et al., 
2003). 
According to the CLSI (M100-S19) (CLSI, 2010), the resistant and susceptible 
designations are determined by the breakpoints, which are specific levels of 
antimicrobial concentration (MIC) that inhibit bacterial growth because of resistance 
genes in the bacterial isolate. Also, breakpoints predict an outcome for a specific 
pathogen, in a specific disease, in a host species, given a particular regimen (i.e. dose, 
frequency, route, and duration) (CLSI, 2010). Some pathogen/drug combinations have 
an intermediate breakpoint, some have a susceptible and resistant breakpoint, and some 
have only a susceptible breakpoint when resistance to an antimicrobial drug has not yet 
been identified. Above and beyond the breakpoint MIC, a sample is considered to be 
meaningfully different from wild-type bacteria, in other words, to be a resistant strain 
(MacGowan and Wise, 2005). Clinically, breakpoints divide a population of bacterial 
isolates into those that are more likely to be susceptible to treatment and those that are 
more likely to be resistant to treatment. If breakpoints are too conservative, borderline 
susceptible bacteria may be considered fully susceptible, rather than partially resistant 
(Dalhoff et al., 2009). 
Using microbiological breakpoints to categorize samples into a simple 
susceptible/resistant dichotomy may limit researchers’ ability to compare susceptibility, 
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especially in cases where very few of the samples are classified as resistant. Using the 
simplified dichotomy does not always reflect the actual spectrum of resistance that exists 
in the samples. In addition, there is no gold standard for defining the breakpoints. The 
specific concentrations that define a resistant sample may vary in different countries (the 
CLSI’s counterparts in Germany and the Netherlands use slightly different definitions) 
(GENARS, 2004; Schwaiger et al., 2009; MARAN 2004; Hoogenboom et al., 2008) and 
Europe as a whole has a separate standard (EUCAST). Another limitation is that the 
CLSI or other agencies may not have determined breakpoints for some bacterial–
antimicrobial combinations (e.g., E. coli and ceftiofur) (Cho et al., 2007). Therefore, 
some of the studies under review used alternate sources for breakpoints. Some 
substituted human medical literature for veterinary standards (Pol and Ruegg, 2007; Ray 
et al., 2006). The standards for animal isolates and human isolates are established 
separately and, in theory, should not be used interchangeably in this manner. However, if 
the breakpoints were not established for animal isolates then authors had no choice but 
to use breakpoints from human standards or animal standards from different species. 
Another alternative source of breakpoints in some studies was the National 
Antimicrobial Resistance Monitoring System (NARMS) (FDA, 2008). For example, 
Sato et al. (2004a) used NARMS breakpoints for Campylobacter, since no CLSI 
standards had been established for this bacterium. However, NARMS only had 
breakpoints for C. jejuni and not for other variants such as C. coli. In Sato et al’s study, 
30% of the isolates failed the hippurate test, indicating that the speciation was something 
other than C. jejuni (Sato et al., 2004a). Furthermore, the approved method of testing 
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Campylobacter susceptibility was not established until May of 2002, when NCCLS, the 
National Committee for Clinical Laboratory Standards, now the CLSI, published M31-
A2 (NCCLS, 2002). M31-A2 clearly states that agar dilution is the method of choice for 
testing Campylobacter in relation to their breakpoints. However, Sato et al., 2004a used 
a different testing method, disc diffusion, and still other methods such as microbroth 
dilution have been used in later studies (Halbert et al., 2006). In summary, comparisons 
between studies can be greatly hampered by differences in the testing methods used and 
in the definition of breakpoint concentrations. 
 In many of the studies under review the breakpoints were not directly reported. 
However, the articles frequently referenced breakpoint sources, including CLSI 
publication M31-A2 (Gebreyes et al., 2006; Bombyk et al., 2008; Ray et al., 2006; 
Roesch et al., 2006; Hoogenboom et al., 2008), CLSI publication M2-A6-7 (Nulsen et 
al., 2008; Ray et al., 2006; Roesch et al., 2006), and CLSI publication M100-S10-12 
(Nulsen et al., 2008; Ray et al., 2006). There are a few exceptions from the CLSI 
standards, including studies of ceftiofur and streptomycin that were based on NARMS 
breakpoints (Ray et al., 2006). In the studies under review here, significant breakpoint 
variations were not noted. However, researchers should understand that breakpoints can 
change as new information is obtained and new forms of resistance develop within 
bacteria (CLSI, 2010; specifically, see ceftriaxone reset breakpoints from earlier CLSI). 
The recommended practice is to use the standards of microbiological methodology and 
designated breakpoints from the most recent CLSI publication, and to report these 
methods and breakpoints explicitly in research articles. To facilitate comparisons 
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historically, the need for reporting of MIC values, in addition to breakpoint 
interpretations, is therefore readily underscored. 
Beyond the issue of what breakpoint definitions are used, the results of 
antimicrobial susceptibility testing can be reported in a number of ways. The most 
common and straightforward way, as described above, is to divide the samples into 
resistant, intermediate, and susceptible categories following the breakpoints of the day. 
In studies where this method of reporting was used, there was a great deal of discrepancy 
in how isolates that fell in the “intermediate” category were classified. In some studies, 
isolates that fell in the intermediate category were consolidated into the resistant 
category (Pol and Ruegg, 2007; Roesch et al., 2006). In other studies they were 
consolidated into the susceptible category (Sato et al., 2005; Luangtongkum et al., 2006). 
Furthermore, while some researchers interpreted an isolate as resistant if its minimum 
inhibitory concentration (MIC) was greater than the listed breakpoint (e.g., Heuer et al., 
2001), most interpreted an isolate as resistant if its MIC was equal to or greater than the 
breakpoint. Thus, there is a discrepancy in how the isolates that have an MIC equal to 
the breakpoint were treated. 
Another way to report the resistance of bacteria in a group of isolates is to use the 
median level of resistance (median MIC; MIC50) (Reinstein et al., 2009) or the mean 
level of resistance (mean MIC) (Docic and Bilkei, 2003; Mathew et al., 2001; Schwaiger 
et al., 2008, 2010). These techniques are applicable when all of the bacteria samples are 
being tested for susceptibility to a single antimicrobial agent. When the median MIC is 
used for comparison, the median values in two samples could be the same while the 
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actual MIC distribution differs. This is because the data are right censored and the group 
of isolates that did not exhibit growth inhibition at the highest dilution were classified as 
being equal to the highest dilution; when in reality, inhibition could truly occur at 
concentrations greater than the highest dilution. A statistical difference may be reported 
if one herd type had more values in the censored category, even when the median is the 
same for both herd types (Reinstein et al., 2009). 
In some studies, the mean MIC (log2 transformed) was compared by t-test 
(Schwaiger et al., 2008; Docic and Bilkei, 2003; Mathew et al., 2001). The interpretation 
of this by one author was that the mean MIC described the prevalence and susceptibility 
(Docic and Bilkei, 2003). Reporting a mean differs from using a median, because the 
median divides the distribution in such a way that 50% of the isolates fall above and 
50% below a given dilution (or discrete category), whereas the mean is just the average 
of all MIC values for each group of isolates. Moreover, the median does not depend on 
the nature of the underlying MIC distribution; be it unimodal or bimodal, for instance.  A 
problem that emerged in some of the reviewed studies that reported a mean was that 
isolates in the dilution that were greater or equal to 256 µg/mL were designated as just 
being equal to 256 µg/mL, or in other words, were right-censored. In these cases, it has 
to be understood that the mean estimate is lower than the true mean and that the true 
value of the mean cannot truly be defined. Furthermore, in studies that reported the mean 
MIC, the breakpoints used for each of the antimicrobials tested were unspecified in the 
research reports (Docic and Bilkei, 2003; Mathew et al., 2001, Schwaiger et al., 2008, 
2010). 
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Another variation in reporting when testing for susceptibility to one antimicrobial 
in a group of isolates from different farming systems was the use of MIC50 and MIC90 as 
alternative descriptive values (Soonthornchaikul et al., 2006; Bunner et al., 2007; 
Halbert et al., 2006). The MIC50 is the drug concentration that inhibits the growth of 
50% of the isolates tested, while the MIC90 is the drug concentration that inhibits the 
growth of 90% of the isolates tested. The MIC90 was also used as a breakpoint when 
isolates fell below the threshold values designated by DANMAP, the Danish Integrated 
Antimicrobial resistance Monitoring and Research Programme (Sato et al., 2004b). 
The implication of using different breakpoints and different methods in 
describing levels of bacterial resistance is that it greatly impedes our ability to make 
generalizations from the literature. When different studies report different kinds of 
measurements in their comparisons of organic versus conventional farms (e.g., using 
MIC50 or an MIC distribution), these results cannot be easily regarded as equivalent for 
the sake of making generalizations—even though some of the existing reviews attempt 
to do just this (Young et al., 2009; Wilhelm et al., 2009; Jacob et al., 2008). 
Summarizing across studies that use different outcome measures is neither appropriate 
nor justified in regards to making a broad inference based on individual study results. 
As an alternative to comparing the proportions of resistance in two or more populations, 
review studies could try to compare the full distribution of MIC values in these bacterial 
populations. However, the comparison of MIC distributions is inherently more 
complicated than comparing, for example, two different proportions that were reported 
in existing analyses. Some of the studies included in this review included a full MIC 
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distribution for their data (Sato et al., 2004b, 2005; Mathew et al., 2001; Ray et al., 
2006). In some cases, differences between the MIC distributions of each herd type were 
measured rather than using mean, median, or MIC50 (Sato et al., 2004a), and in other 
cases the proportion within each MIC dilution was also reported for each bacteria 
(Thakur and Gebreyes, 2005; Bunner et al., 2007). By using the entire MIC distribution 
as an outcome measure as well as the proportion within each dilution, the assumptions 
inherent in using a breakpoint are eliminated and historical comparisons are more readily 
made, as standardized breakpoints change: now and into the future. 
1.2.6 Methods used to isolate bacteria 
Even if the full susceptibility data are available for cross-study comparisons, 
additional concerns about inherent microbiological limitations and potential biases in 
study design can hamper our ability to make generalizations across studies. For example, 
there is no single standard for Campylobacter isolation (Silley, 2003). When dealing 
with this bacterium, Sato et al. (2004a) did not use an enrichment media, as is commonly 
done by other researchers. Furthermore, Sato et al. used an incubation temperature of 
37°F, rather than the standard 42°F, thereby discouraging thermophilic Campylobacter 
species such as C. jejuni, C. coli, and C. lari. A similar methodological divergence was 
made by Mathew et al. (2001), who used an enrichment broth to obtain more isolates of 
Salmonella.  
A related methodological problem was that some researchers did not make 
distinctions between different subspecies of bacteria—for example, Heuer et al. (2001) 
did not differentiate Campylobacter species isolates into C. jejuni and C. coli. This may 
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have produced biased results, because each subspecies has been shown to exhibit 
different patterns of resistance (Moore et al., 2006). Erythromycin resistance has been 
shown to be rare in C. jejuni but common among C. coli strains, particularly among 
isolates from pigs (Moore et al., 2006; Harrow et al., 2004). The higher frequency of 
resistance of erythromycin in pigs has not been fully explained; however, Aarestrup and 
Engberg (2001b) suggested that it may be due to a generally higher frequency of 
mutations conferring resistance among C. coli or more selective pressure from prior use 
of antimicrobial agents. Likewise, Enterococcus species (E. faecium and E. faecalis) 
differ in susceptibility because E. faecalis is known to carry a unique, natural innate 
resistance to virginiamycin (Delgado et al., 2000). This lack of differentiation between 
subspecies greatly decreases the comparability between the results of different studies. It 
would be desirable for standard microbiological methods, as stipulated in the current 
publications of CLSI, to be used across all studies. This would improve comparisons 
across studies and reduce or prevent any biases that may occur in the laboratory. 
1.2.7 Statistical analysis 
In many of the studies that were reviewed, results were reported based on 
inappropriate statistical models. Ideally, the chosen statistical model(s) should reflect the 
nature of the data and account for assumptions or characteristics of the minimum 
inhibitory concentration frequency distribution. There are three major discrepancies in 
the statistical models used in the reviewed literature. First, many studies limited their 
analysis to reporting proportions without adjusting for the hierarchical nature of the data 
(Roesch et al., 2006; Gebreyes et al., 2006; Halbert et al., 2006). The hierarchical nature 
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of the data (individual animal level, production unit level, farm level, etc.) results in 
isolates from individual animals forming clusters. Clustered data should be accounted 
for in a statistical model in order to obtain valid estimates and appropriate standard 
errors (Dohoo et al., 2003). The underestimation of the standard error could result in 
researchers reporting differences that are not truly present (Type I errors). Using a 
statistical model that accounts for clustering will result in a more appropriate standard 
error measurement, which will likely be greater than the one found when using 
generalized linear models and not adjusting for herds. 
There are two types of statistical models that can be used to explain dependency 
between animals (i.e., clustering). One is a subject-specific model that includes a random 
effect for each cluster (e.g., for each farm; or animal, if multiple isolates are tested) in 
the linear predictor of the model. A subject-specific model should be used if the goal is 
to interpret the results at the farm (animal) level. The second type of model that could be 
used is a population-averaged model, which involves using the expected values for a 
particular set of predictors averaged across the population of clusters. This would allow 
inferences to be made across all herds (animals) (Dohoo et al., 2003). Although several 
of the studies that were reviewed did account for clustering in the analysis (e.g., Bunner 
et al., 2007), most did not (e.g., Schwaiger et al., 2008, 2010; Cho et al., 2007; Gebreyes 
et al., 2006). One example of this is Sato et al. (2005), who did not account for 
dependency among animals within herds but rather used a simple logistic regression 
which assumes independence between animals. These authors stated that they avoided 
the issue of clustering by only obtaining one isolate per animal, but this does not account 
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for the dependence that would be expected between animals from the same farm. This 
inadequacy was corrected in an additional study (Sato et al., 2004a), in which the authors 
examined a different bacterium, Campylobacter, on the same farms as the previous 
study. Here, the researchers accounted for clustering and used a generalized estimating 
equation for the chi-square test (population-averaged). 
The second major statistical discrepancy in the literature arose when the outcome 
of isolate susceptibility was reported as MIC distributions. Most of the researchers who 
did this failed to consider the censored nature of the data. Antimicrobial susceptibility 
tests such as agar dilution or microbroth dilution only have a set number of dilutions, 
concentrations, or categories, and in some cases there are only two to four dilutions 
around a breakpoint.  Due to cost issues, increasing the number of dilutions may 
compromise the number of antibiotics that can be tested on a 96-well microbroth dilution 
plate. Any isolates that are not inhibited up to the highest dilution will be grouped in the 
highest category. For example, the graphs in Figure 3.1-3.6 illustrate the difference in 
distributions when various isolates are categorized in the highest dilution. Because of 
this, comparisons of left- and/or right-censored distributions should be done using a 
method that accounts for the censored nature of the data. Survival analysis (SA) is a 
statistical method that can be used when analyzing MIC distributions. SA, which is often 
considered for time to event data, can be used if the sequential dilutions of the test are 
interpreted as the time variable and SA is clearly favored when dealing with censored 
data. In the majority of the studies that were reviewed, the researchers did not consider 
the isolates in the highest dilution as censored when reporting and comparing MIC 
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distributions (this is reflected in the studies that mistakenly reported a mean MIC, as 
described previously). However, in a few studies researchers did consider the outcome 
data as a censored distribution and used SA for the analysis (Reinstein et al., 2009; Pol 
and Ruegg et al., 2007). The Wilcoxon test was used in some cases to determine the 
difference between herd type based on median MICs (Reinstein et al., 2009; Pol and 
Ruegg et al., 2007); however the Wilcoxon test does explicitly account for censoring. 
The third major problem with the statistical methods used in the reviewed 
literature is that some researchers attempted to account for censoring by using a Cox 
model (also called a continuous-time proportional hazard model), but this model is not 
appropriate for such a task. The Cox model is popular and easily accessible in most 
statistical software programs. Continuous time models such as the Cox model make the 
assumption that an event (outcome) occurs at an exact moment in time. Instead, MIC 
data are measured discretely, by dilutions or concentrations where bacterial growth is 
inhibited. When two events occur at the same time, these are referred to in the Cox 
model as tied outcomes. If there are an excessive number of tied outcomes, then the Cox 
model will often fail (Willett and Singer, 2003). A study by Ray et al. (2006) is an 
example in which the Cox model was used to account for right-censoring while 
comparing organic and conventional farms. Farms were classified based on the highest 
MIC recorded among the isolates tested from that farm. The isolates with an MIC value 
in the highest dilution were considered censored; however, there were likely a large 
number of tied outcomes. The Cox model is inappropriate for data such as with MICs 
because of the number of tied outcomes involved (Cox models also involve an 
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assumption that the predictor does not change over time; more details about the use of 
such models is provided in Section 3). An alternative model that could be used for 
similar purposes is a discrete-time SA model as derived by Willet and Singer (2003). 
Such a model would be more appropriate because it would allow for discrete outcomes 
and would let the researcher take into account the censoring of the distribution. 
An additional statistical consideration that should be taken into account is the 
systematic differences between organic and conventional farms. In general, organic 
farms are notably smaller. Herd size should therefore be checked as a potential 
confounder and should be included in the statistical model. If possible, factors such as 
age group or season should be considered for inclusion in the statistical model (Sato et 
al., 2004a, 2005). Another potential discrepancy that can arise in these studies is in 
regard to the type of covariates included in the model, that is, whether the covariate is 
measured at the animal level (e.g., weight, age) or at the herd level (e.g., herd size, 
season). The use of covariates may differ between studies, and this will alter the results 
and lead to a bias when making cross-study comparisons. 
There are also inherent limitations in the reviewed studies in that most of them 
are cross-sectional studies. To our knowledge, there have not been any longitudinal 
studies conducted to compare the proportion of bacterial antimicrobial resistance in 
organic versus conventional farms. One reason for this is that longitudinal studies are 
time-consuming and costly. Making inferences based on cross-sectional studies should 
be done cautiously, because sampling in a cross-sectional study is a snap-shot of a 
particular time frame. Cross sectional studies do not allow researchers to determine rates 
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or to determine whether the exposure or the outcome occurred first. Cross-sectional 
studies are also subject to selection misclassification. In regard to sampling, small 
sample sizes favor the process of generating hypotheses rather than the process of testing 
them. In food animal production, cohort studies or hybrid cohort studies are the preferred 
type of observational study to provide validity in inference (even though these kinds of 
studies are difficult to implement). In a well-designed cross-sectional study, the test 
population should reflect the target population. This task is difficult to accomplish; 
however, considering the logistics of sampling multiply randomized farms, followed by 
a randomization sampling format within the farm environment. 
 
1.3. Summary 
Overall, our conclusion from this literature review is that caution should be used 
in interpreting previous studies in which antimicrobial susceptibility was compared in 
organic versus conventional farms, due to a number of inherent limitations and potential 
biases in these studies. The small number of isolates that were available for testing, the 
variations in how farms were selected and how isolates were collected, and the 
procedural problems in measurement and statistical analysis all indicate that 
generalizations and cross-study comparisons cannot be readily made from this literature. 
While we found that more studies suggested a greater prevalence of antimicrobial 
resistance on conventional farms, some studies suggested the opposite, and the prospect 
of reaching any definitive conclusion on the basis of the existing literature seems 
extremely unlikely. Presently, each bacterial species and each study should be evaluated 
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on an individual basis, and hopefully a consensus will become more likely after future 
studies in which attention to future comparisons is included at the design stage. There is 
a need for the interdisciplinary development of common protocols for quantifying 
resistance within and between bacterial and host populations, including laboratory 
methodologies and sampling designs in animal populations (Davison et al., 2000). 
In the following subsections, we examine these methodological issues in even 
greater detail, with a particular focus on the format of the data. We make 
recommendations for common protocols that can be used in future studies to allow for a 
greater possibility of cross-study comparison and generalization. In Section 2, we use a 
population averaged model to account for the hierarchical nature of the data. In Section 3 
we address the issue of MIC frequency distribution and present a new model that 
accounts for characteristics of a MIC distribution such as censoring and discrete 
outcomes. In the fourth section we consider whether particular risk factors can 
potentially be associated with the proportion of bacterial antimicrobial resistance on 
conventional and organic farms; this is a subject that is not adequately discussed in the 
current literature. The final section provides a summary and conclusion.
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2. PREVALENCE AND PATTERNS OF ANTIMICROBIAL RESISTANCE IN 
Campylobacter SPP. ISOLATED FROM PIGS REARED UNDER 
ANTIMICROBIAL-FREE AND CONVENTIONAL PRODUCTION METHODS 
IN EIGHT STATES IN THE MIDWESTERN UNITED STATES* 
 
2.1. Introduction 
 Campylobacter spp. are one of the most common causes of human diarrheal 
illness in the United States (Mead et al., 1999). Although most cases of 
campylobacteriosis are self-limiting, treatment with antimicrobial drugs is required in 
more severe or recurrent cases. The first and second most commonly identified 
subspecies that cause enteritis in humans are Campylobacter jejuni and Campylobacter 
coli, respectively (Tam et al., 2003; Moore et al., 2005). The contribution of 
Campylobacter spp. in pigs to human infection has been estimated at 10%, but this 
varies by country (Gillespie et al., 2002). 
 Campylobacter spp. are intestinal tract commensals in poultry, cattle, and swine; 
however, they can be associated with enteritis in calves and young pigs (Moore et al., 
2005).  
 
_____________________ 
*Reprinted with permission from “Prevalence and patterns of antimicrobial resistance in 
Campylobacter spp. isolated from pigs reared under antimicrobial-free and conventional 
production methods in eight states in the Midwestern United States” by S.N. Rollo, B. 
Norby, P.C. Bartlett, H.M. Scott, D.L. Wilson, V.R. Fajt, J.E. Linz, C.A. Bunner, J.B. 
Kaneene, J.C. Huber, 2010. Journal of the American Veterinary Medical Association, 
236, 201-210, Copyright 2010. 
  
36 
Although pigs are carriers of C. coli and C. jejuni, C. coli are isolated more frequently 
than C. jejuni in this species (Harvey et al., 1999; Payot et al., 2004b). In addition, C. 
coli are also readily identified in environmental samples from swine production units 
(Leatherbarrow et al., 2004). Because campylobacteriosis is a zoonosis, AMR in 
Campylobacter spp. in food animals is a public health concern. Antimicrobial resistance 
among Campylobacter spp. that infect humans has increased in the last 15 years (Blaser 
and Engberg, 2008), and in general, C. coli are resistant to a larger number of 
antimicrobials than C. jejuni (Bywater et al., 2004). Campylobacter organisms that are 
resistant to tetracycline, ciprofloxacin, macrolides, chloramphenicol, aminoglycosides, 
ampicillin and other β-lactams, and trimethoprim-sulfamethoxazole have been isolated 
from animals including poultry and swine (Alfredson and Korolik, 2007). For human 
patients with campylobacteriosis, both azithromycin (Gilbert et al., 2007) and 
erythromycin (Bardon et al., 2008) may be used effectively when antimicrobial 
treatment is indicated. The therapeutic use of fluoroquinolones in human patients has 
been greatly reduced by the widespread development of fluoroquinolone-resistant 
Campylobacter strains worldwide (Taylor et al., 2008). 
A review by (Andersson, 2003) revealed that continuous antimicrobial use exerts 
selective pressure that ultimately results in the emergence of resistant strains. In 2007, 
Alfredson and Korolik (Andersson, 2003) reviewed the results of several studies that 
indicated that fluoroquinolone resistance among Campylobacter spp. in humans 
increased following approval of a drug in the same class for use in food animals. 
However, cause and effect were not established. In addition, the presence of resistance 
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genes, whether derived from commensal bacteria or environmental sources, has been 
implicated in the increased incidence of resistance over time (Moore et al., 2005). 
Mitigating AMR is necessary to prevent the emergence and dissemination of 
resistant strains and to ensure continued successful treatment of microbial infections in 
humans and animals. Antimicrobial use practices in agriculture may be an area in which 
intervention will reduce the prevalence of AMR determinants in the food chain. One 
such intervention is antimicrobial-free farming.  Antimicrobial-free farming is defined as 
farming without the use of any antimicrobial drugs (Baker, 2006). However, reduction in 
antimicrobial drug use in food animals may lead to an increase in pathogen load 
(Casewell et al., 2003). The objective of the study reported here was to identify and 
compare the apparent prevalence of Campylobacter spp. and the apparent prevalence 
and patterns of AMR for fecal Campylobacter spp. isolated from pigs reared under 
antimicrobial-free and conventional production methods in the Midwestern United 
States. 
 
2.2. Materials and Methods 
2.2.1 Sample collection 
This research was a part of a large study investigating the apparent prevalence of 
and risk factors associated with antimicrobial susceptibility patterns of E. coli and 
Campylobacter spp. isolated from finisher pigs on antimicrobial-free and conventionally 
managed farms in 8 states in the Midwestern United States. Results regarding AMR 
patterns in E. coli from the study have been reported (Bunner et al., 2007). 
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The present study included 95 farms in the Midwestern United States, including 
Iowa (n = 37), Illinois (15), Indiana (5), Michigan (21), Minnesota (8), Nebraska (6), 
Ohio (2), and Wisconsin (1). Sixty farms were managed under conventional swine farm 
practices, and 35 farms were considered antimicrobial-free facilities. The production 
systems that were classified as antimicrobial-free had not used antimicrobial drugs for a 
minimum of 1 year prior to enrollment in the study. Antimicrobial-free farms were 
selected from membership lists of 2 cooperatives; conventional farms were selected on 
the basis of close geographic proximity to the antimicrobial-free farms, or the number of 
slaughter pigs produced per year (Bunner et al., 2007). The total number of pigs 
marketed per year was used as a surrogate for herd size. 
Samples of feces were collected from 15 pigs on each farm with the exception of 
1 farm, where only 12 pigs were available for sample collection. Collection of feces 
from individual pigs on farms has been previously described (Bunner et al., 2007). 
Briefly, farms were visited once in 2002 or 2003, and samples were collected only from 
healthy pigs. Approximately 5 g of fresh fecal material/pig was collected and placed in a 
tube containing Cary-Blair transport medium (Medical Chemical Corp, Torrance, CA). 
The specimens were sent on ice to the National Food Safety and Toxicology Center, 
Michigan State University, and plated within 48 hours of collection. 
2.2.2 Bacterial culture 
Approximately 1 gram of fecal material/sample from the Cary-Blair transport 
medium was inoculated onto 1 blood agar plate (VMR, West Chester, PA). The 
inoculated plates were incubated for 48 hours at 42°C in a microaerophilic atmosphere 
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of 5% to 12% CO2 and 5% to 15% O2 (BBL Microbiology Systems, Cockeysville, MD). 
On each plate, 4 Campylobacter-like colonies were identified, if present, and plated on 1 
of 4 quadrants on a blood agar plate and incubated. Colonies typical for Campylobacter 
spp. were further characterized by Gram stain results, microscopic appearance, and 
catalase and oxidase production in accordance with the standard methods at the National 
Food Safety and Toxicology Center, Michigan State University (Nachamkin, 1999). 
Isolates were identified as Campylobacter spp. if they were gram negative with a typical 
curved appearance microscopically, grew at 42°C under microaerophilic conditions, and 
were positive for catalase and oxidase. Campylobacter jejuni was further characterized 
by positive results of a hippurate hydrolysis test (Fitzgerald et al., 2008). Because some 
species of Campylobacter can be difficult to distinguish, a colony m-PCR assay was also 
used for isolate identification. Campylobacter isolates were frozen in 2% skimmed milk 
at –70°C in preparation for antimicrobial susceptibility testing and final identification by 
the use of the m-PCR procedure (Wang et al., 2002). 
2.2.3 Differentiation of Campylobacter spp. 
Pure cultures of Campylobacter spp. were thawed at room temperature (approx 
20°C). Subsequently, Campylobacter spp. were differentiated by use of a colony m-PCR 
with slight modifications (Wang et al., 2002); the original PCR assay also identified 
Campylobacter upsaliensis and Campylobacter fetus subsp fetus. In brief, the m-PCR 
procedure identified the 23S rRNA from Campylobacter spp., the hipO gene 
(hippuricase) from C. jejuni, and the glyA gene (serine hydroxymethyltransferase) from 
C. coli and from C. lari by use of specific primer pairs (Appendix C) (Wang et al., 
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2002). Primers and reagents were used in a 50-µL PCR system. The m-PCR assay 
mixture contained 1X Taqman buffer, 0.2mM deoxyribonucleotide triphosphate mix, 
7.5mM MgCl2, 0.5µM C lari glyA forward and reverse primers, 0.5µM C jejuni hipO 
forward and reverse primers, 1.0µM C coli glyA forward and reverse primers, 0.2µM C 
jejuni 23S rRNA forward and reverse primers, 0.05 U/ µL (2.5 units) Taq DNA 
polymerase (Roche Diagnostics GmbH, Mannheim, Germany) and approximately 106 
whole bacterial cells. Amplification was achieved by use of a thermocycler (Bio-Rad 
Laboratories, Hercules, CA) with an initial denaturation step at 95°C for 6 minutes. An 
additional denaturation step at 95°C for 30 seconds followed by annealing at 59°C for 30 
seconds and polymerization at 72°C for 30 seconds was repeated for 30 cycles. Final 
extension was carried out at 72°C for 7 minutes. Polymerase chain reaction products 
were separated on a 1.5% agarose gel at 90 V for 2.25 hours with ethydium bromide (0.5 
µg/mL) added to the Tris, boric acid, EDTA buffer. 
2.2.4 Assessment of AMR 
Antimicrobial susceptibility testing was performed by use of commercially 
available gradient disk diffusion strips, Etest® (AB Biodisk, Piscataway, NJ), according 
to the manufacturer’s instructions. Frozen bacterial isolates were thawed at room 
temperature, inoculated onto blood agar plates, and incubated at 42°C in a 
microaerophilic atmosphere (BBL Microbiology Systems, Cockeysville, MD) for a 
minimum of 48 hours. Typical colonies were selected and subcultured on plates 
containing trypticase soy agar with 5% sheep blood (VMR, West Chester, PA). These 
plates were incubated under microaerophilic conditions at 42°C for 48 hours. Colonies 
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from subculture were tested as described by Sato et al.(Sato et al., 2004a). Six 
antimicrobials were tested: azithromycin (0.016 to 256 µg/mL), erythromycin (0.016 to 
256 µg/mL), ciprofloxacin (0.002 to 32 µg/mL), nalidixic acid (0.016 to 256 µg/mL), 
gentamicin (0.016 to 256 µg/mL), and tetracycline (0.016 to 256 µg/mL). The gradient 
disk diffusion strips provided 29 possible MIC values for each antimicrobial drug tested. 
For each antimicrobial drug, there were 15 possible log2 dilutions on a strip (eg, 0.016 
through 256) and intermediate values between each log2 dilution. Intermediate values 
between log2 dilutions were rounded up to the higher log2 dilution during post study data 
management, as recommended by the manufacturer. Campylobacter jejuni (ATCC 
3356022) and E. coli (ATCC 25922) were used as quality control strains. Resistance 
breakpoint (MacGowan and Wise, 2001) is defined as the MIC at which a bacterial 
isolate is considered resistant to a particular antimicrobial drug. Resistance breakpoints 
used by the National Antimicrobial Resistance Monitoring System were adopted (CDC, 
2003). The resistance breakpoints were azithromycin (≥ 2 µg/mL), erythromycin (≥ 8 
µg/mL), ciprofloxacin (≥ 4 µg/mL), nalidixic acid (≥ 32 µg/mL), gentamicin(≥ 16 
µg/mL), and tetracycline (≥ 16 µg/mL). 
2.2.5 Statistical analysis 
Data regarding Campylobacter isolates, AMR, and farm management factors 
were compiled in a commercially available database software program (Microsoft 
Access, 2003, Microsoft Corp, Redmond, WA). Apparent prevalence is reported as a 
proportion with 95% exact CIs. Results of susceptibility testing are reported as MIC 
distributions and proportions of resistant and susceptible isolates according to the 
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Clinical and Laboratory Standards Institute guidelines (CLSI, 2008). Statistical analysis 
was performed by use of a commercial software package (STATA, version 10.0, 
StataCorp, College Station, TX). Logistic regression analysis was used to test the 
associations between resistant isolates for each of the 6 antimicrobial agents and 
production method (i.e., conventional or antimicrobial-free farms) (Hosmer and 
Lemeshow, 2000). At the individual animal level, a population-averaged logistic 
regression model involving a generalized model framework with a logit link and 
binomial error distribution was used to determine the potential association between the 
proportion of resistance for each of the 6 antimicrobial agents and production method 
(Dohoo et al., 2003). A generalized estimating equation involving an exchangeable 
working correlation structure and semi-robust variance estimator was used to model 
within farm dependence (Hosmer and Lemeshow, 2000; Dohoo et al., 2003). Potential 
confounding effects by herd size and season were assessed for each antimicrobial agent. 
Season was defined as winter (January through March), spring (April through June), 
summer (July through September), and fall (October through December). Herd size was 
defined as the total number of finisher pigs marketed per year. Herd size was then 
dichotomized at a cutoff of 2,000 animals. The generalized Wald test was used to test 
significance (set at a value of P < 0.05) of independent variables in the models. Potential 
confounding variables were assessed by comparison of the differences in the regression 
coefficients with and without the presence of the potential confounder in the model. If 
there was a change of 20% or more, then adjusted measures of association were reported 
(Dohoo et al., 2003). Additionally, a possible dose-dependent relationship between the 
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number of years that antimicrobial drugs were not used on antimicrobial-free farms, and 
the level of resistance to the 6 antimicrobial drugs was investigated. 
Pan-susceptible isolates were defined as those susceptible to all 6 antimicrobial 
drugs. Multidrug resistance was defined as resistance to 2 or more antimicrobial drugs. 
We assessed multidrug resistance using 2 approaches: specific and nonspecific MDR 
patterns. Nonspecific MDR was defined as resistance to any combination of ≥ 2 
antimicrobials. Specific MDR was defined as resistance to a specific combination of ≥ 2 
antimicrobials (e.g, azithromycin-erythromycin-tetracycline). 
 
2.3. Results 
2.3.1 Sampling 
Fecal samples were collected from 1,422 pigs on antimicrobial-free (n = 35) and 
conventional (60) swine farms in the Midwestern United States. The number of years 
that antimicrobial drugs were not used on farms ranged from 1 to 14, with a median of 3 
years. The mean number of pigs from farms that were considered antimicrobial-free 
production systems was 1,262 (range, 150 to 11,000; median, 800), whereas the mean 
number of pigs from conventional farms was 7,909 (range, 500 to 45,000; median, 
4,800; P < 0.001). The proportions of antimicrobial-free and conventional farms 
evaluated in each season were as follows: winter, 11 of 35 (31%) and 22 of 60 (37%) 
farms, respectively; spring, 6 of 35 (17%) and 13 of 60 (22%) farms, respectively; 
summer, 8 of 35 (23%) and 9 of 60 (15%) farms, respectively; and fall, 10 of 35 (29%) 
and 16 of 60 (27%) farms, respectively. 
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2.3.2 Apparent prevalence of Campylobacter spp. 
Culture results were positive for Campylobacter spp. for 1or more pigs on 90 of 
the 95 (94.7% [95% CI, 88.1% to 98.3%]) farms included in the study (Table 2.1). 
Among the 35 antimicrobial-free farms, 33 (94.3% [95% CI, 80.8% to 99.3%]) had 1 or 
more Campylobacter-positive samples, and among the 60 conventional farms, 57 (95.0% 
[95% CI, 86.1% to 99.0%]) had 1 or more Campylobacter-positive samples. Across all 
farms, 512 fecal samples (36.0% [95% CI, 33.5% to 38.6%]) were positive for 
Campylobacter spp. Among antimicrobial-free farms, 190 of 522 (36.4% [95% CI, 
32.3% to 40.7%]) samples were positive for Campylobacter spp. Among conventional 
farms, 322 of 900 (35.8% [95% CI, 32.6% to 39.0%]) isolates were Campylobacter spp. 
The herd-level and individual animal–level apparent prevalences were not significantly 
different between antimicrobial-free and conventional farms. In addition, herd size was 
not associated with apparent prevalence. The m-PCR assay was performed on 427 of the 
512 isolates, and they were identified as C. coli (n = 426 [99.6%]) and C. jejuni (1 
[0.4%]). 
2.3.2 Antimicrobial susceptibility 
Of the 512 Campylobacter spp. isolates, 464 (90.6%) were available for 
antimicrobial susceptibility testing; these isolates were obtained from 30 of 33 (90.9%) 
antimicrobial-free farms and 55 of 57 (96.5%) conventional farms that had ≥ 1 pig with 
positive culture results. Forty-eight (9.4%) samples across all samples were not 
recoverable after storage at –70°C; the unrecoverable samples included 16 of 190 (8.4%) 
samples collected from antimicrobial-free farms and 32 of 322 (9.9%) samples collected.
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Table 2.1. Animal- and herd-level apparent prevalence of Campylobacter isolates from 1,422 fecal samples obtained from 
35 antimicrobial-free and 60 conventional swine farms in the Midwestern United States. 
 
  
 Level Farm type 
No. of 
Campylobacter 
isolates/total No. 
of samples 
Percentage of 
Campylobacter 
isolates (95% CI) Median Range 
Odds ratio * 
(95% CI) P value† 
 Conv 322/900 35.8 (32.6-39.0) 5 0-12 
Animal  ABF 190/522 36.4 (32.3-40.7) 6 0-13 
  Total 512/1,422 36.0 (33.5-38.6) 5 0-12 
0.99 (0.91-
1.09) 0.92 
 Conv 57/60 95.0 (86.1-99.0) NE NE 
Herd  ABF 33/35 94.3 (80.8-99.3) NE NE 
  Total 90/95 94.7 (88.1-98.3) NE NE 
1.15 (0.18-
7.25) 0.88 
 
*Odds ratios were calculating by use of a population-averaged model (general estimating equations). †A value of P≤0.05 
was considered significant. 
ABF = Antimicrobial-free farm. Conv = Conventional farm. NE = Not estimable. CI = Confidence interval.
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from conventional farms. Five (3/33 [9.1%] antimicrobial-free farms and 2/55 [3.6%] 
conventional) farms on which Campylobacter spp. were isolated from at least 1 pig had 
at least 1 sample that was not available for susceptibility testing. 
 At the farm level, the proportion of farms with 1 or more Campylobacter isolate 
resistant to azithromycin or to erythromycin was significantly (P < 0.001) higher for 
conventional farms, compared with antimicrobial-free farms (Table 2.2). The number of 
herds with at least 1 ciprofloxacin-or nalidixic acid–resistant isolate was higher for 
antimicrobial-free farms, compared with conventional farms.  Conversely, the individual 
animal apparent prevalence of resistance to ciprofloxacin or nalidixic acid was greater on 
conventional farms (Table 2.3). 
 The distributions of MICs were bimodal for azithromycin, erythromycin, 
ciprofloxacin, and nalidixic acid (Table 2.4). The distribution of MICs for tetracycline 
was almost uniform across the various dilutions. Across farm type, significantly more 
Campylobacter isolates had a higher apparent prevalence of resistance to azithromycin, 
erythromycin, or tetracycline on conventional farms, compared with findings on 
antimicrobial-free farms (P < 0.001). For the macrolide antimicrobials erythromycin and 
azithromycin, the MIC50 value for each drug was 256 µg/mL for isolates obtained from 
conventional farms; for isolates obtained from antimicrobial-free farms, the MIC50 for 
azithromycin and erythromycin was 0.5 and 2 µg/mL, respectively. The MIC50 values for 
ciprofloxacin and nalidixic acid did not differ significantly between the two production 
systems, and none of the 464 isolates were resistant to gentamicin. 
  
47
 
Table 2.2. Herd-level apparent prevalence of resistance to 6 antimicrobial agents in 464 Campylobacter isolates from 30 
antimicrobial-free and 55 conventional swine farms in the Midwestern United States. 
 
Farm Odds ratio* 
Antimicrobial 
drug 
type 
No. of farms 
with ≥ 1 
resistant 
isolate/total No. 
of farms 
Percentage of 
farms with ≥ 1 
resistant isolate 
(95% CI) (95% CI) P value† 
Azithromycin Conv 52/55 94.5 (84.9-98.9)   
 ABF 14/30 46.7 (28.3-65.7) 0.05 (0.01-0.20) < 0.001 
Erythromycin Conv 52/55 94.5 (84.9-98.9)   
 ABF 15/30 50.0 (31.3-68.7) 0.06 (0.02-0.23) < 0.001 
Ciprofloxacin Conv 1/55 1.8 (0.05-9.7)   
 ABF 4/30 13.3 (3.8-30.7) 8.31 (0.88-78.09) 0.06 
Nalidixic acid Conv 3/55 5.5 (1.1-15.1)   
 ABF 4/30 13.3 (3.8-30.7) 2.67 (0.56-12.81) 0.22 
Gentamicin Conv 0/55 0 (0-6.5) ‡   
 ABF 0/30 0 (0-11.6) ‡ NE§ NE 
Tetracycline Conv 50/55 90.9 (80.0-97.0)   
 ABF 25/30 83.3 (65.3-94.4) 0.5 (0.13-1.89) 0.31 
Conventional farms were the reference level. 
‡One-sided 97.5% confidence interval. 
§No farms had detectable Campylobacter isolates that were resistant to gentamicin and a measure of association was 
not estimable (NE). 
See Table 2.1 for remainder of key. 
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Table 2.3. Prevalence of resistance of 6 antimicrobial agents and MIC (50% and 90%) of 464 Campylobacter 
isolates from 30 antimicrobial-free and 55 conventional swine farms. 
Odds Ratio Antimicrobial 
drug 
Farm 
type 
No. of resistant 
isolates/total 
No. of isolates 
Percentage of 
resistant isolates 
(95% CI) MIC50 MIC90 (95% CI) P value 
Azithromycin Conv 200/290 69.0 (63.3-74.3) 256 256   
 ABF 35/174 20.1 (14.4-26.8) 0.5 256 
0.16  
(0.07-0.38)** <0.001 
Erythromycin Conv 198/290 68.3 (62.6-73.6) 256 256   
 ABF 37/174 21.3 (15.4-28.1) 2 256 
0.16  
(0.07 -0.37)** <0.001 
Ciprofloxacin Conv 11/290 3.8 (1.9-6.7) 0.125 0.25   
 ABF 6/174 3.4 (1.3-7.4) 0.125 0.25 
0.91  
(0.09-8.74)& 0.93 
Nalidixic Acid Conv 13/290 4.5 (2.4-7.5) 4 8   
 ABF 6/174 3.4 (1.3-7.4) 4 8 
0.94  
(0.16 – 5.63) 0.94 
Gentamicin Conv 0/290 0 (0-1.3)* 1 1   
 ABF 0/174 0 (0-2.1)* 1 1 NE† NE† 
Tetracycline Conv 216/290 74.5 (69.1-79.4) 64 256   
  ABF 85/174 48.8 (41.2-56.5) 8 256 
0.17  
(0.06 – 0.50)** <0.001 
Conventional farms were the reference level. Odds ratios were adjusted for confounding by herd size. 
*One sided 97.5% CI  
See Table 2.1 for remainder of key.  
 
  
49
 
 
 
Table 2.4. Results of antimicrobial susceptibility testing of 464 Campylobacter isolates obtained from fecal samples 
from finisher pigs on 35 antimicrobial-free and 60 conventional swine farms in the Midwestern United States. 
Antimicrobial 
drug 
MIC 
(µg/mL) 
ABF 
(No. [%] of 
isolates) 
Conv 
(No. [%] of 
isolates) 
 
Antimicrobial 
drug 
MIC 
(µg/mL) 
ABF 
(No. [%] of 
isolates) 
Conv 
(No. [%] of 
isolates) 
Azithromycin ≤ 0.016 0 (0.0) 0 (0.0)  Nalidixic Acid ≤ 0.016 0 (0.0) 0 (0.0) 
 
0.03 0 (0.0) 0 (0.0) 
  
0.03 0 (0.0) 0 (0.0) 
 
0.064 1 (0.6) 4 (1.4) 
  
0.064 0 (0.0) 0 (0.0) 
 
0.125 34 (19.5) 7 (2.4) 
  
0.125 0 (0.0) 0 (0.0) 
 
0.25 39 (22.4) 39 (13.5) 
  
0.25 0 (0.0) 0 (0.0) 
 
0.5 38 (21.8) 31 (10.7) 
  
0.5 0 (0.0) 0 (0.0) 
 
1 27 (15.5) 9 (3.1) 
  
1 13 (7.5) 10 (3.5) 
Breakpoint, ≥2 
µg/mL 2 2 (1.2) 2 (0.7)   2 71 (40.8) 123 (42.4) 
 
4 0 (0.0) 0 (0.0) 
  
4 71 (40.8) 115 (39.7) 
 
8 0 (0.0) 0 (0.0) 
  
8 12 (6.9) 27 (9.3) 
 
16 0 (0.0) 0 (0.0) 
  
16 1 (0.6) 2 (0.7) 
 
32 0 (0.0) 0 (0.0) 
 
Breakpoint, ≥ 
32 µg/mL 32 0 (0.0)  2 (0.7) 
 
64 0 (0.0) 0 (0.0) 
  
64 0 (0.0) 0 (0.0) 
 
128 0 (0.0) 0 (0.0) 
  
128 2 (1.2) 0 (0.0) 
 
≥256 33 (19.0) 198 (68.3) 
  
≥256 4 (2.3) 11 (3.8) 
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Table 2.4 (continued)        
Antimicrobial 
drug 
MIC 
(µg/mL) 
ABF 
(No. [%] of 
isolates) 
Conv 
(No. [%] of 
isolates)  
Antimicrobial 
drug 
MIC 
(µg/mL) 
ABF 
(No. [%] of 
isolates) 
Conv 
 (No. [%] of 
isolates) 
Erythromycin ≤ 0.016 0 (0.0) 0 (0.0)  Gentamicin ≤ 0.016 0 (0.0) 0 (0.0) 
 
0.03 0 (0.0) 0 (0.0) 
  
0.03 0 (0.0) 0 (0.0) 
 
0.064 0 (0.0) 0 (0.0) 
  
0.064 0 (0.0) 0 (0.0) 
 
0.125 0 (0.0) 0 (0.0) 
  
0.125 0 (0.0) 0 (0.0) 
 
0.25 2 (1.2) 1 (0.3) 
  
0.25 1 (0.6) 8 (2.8) 
 
0.5 8 (4.6) 7 (2.4) 
  
0.5 76 (43.7) 118 (40.7) 
 
1 40 (22.9) 21 (7.2) 
  
1 153 (52.3) 153 (52.8) 
 
2 57 (32.8) 41 (14.1) 
  
2 5 (2.9) 10 (3.5) 
 
4 30 (17.2) 22 (7.6) 
  
4 1 (0.6) 0 (0.0) 
Breakpoint, ≥ 8 
µg/mL 8 4 (2.3) 3 (1.0)   8 0 (0.0) 1 (0.3) 
 
16 0 (0.0) 0 (0.0) 
 
Breakpoint, ≥ 
16 µg/mL 16 0 (0.0) 0 (0.0) 
 
32 0 (0.0) 1 (0.3) 
  
32 0 (0.0) 0 (0.0) 
 
64 1 (0.6) 1 (0.3) 
  
64 0 (0.0) 0 (0.0) 
 
128 0 (0.0) 0 (0.0) 
  
128 0 (0.0) 0 (0.0) 
 
≥256 32 (18.4) 193 (66.6) 
  
≥256 0 (0.0) 0 (0.0) 
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Table 2.4 (continued)        
Antimicrobial 
drug 
MIC 
(µg/mL) 
ABF 
(No. [%] of 
isolates) 
Conv 
(No. [%] of 
isolates)  
Antimicrobial 
drug 
MIC 
(µg/mL) 
ABF 
(No. [%] of 
isolates) 
Conv 
(No. [%] of 
isolates) 
Ciprofloxacin ≤ 0.016 1 (0.6*) 3 (1*)  Tetracycline ≤ 0.016 0 (0.0) 0 (0.0) 
 
 
0.03 5 (2.9) 25 (8.6) 
  
0.03 1 (0.6) 0 (0.0) 
 
0.064 45 (25.9) 82 (28.3) 
  
0.064 2 (1.2) 1 (0.3) 
 
0.125 77 (44.3) 111 (38.3) 
  
0.125 12 (6.9) 3 (1) 
 
0.25 33 (19.0) 50 (17.2) 
  
0.25 18 (10.3) 2 (0.7) 
 
0.5 7 (4.0) 7 (2.4) 
  
0.5 26 (14.9) 7 (2.4) 
 
1 0 (0.0) 1 (0.3) 
  
1 8 (4.6) 7 (2.4) 
 
2 0 (0.0) 0 (0.0) 
  
2 6 (3.5) 16 (5.5) 
Breakpoint, ≥ 4 
µg/mL 4 0 (0.0) 0 (0.0)   4 7 (4.0) 19 (6.6) 
 
8 0 (0.0) 0 (0.0) 
  
8 9 (5.2) 19 (6.6) 
 
16 0 (0.0) 0 (0.0) 
 
Breakpoint, ≥ 
16 µg/mL 16 8 (4.6) 21 (7.2) 
 
32 6 (3.5) 11 (3.8) 
  
32 19 (10.9) 40 (13.8) 
 
   
  
64 15 (8.6) 29 (10.0) 
 
   
  
128 13 (7.5) 27 (9.3) 
 
   
   
≥256 30 (17.2) 99 (34.1) 
 
   
 
ABF=Antimicrobial-free farms. Conv=Conventional 
farms. 
 
   
 
*Dilution’s for ciprofloxacin ranged from 0.02-32µg/mL; 
all samples tested at dilutions ≤ 0.016 µg/mL were 
combined. 
  
52 
Inclusion of season as a potential confounder in the statistical model did not 
change the association between production system and AMR. Inclusion of herd size in 
the model changed the overall effect of production method (conventional and 
antimicrobial free) on AMR prevalence by more than 20%; therefore, herd size was 
considered a confounder. To account for the confounding effect of herd size on the 
model, herd size was forced into each model for all 6 antimicrobial drugs.  In addition, 
herd size was added to the models investigating nonspecific and specific resistance 
patterns. However, there was no significant interaction between herd size and production 
system type.  In the present study, nondifferential misclassification was unlikely since 
the culture and MIC methods were equivalent for antimicrobial-free and conventional 
farms. In either case, the effects of nondifferential misclassification would likely bias the 
estimates of association in this study toward a null (a more conservative P value). 
As the number of years that an antimicrobial-free production scheme was 
implemented on a farm increased, there was a significant (P = 0.002 for the first 2 years 
then P < 0.001 for years 3 to 15) and consistent decrease by year in the proportion of 
isolates that were resistant to azithromycin or erythromycin (Table 2.5). Resistance to 
tetracycline did not decrease consistently as the duration of antimicrobial-free 
production increased, but after 3 years, the number of resistant strains was significantly 
(P < 0.001) less, compared with the number of resistant strains on conventional farms. 
On antimicrobial-free farms on which antimicrobial drugs had not been used for 6 or 
more years, the apparent prevalence of resistance to tetracycline was 40% less than that 
of conventional farms; the apparent prevalences of resistance to azithromycin and 
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erythromycin were each 83% less than that of conventional farms. 
Ten specific resistance patterns to 2 or more of 5 antimicrobial drugs were 
identified (none of the isolates were resistant to gentamicin; Table 2.6). The most 
common pattern was resistance to azithromycin, erythromycin, and tetracycline, which 
was significantly (P< 0.001) higher on conventional farms than on antimicrobial-free 
farms. The proportion of pan-susceptible isolates was higher on antimicrobial-free farms 
(42.5% [95% CI, 35.1% to 49.0%]), compared with the proportion on conventional 
farms (7.9% [95% CI, 4.8% to 11.1%]; Figure 2.1). Across both production systems, 
one isolate was resistant to 4 (azithromycin, erythromycin, nalidixic acid, and 
tetracycline) antimicrobial drugs, and one isolate was resistant to 5 (azithromycin, 
erythromycin, nalidixic acid, tetracycline, and ciprofloxacin) antimicrobial drugs. 
 
2.4. Discussion 
In the present cross-sectional study, Campylobacter spp. were isolated from 
approximately a third of samples collected on both conventional and antimicrobial-free 
swine farms. This is within the previously reported range of Campylobacter spp. 
apparent prevalence among finishing pigs (16% to 100%) (Harvey et al., 1999; Payot et 
al., 2004b; Gebreyes et al., 2005) including findings of one study (Thakur and Gebreyes, 
2005) that compared prevalence in antimicrobial-free and conventional production 
systems (53% and 55.8%, respectively). A similar study (Sato et al., 2004a) in cows also 
did not identify a significant difference in prevalence between the two production 
systems. Often, shedding of pathogens is greater in larger herds (Fossler et al., 2005); 
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however, in our study, Campylobacter spp. apparent prevalence was not associated with 
herd size. In addition, 95% of all farms had at least one Campylobacter-positive pig, 
which suggests that Campylobacter spp. are widespread. The results of the present study 
further emphasize that pigs are common reservoirs for Campylobacter spp., regardless of 
production system and herd size. 
At the farm level, resistance of Campylobacter spp. to azithromycin or 
erythromycin for one or more individual pigs/farm was detected on most of the 
conventional farms, yet resistance to each of these macrolides was detected on 
approximately half as many antimicrobial-free farms. The lack of recent exposure to 
macrolides may have contributed to the lower number of antimicrobial-free farms with 
resistance to macrolides because of a reduction in selective pressure. Resistance to 
macrolides may confer a fitness cost (a decrease in the ability of a bacterium to compete 
with other bacteria in the environment) that would cause bacteria that acquire additional 
resistance genes to become less fit (Andersson, 2003). Tetracycline resistance was 
evident on almost all conventional and antimicrobial-free farms (7% difference). This 
may result from mutations that confer resistance without reducing the fitness of the 
bacteria, or from environmental persistence of plasmid-mediated resistance genes 
associated with Campylobacter spp. resistance to tetracycline (Andersson, 2003; Jindal 
et al., 2006). Resistance to ciprofloxacin or nalidixic acid was rare and was evident on 
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Table 2.5 Effect of years of antimicrobial-free production on prevalence of antimicrobial resistance among 
Campylobacter isolates from 30 antimicrobial-free and 55 conventional Midwestern swine farms. Three antimicrobials 
(ciprofloxacin, nalidixic acid, and gentamicin) did not have enough observations to calculate odds ratios. 
Antimicrobial 
drug 
Farm type and 
years 
antimicrobial-free 
No. of 
resistant 
isolates / total 
No. of isolates 
No. of 
farms 
Percentage of 
resistant 
isolates  
(95% CI) 
Odds ratio 
(95% CI) P value 
Azithromycin Conv 200/290 55 69.0 (63.6-74.3)   
 ABF (1-2 y) 11/29 7 37.9 (20.7-57.7) 0.23 (0.09-0.57) 0.002 
 ABF (3 y) 12/55 9 21.8 (11.8-35.0) 0.09 (0.03-0.28) < 0.001 
 ABF (4-5 y) 7/47 8 14.9 (6.2-28.3) 0.06 (0.02-0.22) < 0.001 
 ABF (≥ 6 y) 5/43 6 11.6 (3.9-25.1) 0.04 (0.01-0.17) < 0.001 
Erythromycin Conv 198/290 55 68.3 (62.7-73.6)   
 ABF (1-2 y) 11/29 7 37.9 (20.7-57.7) 0.25 (0.10-0.61) 0.002 
 ABF (3 y) 12/55 9 21.8 (11.8-35.0) 0.11(0.04-0.31) < 0.001 
 ABF (4-5 y) 8/47 8 17.0 (7.6-30.8) 0.07 (0.02-0.23) < 0.001 
 ABF (≥ 6 y) 6/43 6 14.0 (5.3-27.9) 0.06 (0.02-0.21) < 0.001 
Tetracycline Conv 216/290 55 74.5 (69.1-79.4)   
 ABF (1-2 y) 17/29 7 58.6 (30.9-76.5) 0.47 (0.16-1.36) 0.164 
 ABF (3 y) 34/55 9 61.8 (47.7-74.6) 0.58 (0.22-1.53) 0.272 
 ABF (4-5 y) 15/47 8 31.9 (19.1-47.1) 0.17 (0.07-0.39) < 0.001 
 ABF (≥ 6 y) 19/43 6 44.2 (29.1-60.1) 0.24 (0.12-0.52) < 0.001 
Odds ratios were adjusted for confounding by herd size. 
See Table 2.1 for remainder of key. 
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Table 2.6 Specific patterns of resistance among 464 Campylobacter isolates recovered from finisher pigs on 35 
antimicrobial-free and 60 conventional Midwestern swine farms. 
Antimicrobial drug 
combination 
Farm 
Type 
No. of resistant 
isolates/total No. of 
isolates 
Percentage of 
resistant isolates 
(95% CI) 
Odds ratio 
(95% CI) P value 
None Conv 23/290 7.9 (5.1-11.7)   
 ABF 74/174 42.5 (35.1-50.2) 10.60 (2.15-52.12) 0.004 
Azithromycin-erythromycin Conv 37/290 12.8 (9.1-17.2)   
 ABF 12/174 6.9 (3.6-11.7) 1.07(0.37-3.09) 0.9 
Ciprofloxacin-nalidixic acid Conv 10/290 3.4 (1.7-6.2)   
 ABF 2/174 1.1 (-0.1-4.1) 0.81 (0.16-4.06) 0.8 
Azithromycin-erythromycin-
tetracycline Conv 157/290 54.1 (48.2-60.0)   
 ABF 21/174 12.1 (7.6-17.8) 0.13(0.05-0.32) < 0.001 
Conventional farms were the reference level. Odds ratios were adjusted for confounding by herd size. 
See Table 2.1 for key. 
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Figure 2.1. Nonspecific MDR among 464 Campylobacter isolates from 35 antimicrobial-free (black bars) 
and 60 conventional (white bars) swine farms. 
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more antimicrobial-free than conventional farms; this may have resulted from 
unidentified mechanisms, possibly including adaptation of resistant strains or the 
presence of efflux pumps (Luo et al., 2005). These efflux pumps limit access of 
antimicrobial drugs to their targets by actively pumping out these molecules (Kohler et 
al., 1999). 
At the animal level, the highest apparent prevalences of AMR were to 
erythromycin, azithromycin, and tetracycline. This finding was similar to the results of 
other studies (Payot et al., 2004b; Thakur and Gebreyes, 2005). Resistances to the 
macrolide antimicrobial drugs (azithromycin and erythromycin) were approximately 
70% higher on conventional than antimicrobial-free farms. In addition, conventional 
farms had a higher proportion of isolates resistant to high concentrations of macrolides 
(MIC ≥ 256 µg/mL). One explanation for the high prevalence of macrolide resistance 
may be the use of tylosin, a macrolide, which is approved for use for growth promotion 
and therapeutic purposes in swine (Lin et al., 2007; Zhang and Plummer, 2008). 
Antimicrobial-free farms that lack exposure to macrolides might be expected to 
eliminate the high concentration–resistant strains first. 
The high level of erythromycin and azithromycin resistance on conventional 
farms is of concern because erythromycin and azithromycin are currently the most 
common antimicrobial treatments for Campylobacter infections in humans (Guerrant et 
al., 2001; Gilbert et al., 2007). Erythromycin and azithromycin resistances result from a 
chromosomal mutation of the ribosome 23S rRNA genes or genes encoding ribosomal 
proteins L4 and L22, not from horizontally acquired genes from other bacteria (Engberg 
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et al., 2001; Zhang and Plummer, 2008). Erythromycin and azithromycin resistances are 
rare in C. jejuni but common among C. coli strains, particularly among isolates from 
pigs and pig offal (Moore et al., 2006). The higher prevalence of resistance to 
erythromycin in pigs has not been fully explained; however, Engberg et al (Engberg et 
al., 2001) suggest this may be due to a generally higher frequency of mutations 
conferring resistance among C. coli, or due to greater selective pressure resulting from 
prior use of antimicrobial agents.  In addition, C. coli also has an efflux pump system 
that contributes to acquired resistance to macrolides (Gibreel et al., 2007). 
The antimicrobial drug with the highest apparent prevalence of resistance on 
antimicrobial-free and conventional farms was tetracycline (49% and 75%, respectively). 
The high apparent prevalence of tetracycline resistance is most likely due to the presence 
of the genetic determinant tet(O) on transferable plasmids that prevent tetracycline from 
binding to the ribosome, as well as the presence of efflux pumps (Pumbwe and Piddock, 
2002; Dasti et al., 2007). The most common mechanism involves the plasmid encoded 
tet(O) gene, which produces a ribosomal protection protein that confers resistance by 
preventing tetracycline from binding to the ribosome (Moore et al., 2005; Dasti et al., 
2007). Tet(O) is commonly found in a variety of bacteria in farming environments 
(Jindal et al., 2006) and in pig samples, regardless of prior antimicrobial usage (Aminov 
et al., 2001). Comparison of C. jejuni and C. coli isolates derived from humans (Dasti et 
al., 2007) established that all tet(O) genes among C. coli were chromosomally related, 
rather than carried by plasmids as is the case for C. jejuni.  If tet(O) genes are 
chromosomally related among C. coli derived from swine, then this is an important 
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distinction that should be further investigated in food animals, because C. coli is the 
predominant subspecies in swine. Also if tet(O) genes are chromosomally related in C. 
coli derived from swine, this may then explain epidemiological differences between 
swine and other food animals. In addition to transferable plasmids, the multidrug efflux 
pump CmeABC contributes to intrinsic and acquired resistance (Lin et al., 2002; Gibreel 
et al., 2007). The multiple and complex resistance mechanisms of tetracycline are a 
likely explanation for the high proportion of resistant isolates and the broad 
characteristic MIC values observed for tetracycline. 
The present and previous studies (Thakur and Gebreyes, 2005; Price et al., 2007) 
have identified resistance of Campylobacter spp. to ciprofloxacin in both conventional 
and antimicrobial-free farming systems in North America. The presence of 
fluoroquinolone resistance in both production systems is of particular concern because 
this class of drugs was not approved for use in swine production at the time of our study 
(van den Bogaard and Stobberingh, 2000). In addition, in a study (Luo et al., 2003) of 
chickens, fluoroquinolone-resistant Campylobacter spp. colonized and persisted in 
chickens as efficiently as susceptible strains in the absence of fluoroquinolone 
antimicrobials. The gyrA and parC genes are responsible for production of DNA gyrase 
and toposiomerase IV, the proteins that are targets for fluoroquinolones. Campylobacter 
spp. do not produce toposiomerase; hence a single mutation in gyrA gene can cause a 
high level of resistance to fluoroquinolones (≥ 32 µg/mL) (Luo et al., 2003; Ge et al., 
2005). Furthermore, the most frequently reported mechanism of resistance to 
fluoroquinolones is the target mutation of the gyrA gene; at least 4 unique point 
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mutations in the gyrA gene of the fluoroquinolone-resistant mutants, resulting in high 
and intermediate levels of resistance of Campylobacter spp. to the fluoroquinolones, 
have been reported (Payot et al., 2006; Zhang and Plummer, 2008). In addition, the 
CmeABC efflux pump is associated with fluoroquinolone resistance in Campylobacter 
spp. (Luo et al., 2003; Fabrega et al., 2008). In the present study, isolates resistant to 
ciprofloxacin and nalidixic acid were distributed between 4 antimicrobial-free farms and 
one conventional farm that, combined, had 11 pigs with ciprofloxacin-resistant 
Campylobacter spp. Hence, ciprofloxacin resistance among Campylobacter spp. appears 
to be present only on certain farms. Furthermore, it is unknown how long ciprofloxacin-
resistant Campylobacter organisms have been present on the antimicrobial-free farms in 
our study.  In poultry, resistance of Campylobacter spp. to fluoroquinolones persisted for 
at least 4 years after cessation of antimicrobial usage (Pedersen and Wedderkopp, 2003). 
In our study, the data are insufficient to make inferences regarding exposure and 
resistance. Further studies should concentrate on examination of risk factors that might 
be expected to promote the presence or persistence of ciprofloxacin resistance on swine 
farms. 
An apparent dose-response effect was observed for the duration of antimicrobial-
free production (1 to 14 years). The gradual wane in azithromycin and erythromycin 
resistances over time was expected because their resistance mechanisms have a 
chromosomal linkage and would only be transmitted vertically. Following mutation, 
there is often a fitness deficit of the bacteria conferred by resistance (Zhang et al., 2006); 
therefore, susceptible strains may become more predominant over time in the absence of 
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antimicrobial pressure. However, in our study, tetracycline resistance had a threshold 
decline after 3 years, or in other words, tetracycline resistance did not decline until a 
farm was antimicrobial free for 3 or more years. The large variety of mechanisms of 
tetracycline resistance among Campylobacter spp. isolates may explain why there was 
only a 40% decrease in tetracycline resistance on farms that were antimicrobial free for ≥ 
6 years, compared with findings on conventional farms; in contrast, an 80% decrease in 
erythromycin resistance and an 83% decrease in azithromycin resistance was detected 
between those farm types. Ciprofloxacin and nalidixic acid did not have a sufficient 
number of resistant isolates to detect a pattern. 
Considering the predominant mechanism of resistance for each antimicrobial 
tested, the resistance patterns detected in the present study were expected. However, we 
compared 2 production methods at a single point in time, so the assumption was made 
that antimicrobial-free farms had AMR prevalences similar to those on conventional 
farms prior to the cessation of antimicrobial use. Although caution is needed in making 
inferences about a true dose effect, these patterns can serve to generate hypotheses 
regarding why resistance to some antimicrobials but not to others appears to change over 
time. 
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 Multidrug resistance was common in the present study. In 3 other studies, (Payot 
et al., 2004b; Gebreyes et al., 2005; Thakur and Gebreyes, 2005) the most common 
MDR in C. coli in pigs was the combination of erythromycin, nalidixic acid, and 
tetracycline. In our study, this combination was also present on conventional farms 
(0.34% of total MDR combinations). Two isolates were resistant to 4 or 5 antimicrobial 
agents, including erythromycin, ciprofloxacin, and tetracycline, which may be used to 
treat human infections. Multidrug resistance in Campylobacter spp. is most commonly 
due to the presence of multidrug efflux pumps, which contribute to the intrinsic 
resistance of Campylobacter spp. to a broad range of structurally unrelated antimicrobial 
agents (Lin et al., 2002; Payot et al., 2004b; Moore et al., 2006). As previously noted, 
resistances of Campylobacter spp. to fluoroquinolones and macrolides result from 
mutations of the gyrA or 23S rRNA gene, respectively. 
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In a recent review, Payot et al (Payot et al., 2006) concluded that the CmeABC efflux 
system works synergistically with these mutations to confer high-level resistance to 
fluoroquinolones and macrolides. However, in the present study, only 2 of 17 (11.8%) 
Campylobacter isolates that were resistant to fluoroquinolones were also resistant to 
erythromycin or azithromycin. At present, the mechanisms of MDR in Campylobacter 
spp. are still incompletely understood; however, it appears that the role of efflux pumps 
should be a focus of further research in this area. 
Campylobacteriosis in humans is primarily associated with consumption of food 
animal products (Jacobs-Reitsma et al., 2008). Intuitively, removal of antimicrobials 
from a production system should decrease AMR. In the study reported here, decreased 
AMR to erythromycin, azithromycin, and tetracycline was observed on antimicrobial-
free farms. However, one issue with cross-sectional studies is that the rate of decrease in 
resistance cannot be directly quantified. In our study, the assumption was made that prior 
to cessation of antimicrobial use on antimicrobial-free farms, the proportions of 
Campylobacter spp. resistant to the antimicrobials tested were the same as the 
proportions on conventional farms. The cessation of antimicrobial use is a major 
production change, the benefits of which have yet to be fully examined. The changes in 
risk factors associated with this production change may inherently affect the outcome.  
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For example, antimicrobial-free farms are typically small and may use different 
management procedures that may affect risk factors differently than on conventional 
farms. Results of the present study suggest that AMR is greater on conventional farms; 
long-term prospective studies are indicated to examine whether these differences persist, 
and to compare specific risk factors in conventional farming environments with 
antimicrobial-free farms that lack antimicrobial selection pressure. 
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3. USING DISCRETE TIME SURVIVAL ANALYSIS TO MODEL THE 
DISTRIBUTION OF MINIMUM INHIBITORY CONCENTRATIONS OF 
ANTIMICROBIAL DRUGS IN Campylobacter SPP. AND Escherichia coli 
ISOLATED FROM FECES OF ANTIMICROBIAL-FREE AND 
CONVENTIONALLY RAISED SWINE 
 
3.1. Introduction 
  Although contentious, it is argued that antimicrobial-resistant bacteria from food 
animals is a major public health concern (Chiller et al., 2004; Jensen et al., 2004; Karp 
and Engberg, 2004; Phillips et al., 2004). These arguments have led to suggestions to 
reduce the number and uses of antimicrobial drugs in food animal medicine (Wierup, 
2001; Emborg et al., 2003; Grave et al., 2006; FDA, 2000, 2003). The discussions about 
antimicrobial drug use and its potential negative impact on public health have also 
prompted some producers and producer groups to voluntarily eliminate antimicrobial 
drug use in their food animal production systems. The idea behind ceasing antimicrobial 
drug use is that it will reduce the levels of antimicrobial resistance in bacteria isolated 
from animals reared without antimicrobial drug use as compared to animals raised in a 
production system where drugs are used for prevention and therapeutic uses.
 
 
A number of cross-sectional or have been used to compare the proportions of 
antimicrobial resistance among Campylobacter spp., Salmonella, and Escherichia coli 
isolated from food animal populations reared with and without antimicrobial drug use 
(Mathew et al., 2001; Englen et al., 2005; Gebreyes et al., 2005; Halbert et al., 2006; 
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Ray et al., 2006; Bunner et al., 2007; Rollo et al., 2010). In most of these studies, the 
cessation of antimicrobial drug use reduced the proportion of bacteria resistant to some 
antimicrobial drugs while it seemed to have little effect on resistance to other 
antimicrobial drugs.
 
  
Using microbiological breakpoints to dichotomize bacteria into susceptible and 
resistant categories may limit researchers’ ability to compare susceptibility among 
bacteria isolated from animals reared under different production systems; particularly if 
none or very few of the bacteria have MIC values above the breakpoint (i.e., are 
classified as resistant). An alternative to comparing the proportions in two or more 
populations is to compare the distribution of MIC values in these populations. However, 
comparison of MIC distributions is inherently more complicated than comparing two 
proportions. First, MIC data are grouped in discrete categories (i.e., dilutions), and the 
distribution of MIC values may be right- or left-censored. Furthermore, the number of 
categories varies depending on the type of susceptibility test used. Using Etest®, there 
typically are 15 categories; however, for other methods such as microbroth dilution, 
there may be varying but smaller numbers (typically, two to six categories), increasing 
the probability of censored data. Some researchers have used survival analysis to model 
MIC distribution data (Ray et al., 2006; Stegeman et al., 2006; Pol and Ruegg, 2007). 
Survival analysis data consists of time to event measurements (i.e., event: yes or no; and, 
time under observation). In this case, the highest dilution or concentration of 
antimicrobial at which growth is exhibited for the particular isolate is the yes/no 
outcome and the intervals from the lowest dilution up to the MIC value recorded for an 
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isolate are the ‘time’ to the event. Because of the potential for a large number of ties and 
censored data, discrete-time survival analysis model (DTSA) is particularly well-suited 
to modeling MIC data. 
  Using microbiological breakpoints to dichotomize bacteria into susceptible and 
resistant categories also makes assumptions as to what the appropriate breakpoint is. An 
antibiotic breakpoint is an MIC that divides bacteria isolates into categories: susceptible, 
intermediate, and resistant. The definition of susceptible is the antimicrobial drug 
treatment is associated with a high likelihood of therapeutic success. Intermediate is 
associated with an uncertain therapeutic success, and resistant is associated with a higher 
than expected likelihood of therapeutic failure (Kahlmeter et al., 2003). The minimum 
inhibitory concentration determined in vitro is associated with the concentration of an 
antimicrobial that would effectively inhibit or kill the bacteria within the host at a 
species’ anatomic level (Lorian, 2005). Clinically, breakpoints divide a population of 
bacterial isolates into those that are likely to be susceptible to treatment and those that 
are likely to be resistant to treatment. From a bacterial perspective, it would be useful to 
define the dilution in the distribution at which the bacterial population is divided into 
those that have resistance genes that cause them to differ from the wild-type bacteria 
(MacGowan and Wise, 2005). This has been referred to as the ‘epidemiologic’ 
breakpoint, although these breakpoints have been defined for only a few bacterial 
species (Lorian, 2005). If breakpoints are too conservative, borderline susceptible 
bacteria may be considered fully susceptible (Dalhoff et al., 2009). Several agencies 
including the European committee on antimicrobial susceptibility testing, (EUCAST), in 
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Europe or CLSI in North America determine breakpoints by either probabilistic methods 
or by deterministic methods. The new probabilistic approach may be favored because the 
pharmacokinetic and microbiologic variables are determined in addition to data from a 
large number of MIC/drug exposure scenarios (Dalhoff et al., 2009); however, this 
method is not currently utilized by CLSI. By using the entire MIC distribution as an 
outcome measure as well as the drug exposure distribution, the assumptions that are 
inherent in using a breakpoint are conveniently eliminated and comparisons across the 
years are facilitated. 
  The frequency distribution of resistance MICs among a group of bacterial 
isolates will not necessarily be normal. The distribution can be right or left censored, and 
often there will be a spike in the highest MIC category because some isolates will 
continue to grow at the highest dilution of the test; however, these will be grouped into 
the highest dilution despite being ‘right-censored’ (indeterminate MIC). In addition, the 
distribution is not truly continuous because the values are grouped into discrete intervals 
(i.e., dilutions). 
The objective of this study was to introduce a statistical model that accounts for 
censoring and uses discrete time series (Ananth and Kleinbaum, 1997) to compare MIC 
distributions of E. coli and Campylobacter spp. isolated from antimicrobial-free and 
conventional swine farms in the Midwest. 
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3.2. Materials and Methods 
3.2.1 Study design, collection and testing of samples 
The study included data collected from 95 swine farms in the Midwestern United 
States.  Sixty farms used conventional production methods and 35 farms were managed 
as antimicrobial-free farms. The antimicrobial-free farms, by definition, had not used 
antimicrobials for at least one year prior to being included in the study. Descriptive 
results regarding AMR levels and patterns in Campylobacter and in E. coli from this 
study have been reported elsewhere (Bunner et al., 2007; Rollo et al., 2010). 
While visiting the 95 enrolled farms, fecal samples were collected from 15 pigs 
that were in the final stages of production, with the exception of one farm, where only 12 
pigs were sampled. Sampling method, bacterial culture methods, and identification of 
Campylobacter spp. have been described previously (Bunner et al., 2007; Rollo et al., 
2010). Likewise, antimicrobial susceptibility testing has also been described previously 
(Bunner et al., 2007; Rollo et al., 2010). Briefly, antimicrobial susceptibility of 
Campylobacter spp. was performed using a gradient disk diffusion strip, Etest® (AB 
Biodisk, Piscataway, NJ). Six antimicrobial drugs were used for Campylobacter spp. 
isolates; however, only data on azithromycin (0.016-256 ug/mL), gentamicin (0.016-256 
ug/mL), and tetracycline (0.016-256 ug/mL) were used in this study. For E. coli, a 
microbroth dilution method (Trek Diagnostics, Westlake, OH) was used to determine the 
MICs to 14 antimicrobials for each isolate. The broth microdilution method has been 
described by Bunner (2007). For the study described here, three antimicrobials were 
examined: ampicillin (1-32 ug/mL), chloramphenicol (2-32 ug/mL), and gentamicin 
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(0.25-16 ug/mL). A subset of antimicrobials for each bacterial species was chosen for 
this project because they each have a unique shape for their respective MIC 
distributions. 
The MIC value, defined as the lowest antimicrobial concentration that inhibited 
bacterial growth, was reported for each isolate. For isolates that did not exhibit growth 
inhibition at even the highest antimicrobial concentration – for each respective 
antimicrobial drug and susceptibility test (microbroth dilution and gradient diffusion 
test), the highest concentration was reported as the MIC. This is one of the discrepancies 
of using MIC distribution data without considering censoring; all of the isolates whose 
growth was not inhibited are grouped into this category. 
3.2.2 Description of data and descriptive analysis 
  Data regarding Campylobacter spp. isolates, E. coli isolates, minimum inhibitory 
concentrations, and farm management factors were compiled in a commercially 
available database software program (Microsoft Access, 2003, Microsoft Corp, 
Redmond, WA). Statistical analysis was performed by use of commercial software 
package (STATA, version 10.0, Statacorp, College Station, TX). 
  MIC data were converted logarithmically using a log base 2 transformation. 
Discrete-time-series survival analysis was used to examine differences in MIC 
distributions for all six antimicrobial-bacterial combinations and between the two swine 
production methods. Kaplan-Meier survival curves were first produced to visually 
compare the MIC distributions (STATA, version 10.0, StataCorp, College Station, TX). 
For DTSA and Kaplan-Meier, Etest® values at or greater than 256 µg/ml (for 
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azithromycin, gentamicin and tetracycline) were treated as right-censored. Similarly, 
microbroth dilution values greater than 32 µg/ml for ampicillin, 32 µg/ml for 
chloramphenicol, and 16 µg/ml for tetracycline for E. coli were considered right-
censored. 
The Kaplan-Meier estimator of the survival function was calculated for each 
bacteria-antimicrobial combination. This estimator used all isolates including censored 
ones to calculate a cumulative survival probability at each observed interval. Each 
isolate was included in the denominator or as ‘at risk’ isolates for inhibition of growth. 
In general, the survival curve that lies above another has a more favorable survival 
experience (Hosmer et al., 2008) from the bacteria’s perspective, not necessarily the 
patient. The hazard was also calculated as the risk of an event (isolate experiencing 
growth inhibition during interval (q)) divided by the length of the interval (Hosmer et al., 
2008), assuming survival to that point in time. The hazard describes the underlying 
distribution of survival time and it characterizes how the distribution changes as a 
function of the covariates (Hosmer et al., 2008). 
3.2.3 Discrete Time Survival Analysis 
In order for AMR measurements to be used as survival analysis data, the 
following conditions should apply: 1) There should be a target event whose occurrence 
was under study; in our study, a target would be the occurrence of an MIC dilution 
recorded for each isolate (otherwise, right-censored). 2) There should be a beginning 
time where all isolates are susceptible to a target antimicrobial at very low concentration; 
in our study, theoretically each isolate that was naïve to the target antimicrobial would 
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fail to grow (or grow) in the lowest dilution but grow at zero concentration. 3) There 
should be a metric for clocking time where the event occurrence was measured; in our 
study, this was the number of dilutions (intervals) between the very lowest dilution and 
the MIC dilution (or, highest concentration in the assay for right-censored observations). 
The order in which events (in this analysis, MICs) occur is critical in survival analysis. 
Furthermore, handling of ties, i.e. two or more events occurring at the same time, may 
present a problem when comparing among groups with hypothesized differences in 
hazard. Although ties can be handled using different approaches in Cox regression, using 
survival analysis to assess differences in MIC distribution is especially problematic 
because of the very few possible events (MIC values). Hence, discrete-time survival 
analysis provides an alternative to handle data with a great many ties. 
Survival analysis models are also named failure-time models and they calculate 
average time to occurrence of an event (MIC dilution). The basic model is: 
 
  Ln [E(T|X1 = x1] = α – β1x1       [1] 
 
Here, α is the average log incidence time in a subpopulation where X1=0, and –β1 is the 
difference in average log incidence times when comparing the subpopulation with 
X1=x1+1 to the population with X1=x1. Here, the sign for β1 is reversed, whereas in a 
normal regression, positive β1 corresponds to harmful effects from increasing X1, and 
negative values are beneficial effects (i.e. if T is death and there is a positive β1, an 
increase in X1 will be associated with an earlier death) (Hosmer et al., 2008). A more 
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common interpretation of these models (i.e. Cox model or proportional hazards model) 
is a model for the risk of the event up to each point in time (or the rate at each point in 
time). “In statistical theory, the assumption is made that, at each time t, the rate I(t;x1) 
approaches a limit h(t;x1) as delta goes to zero” (Hosmer et al., 2008). This limit is 
usually called the hazard or intensity of the outcome at time (t). 
   
h(t;x1) = exp(β1x1) λ0(t)      [2] 
 
The hazard is a conditional probability in that an event can occur in any time interval, 
only so long as it has not occurred in an earlier time interval. There are three 
assumptions inherent to the population represented by the discrete-time hazard model. 
First, there is a postulated logit hazard function for each value of the predictor. For a 
dichotomous variable such as herd type (organic vs. conventional in our study), there are 
two hazard functions. The second assumption is that each hazard function has an 
identical shape. The third assumption is that the distance between each logit hazard 
function is identical in each time period (Singer and Willett, 2003). 
3.2.4 Data structure for DTSA 
  In order to use a discrete time survival analysis, the data must be converted from 
subject-period format (isolate number and MIC value) into subject-period time data. The 
subject-period data set was expanded so that each isolate was represented in multiple 
lines. Each line represents the dilutions up to and including the isolate’s reported MIC 
value. Each time period or MIC interval was represented as C1 through C15. For 
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example, an isolate with an MIC value at the third concentration (or third interval after 
log base 2 transformation) would have 3 lines of data, and the covariates would be the 
same for each line. The interval indicator, j, would take on values 1, 2, 3 (i.e., each MIC 
value). The binary outcome (y) would be zero for the first 2 lines then one for the third 
line. This concept is illustrated in Tables 3.1 and 3.2 where Table 3.1 is the original data 
format and Table 3.2 represents the modified data format as described above. The 
estimated coefficients for covariates would be presented and interpreted in the same 
manner as a fitted proportional hazards model (Hosmer et al, 2008). The time indicators 
are included as follows where (D) is the ‘Jth’ dummy variable for the time indicator or 
number of MIC categories: 
 
 Logit h(tj) = [α1D1 + α2D2 + …+αJDJ] + [β1X1 + β2X2 +…+βPXP]  [3] 
 
The left side of the function is the link function. The right side includes the alphas, 
which are multiplied by their time or category indicators (D). These are multiple 
intercepts by period (MIC value) and are the baseline logit hazard function. The β’s 
represent the effect of one unit difference in the event while controlling for other 
predictors (Singer and Willett, 2003). The set of the multiple intercepts (α’s) estimate the 
baseline logit hazard function and are not interpretable.  
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Table 3.1. The original “isolate level” MIC data set for Campylobacter isolates’ MIC values from antimicrobial-
free and conventional swine farms. Six isolates were selected. 
    
  MICs (ug/ml) 
Isolate 
ID 
MIC 
Cat. 
Censor Farm 
type 
<= 
0.02 0.03 0.06 0.13 0.25 0.5 1 2 4 8 16 32 64 128 
>= 
256 
1 4 0 0 1 1 1 1 . . . . . . . . . . . 
2 15 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 
3 5 0 0 1 1 1 1 1 . . . . . . . . . . 
462 5 0 1 1 1 1 1 1 . . . . . . . . . . 
463 . 0 1 . . . . . . . . . . . . . . . 
464 8 0 1 1 1 1 1 1 1 1 1 . . . . . . . 
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Table 3.2. Converted “MIC-period” data set for Campylobacter isolates on antimicrobial-free and 
conventional swine farms. 
Isolate 
 Id 
C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 C13 C14 C15 Farm type Y 
1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 
2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
2 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
2 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
2 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
2 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
2 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
2 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
2 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
2 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 
2 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 
2 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
2 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 
2 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 
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Table 3.2 (continued)               
Isolate 
Id 
C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 C13 C14 C15 Farm type Y 
3 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
3 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
3 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
3 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
3 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 
462 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
462 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
462 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
462 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 
 462 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 1 
463 . . . . . . . . . . . . . . .     
464 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
464 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
464 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
464 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 
464 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 
464 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 
464 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 
 464 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 1 
C = interval 1 through 15 (i.e. C1 is the lowest MIC dilution); Y is outcome;  
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A discrete time hazard model based on a logit transformation assumes 
proportional odds. Therefore, a complementary log-log transformation was used to 
create a proportional hazards model (Singer and Willett, 2003) and to account for the 
fact that the fitted hazard values are bounded from [zero to 1]. 
 
 Clog-log=log(-log (1-probablity))     [4] 
 
The clog-log transformation maps probability onto a new scale with no upper or lower 
limit which is similar to the logit link. Using a clog-log link makes the DTSA more 
similar to the Cox regression which analyzes data in continuous time scale and which 
also has a proportionality assumption in the hazards and not the odds (Singer and 
Willett, 2003). 
The proportional odds assumption means that each covariate has an identical 
effect in every time period under study. In the case of our study, we asked, “does the 
effect of herd type (antimicrobial free vs. conventional farms) on the value of the MICs 
from low to high dilutions differ?” The proportional odds assumption was assessed 
graphically to compare the hazards (logit) graph of the two levels of the covariate. In a 
DTSA model, this assumption could be relaxed by including the interaction term of time 
(here MIC) and the covariate. In our study, the interaction term was MIC*herd type and 
could be tested by comparing the deviance between the main effects model and the one 
with the interaction term. Nested models were compared and the one with the lower 
deviance was preferred model based on fit of the model. 
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3.3. Results 
3.3.1 Descriptive results 
 The distribution of the log base 2 transformed MIC values for each 
antimicrobial-bacteria combination are presented for both conventional farms and 
antimicrobial-free farms in Figures 3.1-3.6. Gentamicin-E. coli, chloramphenicol-E. 
coli, and gentamicin-Campylobacter resembled normal curves, while azithromycin-
Campylobacter and ampicillin-E. coli were bimodal with two local maxima; one at a 
relatively low MICs and a second at the highest possible MIC (≥ 256µg/mL). The 
tetracycline-E. coli MIC distribution was uniform in appearance. The large proportion of 
isolates in the highest dilution indicated that each of these had a large percentage of 
isolates whose growth was not inhibited by exposure to the respective antimicrobial 
drugs. In general, the shapes of the MIC distribution between antimicrobial-free and 
conventional farms for each antimicrobial-bacteria pair looked similar. 
3.3.2 Life tables and survival curves 
Life tables were constructed for each antimicrobial bacteria combination 
(Appendix D). Five of the six antimicrobial-bacteria combinations had isolates in the 
highest dilution within both production types. Therefore, those MIC distributions are 
considered right censored. The gentamicin-Campylobacter combination did not have 
isolates in the highest dilution using Etest®.  
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Figure 3.1. Probability (expressed as percentage) distribution of the log2(MIC) values of 
azithromycin among 464 Campylobacter isolates from swine on antimicrobial-free 
(n=174) and conventional  (n=290) farms. The CLSI interpreted breakpoint was ≥2 
ug/mL (log2-MIC category≥8). 
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Figure 3.2. Probability (expressed as percentage) distribution of the log2(MIC) values 
for tetracycline in 464 Campylobacter isolates from swine on antimicrobial-free(n=174) 
and conventional (n=290) farms. The CLSI interpreted breakpoint was (≥16 ug/mL) 
(log2-MIC category≥11). 
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Figure 3.3. Probability (expressed as percentage) distribution of the log2(MIC) values of 
gentamicin in 464 Campylobacter isolates from swine on antimicrobial-free  (n=174) 
and conventional (n=290) farms. The CLSI interpreted breakpoint was (>=16 ug/mL) 
(log2-MIC category≥10). 
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Figure 3.4. Probability (expressed as percentage) distribution of the log2 (MIC) values 
of chloramphenicol in 1,381 E. coli isolates from swine on antimicrobial-free (n=498) 
and conventional (n=883) farms. The CLSI interpreted breakpoint was (≥32 ug/mL) 
(log2-MIC category≥5). 
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Figure 3.5. Probability (expressed as percentage) distribution of the log2 (MIC) values 
of ampicillin in 1,381 E. coli isolates from swine on antimicrobial-free (n=498) and 
conventional (n=883) farms. The CLSI interpreted breakpoint was (≥32 ug/mL) (log2-
MIC category≥6). 
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Figure 3.6. Probability (expressed as percentage) distribution of the log2 (MIC) values 
of gentamicin in E. coli isolates from swine on antimicrobial-free (n=498) and 
conventional (n=883) farms. The CLSI interpreted breakpoint was (≥32 ug/mL) (log2-
MIC category≥6). 
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 Kaplan-Meier survival estimates were constructed graphically by herd type 
(Figures 3.7-3.12). The survival curve for azithromycin-Campylobacter (Figure 3.7) 
showed that a larger proportion of the isolates grew at the highest azithromycin 
concentration in conventional farms compared to antimicrobial-free farms. The survival 
curves for tetracycline susceptibility of Campylobacter were of stair-step shape across 
all possible dilutions and which were parallel between production types. However, the 
gentamicin survival curve for both Campylobacter and E. coli had either no isolates or a 
few isolates, respectively, that survived the highest concentration (were right-censored). 
The shape of the survival curve between production types was similar for the 
gentamicin-Campylobacter and gentamicin-E. coli combinations. The survival curve of 
E. coli isolates that were exposed to ampicillin was similar between production types, 
but there was a higher proportion of isolates at the highest dilution in conventional 
farms. 
3.3.3 Discrete time survival analysis 
The original dataset has one line for each isolate and its respective MIC value 
(Table 3.1). Six isolates were included in this example including three each from 
antimicrobial-free and conventional farms. One isolate in this example was censored 
because the MIC category was ≥256 ug/mL. For use in the DTSA model, these six 
isolates were converted into a subject-period data set (Table 3.2). 
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Figure 3.7. Estimated Kaplan-Meier survival curves for log2-transformed MIC values 
for azithromycin in 464 Campylobacter spp. isolates from antimicrobial-free (ABF) and 
conventional swine herds. 
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Figure 3.8. Estimated Kaplan-Meier survival curves for log2-transformed MIC values 
for tetracycline in 464 Campylobacter spp. isolates from antimicrobial-free (ABF) and 
conventional swine herds. 
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Figure 3.9. Estimated Kaplan-Meier survival curves for log2-transformed MIC values 
for gentamicin in 464 Campylobacter spp. isolates from antimicrobial-free (ABF) and 
conventional swine herds.  
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Figure 3.10. Estimated Kaplan -Meier survival curves for log2-transformed MIC values 
for chloramphenicol in 1,381 E. coli isolates from antimicrobial-free (ABF) and 
conventional swine herds. 
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Figure 3.11. Estimated Kaplan-Meier survival curves for log2-transformed MIC values 
for ampicillin in 1,381 E. coli isolates from antimicrobial-free (ABF) and conventional 
swine herds. 
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Figure 3.12. Estimated Kaplan-Meier survival curves for log2-transformed MIC values 
for gentamicin in 1,381 E. coli isolates from antimicrobial-free (ABF) and conventional 
swine herds. 
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A DTSA model using clog-log link function was used to analyze MIC 
distributions among six antimicrobial-bacteria combinations.  An interaction term 
between MIC dilution and herd type was included to relax the proportionality 
assumption inherent to survival analysis data (Table 3.3). The deviances between the 
model with the interaction term and the main effects model were compared. The model 
with the interaction term had a lower deviance so therefore was considered the more 
parsimonious model. All six models showed a significant difference in the MIC 
distributions (P<0.001) between production types. 
 
3.4. Discussion 
 In this study we introduced DTSA as a potential modeling framework to be used 
with data sets where MIC distributions are the outcome. Previously, a population 
average (GEE) logistic regression model was used to model the proportion of resistant 
isolates for Campylobacter between the two herd types using the same dataset (Rollo et 
al., 2010). Significant differences in the proportions of resistant bacteria between 
antimicrobial-free and conventional farms were reported for Campylobacter and 
tetracycline and Campylobacter and azithromycin. There was not a difference in 
proportion of resistant bacteria for Campylobacter and gentamicin between production 
type using GEE (Rollo et al., 2010). In the present study, there was a significant 
difference (p<0.001) in the MIC distributions of all 3 antimicrobial-bacterial 
combinations. In the DTSA model, the isolates in the highest dilutions were censored.
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Table 3.3. Odds ratios and coefficients of the DTSA of the susceptibility of 
Campylobacter isolates and E. coli isolates to 6 antimicrobials on antimicrobial-
free and conventional swine farms (herd is farm type and referent is ABF farms). 
The main effects model is listed first and the model which uses an interaction 
term to account for the proportional hazards assumption is listed second. 
Azithromycin-Campylobacter B (SE) OR 95%CI p-value† 
herd (model 1) -3.19 (0.11) 0.04 0.03-0.05 <0.001 
 
herd (model 2) 2.67 (0.29) 14.4 8.08-25.65 <0.001 
interaction  -0.61 (0.05) 0.54 0.49-0.60 <0.001 
     
Gentamicin-Campylobacter B (SE) OR 95%CI p-value† 
herd (model 1) -2.02 (0.07) 0.13 0.12-0.15 <0.001 
 
herd (model 2) 2.36 (0.63) 10.6 3.07-36.26 <0.001 
interaction -0.66 (0.10) 0.00 0.43-0.62 <0.001 
     
Tetracycline-Campylobacter B (SE) OR 95%CI p-value† 
herd (model 1) -1.60 (0.08) 0.20 0.17-0.24 <0.001 
 
herd (model 2) 2.14 (0.24) 8.50 5.31-13.58 <0.001 
interaction -0.31 (0.02) 0.73 0.71-0.77 <0.001 
     
      
Gentamicin-E. coli B (SE) OR 95%CI p-value† 
herd (model 1) -0.93 (0.04) 0.40 0.36-0.43 <0.001 
 
herd (model 2) 2.25 (0.17) 9.53 6.83-13.31 <0.001 
interaction -1.46 (0.08) 0.23 0.20-0.27 <0.001 
      
Ampicillin-E. coli B (SE) OR 95%CI p-value† 
herd (model 1) -1.56 (0.05) 0.21 0.19-0.23 <0.001 
 
herd (model 2) 0.06 (0.07) 1.07 0.93-1.23 0.36 
interaction -0.47 (0.02) 0.62 0.59-0.65 <0.001 
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Table 3.3 (continued)     
Chloramphenicol-E. coli B (SE) OR 95%CI p-value† 
herd (model 1) -1.13 (0.04) 0.32 0.30-0.35 <0.001 
 
herd (model 2) 1.48 (0.12) 4.40 3.48-5.56 <0.001 
interaction -1.01 (0.05) 0.37 0.33-0.40 <0.001 
B = Regression coefficient. SE = Standard error. OR = Odds ratio. CI = Confidence 
interval. †A value of P≤0.05 was considered significant. 
97 
 
 
Therefore, these isolates were included in the denominator only, that is, the censored 
isolates were considered in the probability calculation at each interval but did not 
become a numerator in the given timeframe or dilution. 
  The survival curves for Campylobacter and E. coli and gentamicin appeared to 
be very similar in shape; however, the distributions were significantly different using 
DTSA. A possible explanation for this may have been that the number of records in the 
dataset was inflated in the expansion of data into time-period data. Further studies are 
needed to investigate this phenomenon.  
  The proportion of resistant isolates for E. coli was also previously modeled using 
a population average logistic regression model (Bunner et al., 2007). Significant 
differences between production types were reported for E. coli isolates resistant to 
chloramphenicol and ampicillin, but not gentamicin. In the present study, there was also 
a significant difference (P<0.001) in the MIC distributions for all three antimicrobial-
bacteria combinations, including gentamicin. In theory, a model that compares 
distributions should be able to detect subtle differences in the distributions that do not 
necessarily depend on the resistance breakpoint. Six antimicrobials were examined that 
had unique shapes of their distributions to determine if the shape and the proportion of 
censored data would affect the outcomes. However, it is not possible to compare odds 
ratios produced by these models to odds ratios in the logistic regression models because 
of the number of censored isolates. Further analysis of this type of model using 
simulation studies may provide further guidance on the application of the DTSA model 
to MIC data. 
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Discrete time survival analysis models (DTSA) have been used in econometrics 
and the social sciences. This model was introduced here as an option to analyze MIC 
data since MIC data are discrete, have many ties, and are often right and left censoring. 
In the present study, we did not account for left censoring; however, only a few the 
isolates were left censored for the six antimicrobial drug-bacterial combinations 
examined.  
In summary, right censoring will occur with most diagnostic procedures based on 
dilutions such as microbroth dilution and Etest®. Most MIC distributions were right 
censored and all isolates that were not inhibited were grouped in the highest category 
(i.e. 256 ug/mL). In reality, the true concentration where those isolates would be 
inhibited is unknown. Left censoring also occurs with these tests because there is a 
cutoff of measurement at the lowest dilution as well so the outcome may occur at a 
smaller dilution than what is represented by the test. 
In addition to right and left censoring, the data used in the present study were 
also interval censored. The data used in this study, although values were measured on a 
continuum, were grouped into discrete intervals (all outcomes that occur in the interval 
of [64ug/mL to <128ug/mL] were categorized as 64 ug/mL). This would apply to Etest® 
and most microbiological susceptibility tests since true values are grouped into 
categories or intervals based on the test methodology. In addition, interval censored data 
were right censored within each interval. However, addressing censoring within an 
interval is beyond the scope of this paper. 
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Besides the censoring considerations, the discrete time interval format of the data 
created tied outcomes. Hence, the MIC distribution could not be considered to be 
continuous, which is one of the major assumptions of the Cox proportional hazards 
model. Cox first proposed a deviation of his proportion hazards model in that not all 
outcomes would be continuous (Cox, 1972). However, Willet and Singer (2003) have 
extended this model to be utilized with interval data (Singer and Willett, 2003).  Several 
studies have utilized a Cox proportional hazards model to analyze MIC outcomes (Ray 
et al., 2006; Stegeman et al., 2006). Stegeman (2006) compared a Cox model to logistic 
regression. Although several methods to handle ties have been introduced for Cox 
proportional hazard model, the DTSA model may be superior to Cox proportional hazard 
model because it doesn’t require any assumptions regarding the ties. Tied outcomes 
should be considered when making a choice between using a Cox proportional hazards 
model or a DTSA (Singer and Willett, 2003). 
When comparing models using a deviance statistic (-2 log likelihood), a small 
value with a non-significant P-value indicates a good fit of the model. However, if there 
is a large sample size, the deviance statistic is often significant and thus the null 
hypothesis of model fit associated with the deviance statistic will be rejected. Akaike’s 
Information Criterion and Bayesian Information Criterion make a correction of the 
deviance statistic for the number of parameters or for sample size (Singer and Willett, 
2003). These criteria can be compared between models that are not nested if used on the 
same data set. Smaller values indicate better model fit. 
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A dataset used for DTSA must be expanded or converted into subject-period time 
data to include one record for each MIC interval and this might be concerning because 
we inflated the records. That is, there are multiple lines of data per isolate. Multiple lines 
of data are necessary if we realize that a hazard function describes the conditional 
probability of event occurrence at time (t) given it has not occurred up to time (t) (Dohoo 
et al., 2003). Each person or isolate contributes when it is at risk and therefore each 
isolate is also conditionally independent. Another way to express this data 
transformation is that DTSA allows the longitudinal progression of the probability that 
an event will occur. 
The final major assumption that needs to be considered in developing the DTSA 
model is the dependence between outcomes due to clustering or non-independence 
among isolates within farms. One way to overcome this drawback is to add a random 
intercept to the model that represents each farm (Rabe-Hesketh and Skrondal, 2005). 
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 This random intercept is referred to as a shared frailty since it accounts for 
animals from the same farm. Frailty models are complex but they can incorporate an 
unmeasured ‘random’ effect into the hazard function to account for heterogeneity among 
isolates (Hosmer et al., 2008). One problem is that software that fits the proportional 
hazard model may not have an option for including frailty (Hosmer et al., 2008). Hence, 
we did not consider dependence between pigs at this time. For more discussion on this 
subject, refer to Hosmer et al. (2008). 
There are other options that have been suggested for analysis of discrete time-
series and censored data (Hammel et al., 2006). Hammel suggested removing censored 
data or replacing censored data with actual values at the tail of the distributions. Using 
Hammel’s suggestion, the model incorporated censored MIC observations into the 
likelihood function by using the tail probabilities of the error distribution (this preserves 
the uncertainty of the censored MICs). 
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Often, epidemiologists will dichotomize MIC data based on breakpoints 
determined from human drug studies. A limitation of dichotomizing MIC outcomes is 
that variability in MIC distribution that does not include the breakpoint will not be 
detected. Furthermore, difference of the distribution that would occur slowly on the scale 
of genotypic changes are not detected when considering dichotomized outcomes unless a 
table is included that provides the MIC values for each antimicrobial for antimicrobial-
free and conventional farms. When examining longitudinal data, shifts in MICs would 
be reflected readily since the shifts often include a change encompassing the breakpoint 
(Stegeman et al., 2006). Stegeman (2006) was particularly concerned with changes in the 
MIC below the breakpoint because the assumption is that changes occur in a stepwise 
fashion towards the upper limit. By using a proportional hazard’s model, subtle changes 
are detected, whereas by dichotomizing the data, that information would be lost. The 
analysis of MIC data by logistic proportional hazards model provided a more sensitive 
test for detecting incremental differences. 
 
3.5. Conclusion 
  We have described the DTSA model and how it can be used to model MIC data.  
The characteristics of MIC data including right censoring and discrete intervals can be 
accounted for with the assumptions of a DTSA model. The right censored isolates are 
included only in the denominator since their true interval is not definable within the 
limits of the Etest®. The DTSA model should in theory be a better option for modeling 
MIC data as compared to Cox regression. However, some issues in respect to e.g. the 
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impact (if any) of extending the data for an observation to multiples lines on test 
statistics, accounting for hierarchical data, and an additional measure of ‘fit’ must be 
investigated further. 
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4. HERD-LEVEL RISK FACTORS ASSOCIATED WITH ANTIMICROBIAL 
RESISTANCE IN E. coli AND Campylobacter SPP. ON ANTIMICROBIAL-FREE 
AND CONVENTIONAL SWINE FARMS IN THE U.S. 
 
 
4.1. Introduction 
Antimicrobial resistance (AMR) in agricultural systems is an ongoing concern to 
both human and animal health (Molbak, 2004; Mathew et al., 2007). Both commensal 
and pathogenic bacteria obtained from swine farms, including Campylobacter spp. 
Salmonella spp., and Escherichia coli (Rollo et al., 2010, Taylor et al., 2009; Bunner et 
al., 2007; Dunlop et al., 1998) may be resistant to a large range of antimicrobial drugs. 
Antimicrobial-resistant bacteria of food animal origin are of concern because they may 
be transmitted through the food chain to humans. Such resistant bacteria of food animal 
origin may cause human infections that are difficult to treat, and they may exchange 
genetic resistance determinants with commensal or pathogenic bacteria already in the 
human gut. 
E. coli are present in the gastrointestinal tract of most warm-blooded animals as 
commensals (Hartl and Dykhuizen, 1984). E. coli are also present in the environment 
and can serve as reservoirs for resistance genes that can be transferred to pathogenic 
bacteria (Sunde et al., 1998; Windfield and Groisman, 2003; Anderson and Sobsey, 
2006). However, the actual transfer of resistant genes from commensal bacteria to 
pathogenic bacteria has not been thoroughly investigated in vivo (Mathew et al., 2007). 
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The theory suggests that the exposure of commensal bacteria to antimicrobial drugs can 
lead to an increase in prevalence of genes carried on mobile genetic elements such as 
plasmids, integrons, and transposons (Lees et al., 2008). 
In most cases, resistant bacterial strains are associated with the type of 
antimicrobial drugs used both historically and in the present on the farm (Harada et al., 
2008; Rosengren et al., 2009; Varga et al., 2009); however, there are often clones that 
are resistant to antimicrobial drugs for which there is no history of use on the farm 
(Thakur and Gebreyes, 2005). For example, bacteria that are resistant to 
fluoroquinolones are apparent on some poultry farms that have never used drugs in this 
group (Taylor et al., 2009). In countries where some antimicrobial drugs are now 
banned, antimicrobial resistance is still present to these antimicrobial drugs (Bischoff et 
al., 2002; Harada et al., 2006). Furthermore, on antimicrobial-free farms resistance is 
present, although at lower proportions as compared to conventional farms (Sato et al., 
2004a; Halbert et al., 2006; Luangtongkum et al., 2006; Bunner et al., 2007; Rollo et al., 
2010). A number of authors have addressed the multitude of mechanisms promoting 
AMR persistence and the complex interactions between antimicrobial drugs and 
bacterial species (Engberg et al., 2001; Andersson, 2003; Alfredson and Korolik, 2007). 
Co-resistance and cross-resistance are two mechanisms that may help explain the 
persistence of resistance to antimicrobial drugs that have never been, or are not currently 
being, used on a farm. Use of one antimicrobial drug can co-select for resistance to other 
antimicrobial drugs in the absence of use of these other drugs. This phenomenon is 
referred to as co-selection. In other words, the use of an antimicrobial drug which causes 
  106 
 
the selection of a resistance determinant for a particular drug may result in selection of a 
resistance determinant for another antimicrobial drug. Co-resistance, also called 
associated resistance, is due to the co-existence of resistance-determinants in the same 
bacterial strain causing resistance to different antimicrobial drugs. For example 
macrolides, lincosamides, and B streptogramins act on bacterial ribosomes, and 
methylation of a single adenine residue in 50S rRNA confers high-level resistance to the 
three antimicrobial classes despite differences in their chemical structure (Roberts et al., 
1999). 
Cross-resistance occurs when one gene confers resistance to more than one type 
of antimicrobial drug (Guardabassi and Kruse, 2008). Both co-resistance and cross-
resistance occur in most bacterial populations including Campylobacter, Salmonella, and 
E. coli. Besides co-and cross-resistance of bacteria during antimicrobial drug use, other 
herd-level management factors may affect the levels and patterns of antimicrobial 
resistance on swine farms. We have previously shown that the prevalences of resistance 
to some antimicrobial drugs were lower in E. coli and Campylobacter isolated from the 
feces of pigs on antimicrobial-free farms compared to conventionally managed farms 
(Bunner et al., 2007; Rollo et al., 2010). However, there may be other management 
practices on these types of farms that are associated with the occurrence of antimicrobial 
resistance. Examples of such management practices may include biosecurity practices, 
disease history, preventive medicine practices, other farm management practices, and 
vaccine administration. The goal of this study was to identify potential herd-level risk 
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factors associated with AMR among Campylobacter and E. coli in pigs from 
antimicrobial-free and conventional swine farms in the Midwest. 
 
4.2. Materials and Methods 
4.2.1 Study design and sample collection 
This study was a part of a larger study undertaken in 2002-2003 in the 
Midwestern United States. A cross sectional design was used to collect data from 35 
antimicrobial-free and 60 conventional finishing swine farms. The methods for herd 
selection, sample collection, and bacterial isolation, and susceptibility testing have been 
previously described in detail (Bunner et al, 2007, Rollo et al, 2010). In summary, 
antimicrobial-free farms were selected from membership lists of 2 cooperatives that 
produced pigs without the use of antimicrobial drugs. Farmers were contacted by 
telephone and asked if they would participate in the study. Conventional farms were 
selected on the basis of their close geographic proximity to the antimicrobial-free farm 
and the number of slaughter pigs produced per year. The total number of pigs marketed 
per year was used as a surrogate for herd size. Participating swine farms were visited 
once in 2002-2003, and feces were collected from 15 healthy finisher pigs per farm; 
however, on one farm only 12 finishers were sampled. 
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4.2.2 Bacterial isolation and antimicrobial susceptibility testing of Campylobacter 
Each fecal sample was cultured for isolation of Campylobacter spp. and 
subsequently screened with a panel of antimicrobials to determine resistance prevalence 
and patterns. Of the 512 Campylobacter isolates that were recovered, 174 and 290 
isolates were available for susceptibility testing from 30 of 35 antimicrobial-free farms 
and 55 of 60 conventional farms, respectively. 
For specifics on isolation and identification of Campylobacter, please refer to 
Section 2. Antimicrobial susceptibility testing was performed using gradient disk 
diffusion strips (Etest®) according to the manufacturer’s instructions and as described 
by Sato et al. (2004a) and Rollo et al. (2010) (AB Biodisk, Piscataway, NJ). 
Susceptibility results were interpreted as described in Sato et al. (2004a). Six 
antimicrobials were tested: azithromycin, erythromycin, ciprofloxacin, nalidixic acid, 
gentamicin, and tetracycline. Data on azithromycin and tetracycline were included in this 
risk-factor study as single models and all six antibiotics were considered in the multidrug 
resistant model (see Section 2 for other dilution ranges and breakpoints of the additional 
antimicrobials). The dilution ranges were 0.016-256 µg/mL for azithromycin and 0.016-
256 µg/mL for tetracycline. Etest® values were expressed on a quasi-continuous scale 
with intermediate values present between each set of log2 dilutions; however, 
intermediate values between log2 dilutions were rounded up to the higher log2 dilution 
during post-study data management, as recommended by the manufacturer. The 
resistance breakpoints used by the National Antimicrobial Resistance Monitoring 
System in 2003 were adopted (CDC, 2003), since those were the applicable ones for this 
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time period and CLSI had not yet defined breakpoints for Campylobacter. The resistance 
breakpoints were ≥ 2 µg/mL azithromycin and ≥ 16 µg/mL for tetracycline. Results of 
susceptibility testing are reported both as MIC distributions and proportions of resistant 
and susceptible isolates according to CLSI performance standards (CLSI, 2008). 
4.2.3 Bacterial isolation and antimicrobial susceptibility testing of E. coli 
For the E. coli isolates, standard isolation and identification techniques were 
performed as described by Bunner et al, 2007. Of the 1,422 fecal samples collected, 
1,381 E. coli isolates were recovered so that 498 and 883 isolates were available for 
susceptibility testing on all 35 antimicrobial free farms and all 60 conventional farms, 
respectively. 
In addition, susceptibility to 14 antimicrobial agents was determined for each E. 
coli isolate using a microbroth dilution test (Sensititre panel CMV7CNCD, Trek 
Diagnostics, Westlake, OH). However, only data on five antimicrobial agents were used 
as single models:  ampicillin, chloramphenicol, streptomycin, sulfamethoxazole, and 
tetracycline. All 14 antimicrobials were used in the multidrug resistance model. The 
dilution ranges for the four drugs were:  ampicillin (1 to 32 µg/mL), chloramphenicol (2 
to 32 µg/mL), streptomycin (32 to 64 µg/mL), sulfamethoxazole (16 to 512 µg/mL), and 
tetracycline (4 to 32 µg/mL). The resistance breakpoints for the four antimicrobial drugs 
were: ampicillin (≥32 µg/mL), chloramphenicol (≥16 µg/mL), streptomycin (≥64 
µg/mL), sulfamethoxazole (≥512 µg/mL), and tetracycline (≥16 µg/mL) (see Bunner et 
al., 2007 for other antimicrobials and breakpoints used). Isolates with an MIC greater 
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than or equal to the breakpoint MIC were classified as resistant and the MIC breakpoints 
were determined using data from human studies (Bunner et al., 2007). 
4.2.4 Herd management practices and data collection  
At the time of the sampling, a questionnaire modeled after the National Health 
Animal Health Monitoring System – Swine 2000 study was administered to each farm 
manager (USDA, 2001). The questionnaire was divided into the following sections: herd 
information, environment of pigs, medication history, preventive medicine, biosecurity, 
disease history, and production performance (Appendix E). Types of antimicrobial drugs 
used were also collected; however, antimicrobial free farms did not use antimicrobial 
drugs so these data were excluded from further analysis. Data on production 
performance were also excluded because they were only available for some of the farms 
(some producers did not record production data routinely). In addition, data on gilt, sow, 
and nursery pig management practices were excluded. Herd management practices as 
defined for this project include the housing environments of pigs and describe type of 
house, ventilation, bedding, floor type, and flooring. 
Independent variables (risk factors) were constructed from the questionnaire data 
at the farm level. Variables that were excluded were those with high numbers of missing 
values, low variability (less than 20% difference between farm type), or unclear answers 
(Dohoo et al., 2003). Appendix F lists the variables that were recorded for the study. For 
example, some biosecurity measures that captured what visitors had to do when visiting 
a farm were collapsed into fewer variables to account for minimal variability between 
variables. Specifically, only a few farms required visitors to wait at least 24 hours from 
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the last contact with pigs to enter a farm; hence, this variable was combined with a 
variable measuring whether or not visitors had to “shower in” before entering the farm. 
Data were summarized by calculating descriptive statistics including, medians, standard 
deviations (SD), and ranges when indicated. 
Data on Campylobacter and E. coli isolates, AMR, and variables created from 
the questionnaire were compiled in a commercially available database software program 
(Microsoft Access, 2003, Microsoft Corp, Redwood, WA). The dataset was checked for 
proper coding and distribution of values and then was imported into another software 
(STATA, version 10.0, StataCorp, College Station, TX) package for statistical analysis. 
Data validation was conducted by examining a selection of questionnaires and cross-
checking the database to ensure proper coding and to check for potential errors during 
data entry. 
4.2.5 Statistical methods and model building 
In the initial analysis, the dependent variable was the proportion of bacterial isolates 
that were resistant to a specific antimicrobial drug. The dependent variable was 
measured at the individual animal whereas the independent variables were measured at 
the farm level. A total of seven bacteria-antimicrobial combinations were analyzed as the 
outcome in seven separate models:  Campylobacter-azithromycin and -tetracycline, E. 
coli-ampicillin, -chloramphenicol, -streptomycin, -sulfamethoxazole, and -tetracycline. 
All independent variables were screened initially to allow evaluation of simple 
associations with each of the outcome variables by calculating an odds ratios (OR) and 
associated 95% confidence interval. Furthermore, herd-type (antimicrobial-free and 
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conventional) was included in all models, since it was the main exposure variable for 
this study. During the initial screening process, a population-average logistic regression 
model involving a generalized model framework with a logit link and binomial error 
distribution, with generalized estimating equation involving an exchangeable working 
correlation structure and semi-robust variance estimator, was used to determine the 
potential association between the proportion of resistance for each of the antimicrobial 
agents, herd-type (forced into each model), and the additional variable that was being 
screened (Hosmer and Lemeshow, 2000; Dohoo et al., 2003). Screening of variables was 
conducted in subsets (preventive medicines, biosecurity, vaccine status, production 
management, and disease history). A level of significance of 0.25 was used to screen 
variables. The preliminary screening process was used as an approach to eliminate the 
problem of multicollinearity (Dohoo et al., 1996). 
Multicollinearity among categorical predictor variables was also checked by 
considering the associations between each pair of the categorical predictor variables 
within each subset of management variables using the Pearson chi-square test of 
independence (Agresti, 1996). A significance level of less than 0.05 resulted in the 
rejection of the null hypothesis of independence. A pair-wise calculation of Spearman 
rank correlations was used to investigate collinearity between predictor variables within 
each subset of management variables. When two potential risk factors were highly 
correlated (correlation coefficient >0.7), only one variable was used in the multivariate 
analysis. 
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Those variables that met the criterion of independence were further screened for 
inclusion in a multivariable model. Within each subset of management variables, the 
criterion for inclusion in the final multivariate model was a level of significance of 0.l0 
or less. Inclusions of variables for multivariable models were selected by using a 
backwards selection process (Hosmer and Lemeshow, 2000). After deletion of non-
significant variables, eliminated variables were added in a forward selection process to 
check that a variable was not prematurely removed (p<=0.05) to obtain the multivariate 
model. Dichotomous and nominal ordinal variables were assessed using a generalized 
Wald test (Hosmer and Lemeshow, 2000). Standard errors of the coefficients were 
examined to determine any unstable coefficients. Once the main effects model was 
obtained, two-way interactions were tested. An interaction term was added to the model 
and retained if it was significant (P ≤ 0.05). Potential confounding variables were 
assessed by comparison of the differences in the regression coefficients of the main 
exposure variable (herd-type) with and without the presence of the potential confounder 
in the model. If there was a change of 20% or more, then the confounding variable was 
forced in the model. 
Multidrug resistance (MDR) was defined as resistance to two or more 
antimicrobial drugs. Associations between MDR and herd management factors were 
determined for Campylobacter spp. and E. coli separately (E. coli-MDR and 
Campylobacter-MDR). Bunner et al. (2007) analyzed the proportions of MDR for 14 
antimicrobial drugs for E coli isolates and Rollo et al. (2010) analyzed MDR proportions 
for six antimicrobial drugs for each Campylobacter isolate. 
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Multi-bacterial-antimicrobial resistance (MBAR) was considered for fecal 
samples from which both E. coli and Campylobacter spp. were isolated. Multi-bacterial-
antimicrobial resistance was defined, in this study based on the following criteria: 1) any 
combination of Campylobacter spp. and E. coli from a sample from which 
Campylobacter spp. that was resistance to at least one of six antimicrobial drugs and 
from which E. coli that were resistant to at least one of 14 antimicrobial drugs were 
isolated, and 2) that the selected Campylobacter spp. and E. coli isolates were 
cumulatively resistant to three or more antimicrobial drugs. Differences between the pigs 
that had isolates with a combined total of resistance to three or more antimicrobial drugs 
among Campylobacter and E. coli, as well as MDR of Campylobacter and E. coli, were 
analyzed using a population averaged logistic model as described above. 
 
4.3. Results 
Thirty-five antimicrobial-free and 60 conventional farms from 8 Midwestern 
states were enrolled in this cross-sectional study. The number of years that 
antimicrobial-free farms had not used antimicrobial drugs ranged from 1 to 14, with a 
median of 3 years. The mean number of pigs on antimicrobial-free farms was 1262 
(range 150-11000; median 800), whereas the mean size for conventional farms was 7909 
(range 500-45000; median 4800) (P<0.001). 
 Fifteen fecal samples were collected from late-stage finisher pigs on 
antimicrobial-free and conventional farms except on one farm where only 12 finisher 
pigs were available for sampling. A total of 512 Campylobacter isolates were isolated 
  115 
 
from feces of one or more pigs on 90 of the 95 farms (33 of 35 antimicrobial-free farms 
and 57 of 60 conventional farms). Of the 512 Campylobacter isolates, 464 were 
available for susceptibility testing; these isolates were obtained from pigs on 30 of the 33 
antimicrobial-free farms and 55 of the 57 conventional farms that had Campylobacter 
isolates. On the 95 swine farms, 1,381 (97.1%) E. coli isolates were recovered from 
1,422 fecal specimens and at least 12 E. coli isolates were obtained from all 95 farms 
(with the exception of one farm that only had 4 E. coli isolates from 15 pigs). 
4.3.1 Variable description 
 A total of 38 variables (33 dichotomous and five categorical variables) were used 
for the initial analyses (see description of variables in Appendix F). Variables regarding 
the types of antimicrobial drugs used were excluded from this study since antimicrobial-
free farms did not use antimicrobial drugs. Explanatory variables were divided into 5 
categories: biosecurity, disease history, vaccines used, farm management practices, and 
medication history.  Among vaccines used in finishers, data on six vaccines were 
dropped because farms reported no usage (PRRS, Swine flu, Salmonella, Erysipelas, 
atrophic rhinitis, and Escherichia coli vaccines). Additionally, three disease conditions 
were excluded due to lack of variability (Circovirus or Post-weaning Multisystemic 
Wasting Syndrome (PMWS), swine dysentery, and pseudorabies). 
 Most of the antimicrobial-free farms (91%) were classified as farrow-to-finish 
farms and the remaining three farms were grower-to-finish farms. Thirty-nine of 60 
(65%) conventional farms were farrow-to-finish, 17 were grower-to-finish, three were 
wean-to-finish, and six were derivations of the above. The majority of the antimicrobial-
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free farms (80%) were open (i.e. introduction of purchased replacement pigs was 
practiced: breeder stock, nursery pigs from off-site farrowing or nursery units, or feeder 
pigs) whereas (65%) of the conventional farms were open. In addition, 71% 
antimicrobial-free farms brought in breeding stocks compared to 53% of conventional 
farms; seven percent of conventional farms brought in nursery pigs whereas none of the 
antimicrobial-free farms did. Feeder pigs were brought onto 14% of antimicrobial-free 
farms and 5% of conventional farms. All explanatory variables were measured at the 
farm level. Explanatory variables were summarized by antimicrobial-free and 
conventional herd types (Tables 4.1(a)-4.1(e)). 
4.3.2 Model descriptions 
Analysis of each antimicrobial-bacteria combination, MDR, and MBAR to each 
of the 38 explanatory variables did not reveal common patterns (see Appendix G). The 
final multivariate models for each of the seven antimicrobial-bacteria combinations also 
had a variety of significant covariates associated with antimicrobial resistance among the 
seven models (Tables 4.2 -4.8). Herd type was significant in all multivariate models 
(P<0.001). In the multivariable model for E. coli-streptomycin, the interaction of swine 
flu and herd type and the interaction of ulcer to herd type were significant (P<0.05); 
therefore, the interaction terms were included for the E. coli-streptomycin multivariable 
model. 
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Table 4.1 (a). Summary of herd-level biosecurity variables (risk factors) by 
antimicrobial-free and conventional swine farms. 
Variable name Farm type No./total farms Percentage (95% CI) 
ABF 4/35 11.7 (8.9-14.34) 
vistoronfarm_0 Conv 2/60 3.3 (2.16-4.51) 
ABF 24/35 68.2 (64.20-72.20) 
visitoronfarm_1 Conv 37/60 61.7 (58.49-64.85) 
ABF 7/35 20.1 (16.67-23.56) 
visitoronfarm_2 Conv 21/60 35.0 (31.88-38.12) 
ABF 20/35 57.1 (40.29-73.99) 
toilet_0 Conv 18/60 30.0 (18.15-41.85) 
ABF 15/35 42.8 (26.0-59.7) 
toilet_1 Conv 42/60 70.0 (58.1-81.8) 
ABF 20/35 8.6 (6.20-11.03) 
exterm Conv 58/60 1.7 (0.80-2.50) 
ABF 10/35 28.6 (13.2-43.9) 
rendering Conv 11/60 18.3 (8.3-28.3) 
ABF 1/35 2.8 (-2.8-8.5) birdproof Conv 40/60 66.7 (54.5-78.8) 
ABF 23/35 65.7 (49.5-81.9) 
newlivestock Conv 34/60 56.7 (43.8-69.5) 
ABF 13/35 37.1 (20.7-53.6) 
free_roam 
Conv 7/60 11.7 (3.4-20.0) 
ABF 12/35 34.3 (18.1-50.4) 
chickens  Conv 5/60 8.3 (1.2-15.5) 
ABF 19/35 54.3 (37.3-71.2) 
newlivestock Conv 2/60 20.0 (9.7-30.3) 
ABF 13/35 37.1 (20.7-53.6) 
animal_contact Conv 4/60 6.7 (0.2-13.1) 
ABF 12/35 34.5 (30.40-38.57) 
_acclim_0 
Conv 31/60 51.7 (48.40-54.44) 
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Table 4.1 (a). (continued)   
Variable name Farm type No./total farms Percentage (95% CI) 
ABF 9/35 25.9 (22.10-29.63) 
_acclim_1 
Conv 8/60 13.3 (11.11-15.56) 
ABF 14/35 39.6 (35.45-43.86) 
_acclim_2 Conv 21/60 35.0 (31.88-38.12) 
ABF = Antimicrobial-free farms. Conv = Conventional farms. 
CI = Confidence interval. 
A key for the variables in this table is presented in appendix F. 
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Table 4.1 (b). Summary of herd-level disease history variables by antimicrobial-
free and conventional swine farms. 
Variable name Farm type No./total farms Percentage (95% CI) 
ABF 1/35 2.86 (-2.81-8.5) 
actino Conv 4/60 6.67 (0.22-13.1) 
ABF 0/35 0 PRRS Conv 24/60 40.0 (27.3-52.7) 
ABF 5/35 14.3 (2.4-26.2) 
swineflu Conv 25/60 41.7 (28.9-54.4) 
ABF 4/35 11.4 (0.6-22.3) 
salm Conv 2/60 3.33 (-1.3-7.97) 
ABF 2/35 5.7 (-2.1-13.6) Glassers Conv 9/60 15.0 (5.8-24.2) 
ABF 3/35 8.6 (81.9-100.96) 
myco_pn Conv 23/60 38.3 (25.8-50.9) 
ABF 3/35 8.6 (-0.96-18.1) 
rhin Conv 2/60 3.3 (-1.3-7.97) 
ABF 3/35 8.6 (-0.96-18.1) hbs Conv 25/60 41.7 (28.9-54.4) 
ABF 7/35 20.0 (6.4-33.6) ili Conv 24/60 40.0 (27.3-52.7) 
ABF 1/35 2.86 (-2.81-8.5) 
ulcer Conv 14/60 23.3 (12.4-34.3) 
ABF 4/35 11.4 (0.6-22.3) 
erysip Conv 5/60 8.33 (1.2-15.5) 
ABF = Antimicrobial-free farms. Conv = Conventional farms. 
CI = Confidence interval. 
A key for the variables in this table is presented in appendix F. 
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Table 4.1 (c). Summary of vaccine usage at the herd level by 
antimicrobial-free and conventional swine farms. 
Variable name Farm type No./total farms Percentage (95% CI) 
ABF 6/35 17.1 (4.3-30.0) 
vaccine   Conv 13/60 21.7 (11.0-32.3) 
ABF 4/35 11.4 (0.6-22.3) pseudovx Conv 5/60 8.3 (1.2-15.5) 
ABF 1/35 2.8 (-2.8-8.5) 
mycovx Conv 9/60 15.0 (5.8-24.2) 
ABF = Antimicrobial-free farms. Conv = Conventional farms. 
CI = Confidence interval. 
A key for the variables in this table is presented in appendix F. 
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Table 4.1 (d). Summary of management practice variables at the herd-level by 
antimicrobial-free and conventional swine farms.  
Variable name Farm type No./ total Farms Percentage (95% CI) 
ABF 31/35 88.5 (8.75-14.23) 
mixfarm Conv 35/60 58.3 (55.11-61.56) 
ABF 6/35 17.2 (13.995-20.49) premix Conv 33/60 55.0 (51.75-58.25) 
ABF 3/35 8.6 (6.21-11.03) 
corn Conv 11/60 18.3 (15.80-20.86) 
ABF 11/35 31.0 (27.06-35.01) 
soybean Conv 20/60 33.3 (30.25-36.42) 
ABF 6/35 17.1 (4.3-29.98) 
manurespread 
Conv 6/60 10.0 (2.2-17.8) 
ABF 3/35 8.6 (6.21-11.03) 
house_1 Conv 42/60 61.7 (58.49-64.85) 
ABF 11/35 31.0 (27.06-35.01) 
house_2 Conv 9/60 15.0 (12.67-17.34) 
ABF 5/35 14.4 (11.35-17.38) 
house_3 Conv 1/60 1.7 (0.83-2.50) 
ABF 14/35 40.2 (36.06-44.44) 
house_4 Conv 11/60 18.3 (15.80-20.86) 
ABF 2/35 5.8 (3.75-7.75) 
house_5 Conv 2/60 3.3 (2.16-4.51) 
ABF 23/35 65.5 (61.43-69.6) flooring_0 Conv 56/60 93.3 (91.70-94.97) 
ABF 12/35 34.5 (30.40-38.57) flooring_1 Conv 4/60 6.7 (3.40-6.43) 
ABF 32/35 91.4 (88.97-93.79) 
floor_0 Conv 13/60 21.7 (18.97-24.36) 
ABF 3/35 8.6 (6.21-11.03) 
floor_1 
Conv 47/60 78.3 (75.64-81.03) 
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Table 4.1(d). (continued)   
Variable name Farm type No./ total Farms Percentage (95% CI) 
ABF 3/35 8.6 (6.21-11.03) 
_Ibedding_0 Conv 40/60 66.7 (63.58-69.75) 
ABF 25/35 71.8 (67.98-75.70) 
_Ibedding_1 Conv 13/60 21.7 (18.97-24.36) 
ABF 7/35 19.5 (16.13-22.95) 
_Ibedding_2 Conv 7/60 11.7 (9.57-13.77) 
ABF 29/35 82.8 (79.51-86.00) 
_Ivent_0 Conv 4/60 6.7 (5.03-8.30) 
ABF 3/35 8.6 (6.21-11.03) 
_Ivent_1 Conv 28/60 46.7 (43.40-49.90) 
ABF 3/35 8.6 (6.21-11.03) 
_Ivent_2 Conv 28/60 46.7 (43.40-49.90) 
ABF 12/35 34.5 (30.10-38.67) 
aiao_0 Conv 10/60 16.7 (14.23-19.10) 
ABF 23/35 65.5 (61.43-69.60) 
aiao_1 Conv 50/60 83.3 (80.90-85.77) 
ABF = Antimicrobial-free farms. Conv = Conventional farms.  
CI = Confidence interval 
A key for the variables in this table is presented in appendix F. 
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Table 4.1 (e). Summary of medication usage at the herd level by the number of 
farms that used these medications and the proportion on antimicrobial-free and 
conventional swine farms. 
Variable name Farm type No./total farms Percentage (95% CI) 
ABF 22/35 62.8 (46.4-79.3) dewormer Conv 17/60 28.3 (16.7-40.0) 
ABF 10/35 28.6 (13.2-44.0) 
mangelice Conv 4/60 6.7 (0.2-13.1) 
ABF 12/35 34.2 (18.1-50.4) 
probiotics Conv 1/60 1.7 (-1.6-5.0) 
ABF = Antimicrobial-free farms. Conv = Conventional farms. 
CI = Confidence interval 
A key for the variables in this table is presented in appendix F. 
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Table 4.2. Multivariable model of herd-level risk factors for azithromycin resistance in 
Campylobacter isolates from finisher pigs on 95 swine farms. 
Covariate B (SE) OR 95%CI p-value† Wald p (df) 
htype 2.0 (0.56) 7.5 2.5-22.4 0.00  
mixfarm -1.4 (0.49) 0.25 0.1-0.6) 0.004  
rhin -2.7 (0.48) 0.07 0.03-0.17 0.00  
_vent_0 _ _ _ _ _ 
_vent_1 0.12 (0.58) 1.1 0.36-3.52 0.84  
_vent_2 1.29 (0.46) 3.6 1.48-8.85 0.01 0.00 (2) 
_Iacclim_0 _ _ _ _ _ 
_Iacclim_1 1.81 (0.58) 6.1 1.96-19.24 0.00  
_Iacclim_2 0.86 (0.47) 2.4 0.94-6.01 0.07 0.01 (2) 
B = Regression coefficient. SE = Standard error. OR = Odds ratio. CI = Confidence 
interval. 
†A value of P≤0.05 was considered significant. 
*rhinitis and htype interaction caused the model to not converge.  
A key for the variables in this table is presented in appendix F. 
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Table 4.3. Multivariable model of herd-level risk factors for tetracycline 
resistance in Campylobacter isolates from finisher pigs on 95 swine farms. 
Covariate B (SE) OR 95%CI p-value† 
htype 3.45 (0.55) 15.2 5.29-43.89 <0.01 
ili -0.84 (0.34) 0.43 0.22-0.84 0.01 
floor -1.52 (0.48) 0.22 0.08-0.56 0.002 
swineflu -0.73 (0.35) 0.48 0.24-0.96 0.04 
B = Regression coefficient. SE = Standard error. OR = Odds ratio.  
CI = Confidence interval. 
†A value of P≤0.05 was considered significant. 
*no interaction terms were significant.  
A key for the variables in this table is presented in appendix F. 
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Table 4.4. Multivariable model of herd-level risk factors for tetracycline 
resistance in E. coli isolates to from finisher pigs on 95 swine farms. 
Covariate B (SE) OR 95%CI p-value† Wald p (df) 
htype 0.71 (0.28) 2 1.18-3.54 0.01  
_Ihouse_2 0.21 (0.42) 1.24 0.55-2.79 0.61  
_Ihouse_3 -0.58 (0.46) 0.56 0.23-1.36 0.20  
_Ihouse_4 0.35 (0.42) 1.42 0.63-3.20 0.40  
_Ihouse_5 1.71 (0.30) 5.53 1.07-28.63 0.04 0.02 (4) 
floor 0.77 (0.30) 2.15 1.20-3.86 0.01  
myco_pn 0.88 (0.37) 2.41 1.18-4.93 0.02   
B = Regression coefficient. SE = Standard error. OR = Odds ratio.  
CI = Confidence interval. 
†A value of P≤0.05 was considered significant. 
*floor probably a confounder for htype. 
A key for the variables in this table is presented in appendix F. 
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Table 4.5. Multivariable model of herd-level risk factors for streptomycin 
resistance in E. coli isolates from finisher pigs on 95 swine farms. 
Covariate B (SE) OR 95%CI p-value† Wald p (df) 
htype 0.96 (0.20) 2.6 1.77-3.84 0  
_Ihouse_1      
_Ihouse_2 0.08 (0.23) 1.1 0.69-1.69 0.72  
_Ihouse_3 -0.92 (0.52) 0.4 0.14=1.10 0.08  
_Ihouse_4 -0.13 (0.20) 0.9 0.59-1.31 0.53  
_Ihouse_5 0.67 (0.25) 2 1.20-3.19 0.01 0.00 (4) 
flooring 0.89 (0.23) 2.4 1.54-3.83 0.00  
mangelice 0.40 (0.21) 1.5 0.98-2.25 0.06  
ulcer 0.04 (0.28) 1 0.60-1.78 0.90  
free_roam -0.52 (0.17) 0.6 0.42-0.83 0.00  
Swineflu 0.09 (0.23) 1.1 0.70-1.72 0.69  
flu*htype -0.71 (0.30) 0.5 0.27-0.89 0.02  
ulcer*htype -0.72 (0.35) 0.5 0.25-0.96 0.04   
B = Regression coefficient. SE = Standard error. OR = Odds ratio.  
CI = Confidence interval. 
†A value of P≤0.05 was considered significant. 
A key for the variables in this table is presented in appendix F 
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Table 4.6. Multivariable model of herd-level risk factors for ampicillin 
resistance in E. coli isolates from finisher pigs on 95 swine farms. 
Covariate B (SE) OR 95%CI p-value† 
htype 0.66 (0.23) 1.9 1.24-3.02 0.004 
rhin -1.71(0.44) 0.2 0.08-0.43 0.000 
B = Regression coefficient. SE = Standard error. OR = Odds ratio.  
CI = Confidence interval. 
†A value of P≤0.05 was considered significant. 
A key for the variables in this table is presented in appendix F. 
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Table 4.7. Multivariable model of herd-level risk factors for sulfamethoxazole 
resistance in E. coli isolates from finisher pigs on 95 swine farms. 
Covariate B (SE) OR 95%CI p-value† Wald p (df) 
htype 0.54 (0.21) 1.7 1.13-2.61 0.01  
size -0.26 (0.25) 0.8 0.47-1.25 0.29  
_Ihouse_1 - - - _  
_Ihouse_2 -0.01 (0.27) 1.0 0.58-1.67 0.96  
_Ihouse_3 -0.79 (0.41) 0.5 0.20-1.00 0.05  
_Ihouse_4 -0.38 (0.25) 0.7 0.41-1.12 0.13  
_Ihouse_5 0.46 (0.33) 1.6 0.83-3.03 0.17 0.01 (4) 
pseudovx 0.58 (0.25) 1.8 1.1-3.0 0.02   
B = Regression coefficient. SE = Standard error. OR = Odds ratio.  
CI = Confidence interval. 
†A value of P≤0.05 was considered significant. 
A key for the variables in this table is presented in appendix F. 
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Table 4.8. Multivariable model of herd-level risk factors for chloramphenicol 
resistance in E. coli isolates from finisher pigs on 95 swine farms. 
Covariate B (SE) OR 95% CI p-value† Wald p (df)  
htype 0.24 (0.41) 1.3 0.57-2.85 0.56  
chickens 1.12 (0.28) 3.1 1.79-5.32 0.00  
rendering -1.20 (0.540 0.3 0.10-0.86 0.03  
_Ivent_0 _ _ _ _  
_Ivent_1 1.36 (0.53) 3.9 1.38-11.0 0.01  
_Ivent_2 1.53 (0.51) 4.6 1.70-12.6 0.00 0.01 (2) 
B = Regression coefficient. SE = Standard error. OR = Odds ratio.  
CI = Confidence interval. 
†A value of P≤0.05 was considered significant. 
*chickens and ventilation are confounders of htype 
A key for the variables in this table is presented in appendix F. 
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Herd management practices including type of house, ventilation, bedding, floor 
type, and flooring were hypothesized to be correlated. Associations were detected based 
on chi-square associations between each pair of variables listed above. Spearman’s 
Correlation test for independence showed highly significant association between the 
variables ‘bedding’ and ‘house.’ Hence, the variable bedding was excluded from 
development of the multivariable models. 
Herd size was investigated as a potential confounder in all multivariate models; 
however, adding herd size did not change the overall effect of herd type (conventional 
and antimicrobial-free) by more than 20% in any of the models except for E. coli-
sulfamethoxazole and the MDR of E. coli (see below); therefore, herd size was included 
as a confounder in the E. coli-sulfamethoxazole model. 
Some covariates were associated with antimicrobial resistance in more than one 
multivariable model given herd type. The ‘housing environment’ which describes 
whether a farm used complete confinement (referent), used partial confinement, pasture, 
hoop barns or other combinations of confinement types, was the variable that was most 
often associated with AMR of E. coli isolates (streptomycin (P<0.01), tetracycline 
(P<0.02), and sulfamethoxazole (P<0.01)). In the three multivariable models with 
housing environment as a covariate, other covariates that were significant in the models 
included floor type, presence of Mycoplasma pneumonia (tetracycline); use of 
pseudorabies vaccine (sulfamethoxazole); in addition, treatment of mange and lice, 
history of gastric ulcers and swine flu, and allowing free roaming animals on farm 
(streptomycin) was also present in studies where housing environment was a covariate. 
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Among three multivariable models (tetracycline, streptomycin, and sulfamethoxazole), 
pasture was negatively associated with a higher proportion of AMR whereas partial 
confinement was associated with a higher proportion of AMR, and hoop barns was 
associated with a higher proportion of tetracycline AMR, but negatively associated with 
E. coli-streptomycin and E. coli-sulfamethoxazole AMR. 
The flooring variable described whether a farm used dirt, concrete, or some other 
combination thereof. Use of dirt and other combinations (dirt and concrete, dirt and other 
type of floor, or concrete and other type of floor) compared to only concrete flooring 
was associated with streptomycin resistance of E. coli isolates. Mixing of feed on the 
farm as compared to mixing feed offsite was significantly associated with lower 
azithromycin resistance in Campylobacter isolates. 
Use of natural or mechanical ventilation on a farm compared to a barn being 
open to the outside (referent) was positively associated with azithromycin resistance of 
Campylobacter isolates (P<0.01) and chloramphenicol resistance of E. coli isolates 
(P=0.01). The floor type, slats, weaved or a combination of slats and weaved compared 
to solid floors was positively associated with tetracycline resistance among E. coli 
isolates (OR=2.15) but negatively associated with tetracycline resistance among 
Campylobacter isolates (OR=0.22). 
Biosecurity practices that were significantly associated with resistance 
prevalence in at least one of the multivariable models were: ‘acclimation,’ ‘allowing free 
roaming animals on the farm,’ the ‘presence of chickens on the farm,’ ‘allowing 
rendering trucks on the farm,’ and ‘allowing pig contact with other animals,’ The 
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acclimation variable (use of mummies, cull animals, sick animals or feces to acclimate 
replacement animals) was positively associated (OR=2.4) with azithromycin resistance 
in Campylobacter isolates given herd type. Use of vaccines as a method of acclimation 
(OR=6.1) (referent was acclimation not used) was positively associated among farms 
that had a higher proportion of azithromycin resistance as compared to farms that did 
not. Farms with chickens were (OR=3.1) more likely to have chloramphenicol resistance 
of E. coli. Additionally, farms that allow rendering trucks onto farm were less likely to 
have chloramphenicol resistance given the other variables in the model (OR=0.3). 
Accounting for herd type, diseases that were present on the farms within a year 
of the study and that were significant in one or more multivariable models included 
rhinitis, ileitis, swine flu, Mycoplasma pneumonia, and gastric ulcers. The farm level 
covariate, ‘history of atrophic rhinitis’ on a farm, was less likely on farms with a higher 
proportion of azithromycin resistance of Campylobacter isolates (OR=0.07) and 
ampicillin resistance of E. coli isolates (OR=0.2). Tetracycline resistance of 
Campylobacter was less likely on farms with a history of ileitis (OR=0.43) and swine flu 
(OR=0.48). A history of Mycoplasma pneumonia was positively associated (OR=2.4) 
with tetracycline resistance of E. coli. Both a history of gastric ulcers and swine flu were 
included as interaction terms with herd type in the multivariable model for streptomycin 
resistance in E. coli (P=0.04 and P=0.02, respectively). Use of pseudorabies vaccine was 
positively associated with sulfamethoxazole resistance in E. coli (OR=1.8).  In addition, 
treatment for mange and lice was positively associated with streptomycin resistance in E. 
coli isolates (OR=1.5). 
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Table 4.9. Multivariable model of herd-level risk factors for multidrug 
resistance in Campylobacter isolates in a study of 95 swine farms. 
Multidrug resistance was resistance to two or more antimicrobial drugs. 
Covariate B (SE) OR 95%CI p-value† 
htype 1.6 (0.39) 4.8 2.2-10.4 0.00 
hsize* 0.0 (0.00) 1.0 1.0-1.0 0.002 
rhin** -1.6 (0.43) 0.20 0.09-0.47 0.00 
B = Regression coefficient. SE = Standard error. OR = Odds ratio.  
CI = Confidence interval. 
†A value of P≤0.05 was considered significant. 
* herd size added as a confounder 
** rhinitis interaction caused the model to not converge 
A key for the variables in this table is presented in appendix F. 
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Among 464 Campylobacter isolates, MDR was negatively associated with the 
history of rhinitis on the farm (Table 4.9). In addition, adjusted OR were reported to 
account for herd size which was included in the multivariable model as a confounder. 
Among 1,381 E. coli isolates, MDR was positively associated with the history of 
salmonellosis (OR=3.6) (Table 4.10). MDR was negatively associated with house type 
(referent was total confinement) (P<0.01), history of rhinitis on the farm (OR=0.47), 
history of swine flu on the farm (OR=0.58), and biosecurity procedures associated with 
visitors that enter farms (referent was no biosecurity requirements) (P<0.01). In addition, 
herd size was not a confounder in the multivariable model for E. coli-MDR. However, 
an interaction between the history of salmonellosis and herd type was significant and 
included in the final multivariable model. 
Among the 464 pigs that gave rise to a Campylobacter isolate, 456 pigs had a 
Campylobacter isolate that was resistant to one or more of 6 antimicrobial drugs and an 
E. coli isolate that was resistant to one or more of 14 antimicrobial drugs (the MBAR 
model). The median number of resistances per individual pig was 4 with a range of 0-14 
(an isolate that was not resistant to any of the antimicrobial drugs was considered pan-
susceptible). Among antimicrobial-free farms, there were 169 pigs that had multiple 
resistances with a median of 2 and a range of 0-8 and among conventional farms, there 
were 287 pigs with multiple resistances with a median of 4 and a range of 0-14 (Figure 
4.1). The frequencies of resistance among Campylobacter and E. coli within one animal 
were cross-tabulated (Table 4.11). Comparison of multiple-resistance among 
Campylobacter and E. coli indicated non-significant differences (P=0.52):  
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Table 4.10. Multivariable model of herd-level risk factors for multidrug resistance 
(MDR) in E. coli isolates from finisher pigs on 95 swine farms. 
Covariate B (SE) OR 95%CI p-value† Wald p (df) 
htype 0.91 (0.21) 2.5 1.63-3.74 0.00  
_Ihouse_1 _ _ _ _  
_Ihouse_2 0.06 (0.27) 1.1 0.62-1.79 0.83  
_Ihouse_3 -0.82 (0.33) 0.4 0.23-0.85 0.84  
_Ihouse_4 0.14 (0.27) 3.6 1.48-8.85 0.01  
_Ihouse_5 0.08 (0.24) 1.1 0.67-1.75 0.62 0.04 (4) 
swineflu -0.54 (0.22) 0.6 0.38-0.89 0.01  
salm 1.28 (0.20) 3.6 2.42-5.38 0.00  
rhin -0.75 (0.13)  0.5 0.36-0.61 0.00  
_Ivisitoronfarm_0 _ _ _ _  
_Ivisitoronfarm_1 -0.70 (0.27) 0.5 0.29-0.85 0.01  
_Ivisitoronfarm_2 -0.57 (0.31) 0.6 0.31-1.04 0.07 0.04 (2) 
htype*salm -1.24 (0.46) 0.3 0.12-0.72 0.01  
B = Regression coefficient. SE = Standard error for B. OR = Odds ratio.  
CI = Confidence interval. 
†A value of P≤0.05 was considered significant. 
*rhinitis and herd-type interaction terms caused the model to not converge. 
**Herd-type and Salmonella was a significant interaction term. 
A key for the variables in this table is presented in appendix F. 
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Figure 4.1. Frequency of samples with multi-resistance among  
antimicrobial-free (ABF) and conventional swine farms. 
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Table 4.11. Frequency of co-resistance among Campylobacter and E. coli 
isolates in swine farms. 
Campylobacter-- 1 2 3 4 5 6 Total 
E. coli        
1 22 23 8 15 0 0 68 
2 40 41 27 73 0 0 181 
3 16 16 12 38 1 0 83 
4 12 16 10 27 1 1 67 
5 5 14 7 17 0 0 43 
6 0 2 0 6 0 0 8 
7 0 1 0 2 0 0 3 
8 0 0 0 1 0 0 1 
9 0 0 1 0 0 0 1 
12 0 0 0 1 0 0 1 
Total 95 113 65 180 2 1 456 
*Pearson Chi2(45) = 43.944; Pr = 0.517 
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Table 4.12. Multivariable model of herd-level risk factors for multi-
bacterial-antimicrobial resistance (MBAR) in E. coli and Campylobacter 
isolates from finisher pigs on 95 swine farms. 
Covariate B (SE) OR 95% CI p-value† 
htype 2.25 (0.31) 9.5 5.20-17.25 0.00 
rhin -0.24 (0.38) 0.8 0.37-1.68 0.54 
animal_contact -0.74 (0.31) 0.5 0.26-0.88 0.02 
rhin * htype -1.71 (0.48) 0.2 0.07-0.47 0.00 
B = Regression coefficient. SE = Standard error. OR = Odds ratio.  
CI = Confidence interval. 
†A value of P≤0.05 was considered significant. 
A key for the variables in this table is presented in appendix F. 
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The analysis of multiple resistances among pigs with Campylobacter and E. coli and the 
38 explanatory variables is presented in a table in Appendix G. The final multivariable 
model for MBAR (Table 4.12.) included a negative association with animal contact 
(OR=0.5) and an interaction term between rhinitis and herd type. 
 
4.4. Discussion 
 
The apparent prevalence of antimicrobial resistance has been described in and 
compared between antimicrobial-free (including organic) and conventional farms for 
different food animal species: cattle (Sato et al., 2004a; Sato et al., 2005; Halbert et al., 
2006; Ray et al., 2006), poultry (Avrain et al., 2003; Luangtongkum et al., 2006; Siemon 
et al., 2007; Schwaiger et al., 2008), and swine (Docic and Bilkei, 2003; Gebreyes et al., 
2005; Bunner et al., 2007; Rollo et al., 2010). In this study, we investigated whether 
certain herd level practices were associated with antimicrobial resistance in 
Campylobacter and E. coli isolated from pigs on antimicrobial-free and conventional 
swine farms in Midwestern states. The main exposure variable being tested was herd 
type, i.e., antimicrobial-free versus conventional production practices. Herd type was 
included in all models. 
Previously, the proportions of AMR in swine fecal E. coli and Campylobacter 
isolates by herd type were examined using this dataset (Bunner et al., 2007; Rollo et al., 
2010). Two antimicrobial drugs (tetracycline and azithromycin) that had a higher 
proportion of AMR in Campylobacter isolates and five antimicrobial drugs (ampicillin, 
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chloramphenicol, streptomycin, sulfamethoxazole, tetracycline) that had a higher 
proportion of AMR in E. coli in conventional farms as compared to conventional farms 
were used in the current analysis to investigate if other management practices were 
associated with the levels of antimicrobial resistance. Only 2 drugs were considered in 
Campylobacter isolates because erythromycin and azithromycin are both macrolides and 
very similar in their patterns of resistance, and the other antimicrobials had sparse data 
(see Section 2). Five drugs were selected from the E. coli data set because these were the 
ones that a significant difference between herd type and because resistance was sparse 
for several of the other antimicrobial drugs. Findings in this study indicate that AMR in 
Campylobacter and E. coli isolates of swine was associated with unique herd level risk 
factors among each antimicrobial-bacteria combination. 
In addition, multi-drug resistance of E. coli and Campylobacter and multi-
bacterial-antimicrobial resistance were examined. Multi-bacterial-antimicrobial 
resistance in this analysis included any combination of Campylobacter spp. and E. coli 
from a sample from which Campylobacter spp. that was resistance to at least one of six 
antimicrobial drugs and from which E. coli that were resistant to at least one of 14 
antimicrobial drugs were isolated. Also, the selected Campylobacter spp. and E. coli 
isolates were cumulatively resistant to three or more antimicrobial drugs. Multi-
bacterial-antimicrobial resistance was significantly higher on conventional farms 
compared to antimicrobial-free farms. 
Cross-resistance and co-resistance likely contributed to MBAR in this study. 
Since azithromycin and erythromycin are both macrolides, they are almost completely 
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cross-resistant. Also, chlortetracycline use in feed has been associated with ampicillin 
resistance, and the use of tylosin increased the risk of AMR in sulfamethoxazole (Varga 
et al., 2009). Furthermore, co-selection of chloramphenicol and sulfonamide genes 
located on plasmids has been described (Bischoff et al., 2002; Travis et al., 2006). One 
contribution to multidrug resistance is the presence of multidrug efflux pumps. Efflux 
pumps contribute to the intrinsic resistance of Campylobacter spp. to a broad range of 
structurally unrelated antimicrobial agents (Lin et al., 2002; Payot et al., 2004a; Moore et 
al., 2006). Another mechanism is transfer of resistance determinants via integrons which 
integrate resistance genes and transfer them among bacteria. Integrons can be transferred 
themselves or by either plasmids or transposons. There was a higher frequency of E. coli 
bacterial resistance to ampicillin, streptomycin, sulfonamides, and tetracyclines 
compared to other antimicrobials in this study as well as swine herds elsewhere (Burch 
et al., 2008). This study did not examine resistance mechanisms at the molecular level; 
however, the high frequency of resistance of these antimicrobials was likely related to 
the co-selection as described above.  
A surprising result in this study was the association between use of acclimation 
and azithromycin resistance of Campylobacter. Acclimation is an important 
management practice that may help build immunity in pigs in isolation before they enter 
into the main herd. Acclimation includes exposure to manure, cull sows, sick pigs, and is 
often supplemented with vaccines. About 52% of the conventional farms did not use 
acclimation compared to one-third of the antimicrobial-free farms. Vaccination is used at 
different stages of swine production for different purposes. Vaccination of the sow helps 
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stimulate immunity against E. coli, Clostridium perfringens, atrophic rhinitis and 
erysipelas that is passed to piglets (Burch et al., 2008). Growing pigs require vaccination 
for respiratory diseases. Use of vaccination in herd management is a valuable tool for 
combating disease which in turn could reduce the likelihood of antimicrobial drug use 
and AMR. The positive association between the use of vaccines for acclimation and 
resistance in the azithromycin-Campylobacter model may have occurred because only 
farrow to finish farms use acclimation in nursery pigs, and azithromycin resistance of 
Campylobacter was more prevalent among conventional farrowing to finish farms than 
antimicrobial-free farms. On the other hand, use of vaccination as a preventive measure 
(other than as a category of acclimation) was not associated with any AMR of bacteria 
with the exception of the sulfamethoxazole-E. coli model that included usage of 
pseudorabies vaccine. The negative association between pseudorabies vaccine and 
sulfamethoxazole resistance of E. coli may be because it was an intervening variable in 
that model or added by chance which will occur when there are a number of variables 
being examined. A number of studies have been conducted to investigate possible 
associations between herd level risk factors and bacterial prevalence (e.g. Salmonella) 
(Funk and Gebreyes, 2004; Lo Fo Weng et al., 2004; Bahnson et al., 2006; Zheng et al., 
2007; Namata et al., 2009); however, very few studies have been conducted specifically 
to investigate AMR prevalence and association with herd management factors on food 
animal farms (with the exception of Schuppers et al., 2005). Most likely, this is because 
of the added cost of determining the MIC of various antimicrobial drugs as opposed to 
merely determining the prevalence of bacteria. Furthermore, the association of bacterial 
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prevalence to farm-level risk factors may be more directly related based on a causal 
pathway. Some management practices have been developed for the purpose of 
controlling pathogenic bacteria (Burch et al., 2008). With regards to pathogenic bacteria, 
the farm level risk factors associated with a history of Salmonellosis could also be 
related to AMR of Salmonella; however, that does not necessarily have to be the case. In 
addition, management practices that have an impact on pathogen loads most likely will 
also have an impact on antimicrobial use, which could indirectly influence the 
prevalence of AMR. Although conventional farms used some antimicrobial drugs, the 
amounts and types were incomplete and not considered further in this study. This may 
inadvertently have influenced the associations between AMR and farm level 
management practices given the wide variety of antimicrobial drugs and purposes for 
use available on swine farms. Further studies investigating antimicrobial resistance and 
risk factors thereof should be designed to allow control of bacterial prevalence along 
with antimicrobial use. This may also help to identify potential confounders. 
If predictor variables are highly correlated, the standard errors will be inflated 
from incorrect variance estimates resulting in unstable regression coefficients (Hosmer 
and Lemeshow, 2000). We considered the inflated standard errors as a reason to drop a 
variable (i.e. confinement operation or not). In addition, we selected variables according 
to the investigation of potential association between independent and dependent 
variables (Dohoo et al., 2003). In this study, the list of variables was reduced on the 
basis that some variables may serve as proxies for other variables (multicollinearity) 
(Agresti, 1996). In those cases, the variable that made most biological sense was chosen, 
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although this is subjective. Some of the management practices were hypothesized as 
being related (e.g. floor type, housing, flooring, bedding, and ventilation) so potential 
correlation was considered. Only one pair of covariates was above the cutoff of 0.7: 
‘bedding’ and ‘house’. The variable house described whether pigs were maintained 
under total confinement, partial confinement, pasture, hoop barn, or a combination of 
these. Bedding referred to no bedding used compared to straw or corn stalks. Total 
confinement was expected to be highly associated with ‘no bedding used’ as was the 
case in this study (39% of all farms used total confinement housing and no bedding). 
Therefore, the variable ‘bedding’ was not considered in the multivariable models. 
Furthermore, ‘house’ was significant in three multivariable models for E. coli 
(tetracycline, streptomycin, and sulfamethoxazole). The variable ‘house’ probably 
accounts for some of the variation associated with herd size which may explain why 
herd size was not a confounder in most of the final multivariable models. Other options 
to reduce multicollinearity include principal components analysis and factor analysis, but 
those methods cannot determine which individual predictor variables have significant 
associations with the dependent variable — this was the primary goal of this analysis 
(Dohoo et al., 1996). 
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We used stepwise regression as the method for selection of variables to be 
included in the multivariable models. However, stepwise regression has been criticized 
because the addition or elimination of a variable may not be based on the causal 
pathway. In addition, statistical control of confounding can be a problem in stepwise 
regression. Sometimes irrelevant variables can be selected by chance when there is a 
large number of predictors (Agresti, 1996), and it is hard to differentiate between an 
intervening variable and another extraneous variable (Dohoo et al., 1996). Therefore 
each variable should be verified by comparing the estimated coefficient with the 
coefficient from the univariate model. In addition, the Wald statistics should be 
examined, and a smaller model can be compared to the larger by examining any 
significant changes in the coefficients. This process continues until the most 
parsimonious model is selected. When there are a number of covariates that are 
examined for inclusion into a multivariable model, some will be included strictly due to 
chance. This may explain why only a few variables were included in only one 
multivariable model in this study, and this should be considered when making inferences 
based on these results. 
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We used a population averaged model because of the clustered nature of farm 
animals. In this study, the outcome was tested at the individual pig level, yet the 
predictors are at the herd level. If clustering is ignored, the variance in the form of the 
standard errors will be underestimated. GEE models are marginal models, which mean 
the expected values for a set of covariates are averaged across the population of clusters.  
The interpretation is more attractive than a subject specific model where a random effect 
for each cluster is included in the model (Hardin and Hilbe, 2003). The GEE model uses 
weighted versions of likelihood equations. The weights are based on the underlying 
covariance matrix and the shape of the matrix can be selected in the modeling process. 
The exchangeable matrix was used here which assumes that the correlation between 
pairs of responses is constant (Hosmer and Lemeshow, 2000). 
In conclusion, AMR in Campylobacter and E. coli isolates from swine fecal 
samples was associated with a variety of production practices among antimicrobial-free 
and conventional swine farms. Farm-level intervention studies would be helpful in 
determining the importance of some of the risk factors identified. Some farmers have 
chosen to pursue antimicrobial-free farming which likely will reduce AMR in the long 
run. However, when changing to an antimicrobial-free production system, other changes 
in production management most likely also will occur. Studies that account for or 
control these ‘other’ management changes will be valuable in making decisions whether 
or not, for example, to change from conventional to antimicrobial-free production. 
Antimicrobial drug use in food animal production may be needed in order to maintain 
health and well-being of the animals, but may at the same time increase levels of AMR. 
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An increase in AMR in products of animal origin may potentially increase the risk of 
consumers acquiring bacteria of food animal origin which are resistant.  Resistant 
bacteria of food animal origin can be either pathogenic or commensal bacteria that may 
be able to ‘share’ resistance determinants with pathogens already in the human intestinal 
tract. Either way, resistant bacteria of food animal origin may be a source of infections in 
humans that will be difficult to treat using common antimicrobial drugs. As consumers 
demand more wholesome food animal products, including low levels of antimicrobial-
resistant bacteria (when they are present), it will be beneficial to identify factors, beside 
ceasing antimicrobial drug use, that can help reduce AMR and the potential transmission 
to humans through the food chain. 
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5. CONCLUSIONS 
 
For the past 30 plus years, agricultural animal farming has been oriented toward 
highly structured processes that often involve farming units that use various applications 
of antimicrobial drugs. Antimicrobial drugs are used for disease treatment, prevention, 
and control, and for growth promotion (McEwen and Fedorka-Cray, 2002). In the early 
1950s, a beneficial effect on production efficiency led to more trials that tested the use of 
lower dosages of antimicrobials added to feed (Dibner and Richards, 2005). However, 
antimicrobial resistance in animal populations followed the introduction of antibiotics 
(Aarestrup, 2006; Guardabassi and Kruse, 2008). The Swann report (1969) addressed the 
potential of antimicrobial resistance development, and at that time, the concern was 
directed towards antimicrobial resistance among human pathogens. As food animal 
production developed into confinement facilities, feed efficiency as well as disease 
prevention and control were the primary goals of most production managers. Decisions 
to use dosages aimed at growth promotion were, in part, based on demands for a more 
uniform and a less costly product. Furthermore, some antimicrobial drugs were approved 
for both disease prevention and growth promotion, sometimes at different doses, other 
times at the same dose (McEwen and Fedorka-Cray, 2002). 
Antimicrobial resistance continues to be a topic of concern and in the 1990s, the 
European Union banned four antimicrobials which were being used as growth promoters 
and which were considered important in treating human diseases (European 
Commission, 1999). In Denmark, the overall bulk antibiotic use was decreased by 
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implementing a removal of antimicrobial growth promoters (AGPs) in livestock 
production (Danish Integrated Antimicrobial Resistance Monitoring and Research 
Programme; DANMAP, 2004; Aarestrup et al., 2010). In the U.S., the FDA created a 
discussion document in 2000 that addressed current issues regarding the use of 
antimicrobials in food animal production and the effects on human health (FDA, 2000). 
The premise for removing antimicrobials as growth promoters in the 1990s was that 
antimicrobial resistance in food animals was directly linked to antimicrobial drug 
resistance in bacteria that are pathogenic to and transferable to humans (Molbak, 2004). 
Furthermore, the importance of commensal bacteria’s ability to carry resistance genes 
and transfer them to pathogens at a later time was also addressed in the literature (Sunde 
et al., 1998). These reports corresponded with a lot of negative publicity that made the 
consumer take notice. As a result, some countries banned antimicrobial growth 
promotants in feed, and other methods of food production including organic production 
were explored and expanded. 
When AGPs were banned, morbidity or mortality increased in some production 
systems. Banning AGP use in weanling pigs resulted in higher incidence of disease 
which subsequently resulted in an increase usage of therapeutic antibiotics (Aarestrup et 
al., 2010). Hence, a call was made for more scientifically oriented risk assessments to 
determine the justification of an AGP ban (Snary et al., 2004). Recently, risk 
assessments have addressed the use of specific AGPs and potential risk to human health 
(Cox and Popken, 2004; Hurd et al., 2004). They argue that the uses of tylosin and 
tilmicosin present a very low risk of human illness due to macrolide-resistant 
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Campylobacter spp. or E. faecium based on a quantitative risk assessment. However, the 
use of other antimicrobial drugs may pose a risk to human health. It is important not to 
generalize one study to be representative of all potential relationships of AMR in farm 
animal production and public health. 
In the last decade, consumers have demanded more natural foods, and organic 
farming has become popular. The perception is that organic foods are safer, and 
sometimes “better”, than products from conventional farms. Organic farming in the US 
is a system of animal production which, among other things, prohibits use of 
antimicrobials use as described in more detail in the first section of this dissertation. The 
NOP standards for organic animal farming specify that the production system cannot 
involve any use of hormones for growth encouragement or any use of antibiotics 
(however, vaccines are allowed and sick animals can be treated with antimicrobials if 
permanently removed from the production system). Additional requirements are also 
included in the NOP standards. These requirements include the use of organic feed and a 
certain amount of outdoor exposure (USDA, 2010). The NOP develops, implements, and 
administers national production, handling, and labeling standards for organic agricultural 
products. By removing antimicrobials from a production system, the prevalence of 
antimicrobial resistance (AMR) in organic production systems and hence in the food 
chain should decrease. However, there is ambiguous scientific evidence to date to 
support this hypothesis as described in Section one of this dissertation. In addition, 
converting to organic production is more difficult than it sounds. For example, if one of 
the larger swine producers made the decision to change to organic production, then an 
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increase in demand for organic food crops would exceed the supply (Baker, 2006). 
Instead, some producers have designated their production as antimicrobial-free or 
reduced antimicrobials. This production system is less stringent than organic farming 
and in general only requires a cessation of antimicrobial use, although other management 
requirements may be imposed as well. 
The term antimicrobial resistance can be described as a microbiological change 
in a subpopulation of bacteria that in turn leads to new populations that are resistant to 
antimicrobials (Harrison and Lederberg, 1998; Andersson, 2003). The new populations 
of bacteria have change(s) in one or more genes (i.e. mutation) or contain plasmids or 
other mobile genetic elements, all of which render the bacteria resistant to one or more 
antimicrobial drugs. Resistance means that an increase in the concentration of an 
antimicrobial drug is required to inhibit growth of or kill the organism. In animals or 
humans, these increases in antimicrobial concentration in target tissues are not 
achievable, sometimes referred to as ‘clinical resistance.’ This selection for resistant 
determinants that may propagate and then be disseminated in bacterial populations in 
animals results in higher proportions of resistant bacteria. Movement of resistant 
determinants between bacteria can occur on mobile genetic elements such as plasmids 
and transposons (Baquero and Canton, 2009). In general, a gradual increase in the 
proportion of resistant bacteria occurs after prolonged use of an antimicrobial in a 
population, due to selective and evolutionary events accruing over time. And even some 
undetectable changes below breakpoints are noteworthy as a first step towards clinical 
resistance (Phillips et al., 2004). With the cessation of antimicrobial use in a population 
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of animals (such as might occur with organic farming), one would expect a decrease and 
possibly the elimination of resistant bacteria. One way to examine the trends of 
antimicrobial resistance in farming environments is to compare animal populations that 
utilize antimicrobial drugs for growth promotion, prevention, control, or treatment to 
populations that avoid any antimicrobial usage. This project examined these two 
exposures (no antimicrobial usage and conventional use of antimicrobials in swine 
farms). 
The initial objective of this research project was to critically review the literature 
for studies in which levels and patterns of bacterial antimicrobial resistance were 
compared in organic versus conventional farming systems. Specifically, the 
methodology for conducting a systematic review was used to evaluate and appraise 
studies reporting a difference in prevalence of AMR between the two management 
schemes. The hypothesis was that the cessation of antimicrobial use would result in 
fewer isolates that exhibited antimicrobial resistance. In reviewing the literature we 
found that there were significant and systematic methodological factors in these studies 
that limit their usefulness for reaching comparative conclusions about levels of AMR 
bacteria in organic versus conventional farms. The main focus of the critical review 
hence shifted to issues that can make generalizations from these studies unreliable and 
that can cause difficulties in comparison and summation across studies. Some of the 
problems had to do with the internal validity of the studies, while others were related to 
their generalizability and to the possibility of making cross-study comparisons. We 
identified seven specific problem areas. First, we identified that most of the current 
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literature included studies with inadequate sample sizes. In addition, there was a 
significant variation in how subjects were sampled on the farm and how bacterial 
isolates were chosen for antimicrobial susceptibility testing. The predominant method of 
choosing farms to participate in the study was inconsistent, and nonrandomized selection 
methods were always used. In addition, the definition of organic and antimicrobial-free 
farms varied significantly between studies so that, in other words, the exposure 
(antimicrobial use) was not comparable between studies. The fifth problem area was the 
inconsistency in methods used to determine and report antimicrobial susceptibility which 
varied between country and between which bacterial species was studied. Another 
microbiological problem was the inherent microbiological limitations and potential bias 
that may occur if similar isolation techniques are not used between studies. The final 
area of discussion was the fact that many studies used inappropriate statistical models for 
the structure and nature of the data. The three specific statistical problems that we 
identified were a) not accounting for the hierarchical structure of the data; b) the failure 
to account for the censored nature of the MIC distribution; and c) the issue of discrete 
outcomes when comparing MIC distributions and the inadequacy of the Cox regression 
model. 
These major issues limit the cross-summation or inference from these types of 
studies. Although we found that more studies suggested a greater prevalence of 
antimicrobial resistance on conventional farms, some studies suggested the opposite, and 
the prospect of reaching any definitive conclusion on the basis of the existing literature 
seems extremely unlikely. 
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In the second section of this dissertation, the objective of the study was to 
identify and compare the apparent prevalence of Campylobacter spp. and the apparent 
prevalence and patterns of AMR for fecal Campylobacter spp. isolated from pigs reared 
under antimicrobial-free and conventional production methods. This project was 
designed as a cross-sectional study of antimicrobial-free swine farms selected from a list 
of 2 co-ops. Thirty-five farms agreed to participate in the study which involved visiting 
each farm once to collect 15 fecal samples from finishers and the administration of a 
questionnaire for farm managers. Once the 35 farms were selected, conventional farms 
were selected that were close in proximity to each antimicrobial-free farm. Herd size 
was also considered but in most cases, conventional farms were larger than 
antimicrobial-free farms therefore identifying small conventional farms was unrealistic. 
Fifteen fecal samples from 15 finishers were collected from each farm with the 
exception of one farm where only 12 samples were collected. The study was conducted 
in 2002-2003. Healthy finishers were selected because there would be less variation in 
present treatments and they are closer to slaughter. Farms from seven states were 
included in this study (Table 5.1). 
Three bacterial types were selected, Salmonella, Campylobacter, and E. coli, but 
there were insufficient numbers of Salmonella isolates for a statistical analysis. 
Campylobacter spp. are important zoonotic pathogens found in pigs and which may 
carry resistance determinants (Pezzotti et al., 2003; Rollo et al., 2010). Furthermore, 
illness caused by the exposure to Campylobacter in food can be difficult to treat if 
resistant strains are present (Helms et al., 2005). E. coli are present in the gastrointestinal 
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Table 5.1. Ninety-five farms from 8 Midwestern states were included in a study 
of Campylobacter prevalence and antimicrobial susceptibility. 
 ABF  Conventional  Both  
State 
No. of 
farms 
No. of 
pigs  
No. of 
farms 
No. of 
pigs  
Total 
farms 
Total 
Pigs 
Mean 
Farm 
size 
Iowa 20 297  17 255  37 552 2,067 
Illinois 7 105  8 120  15 225 3,123 
Indiana 0 0  5 75  5 75 12,900 
Michigan 0 0  21 315  21 315 13,500 
Minnesota 2 30  6 90  8 120 2,988 
Nebraska 5 75  1 15  6 90 1,508 
Ohio 0 0  2 30  2 30 10,050 
Wisconsin 1 15  0 0  1 15 300 
Total 35 522  60 900  95 1422  
No. = Number, ABF= antimicrobial-free 
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tract of most warm-blooded animals as a commensal bacterium (Hartl and Dykhuizen, 
1984). E. coli are also present in the environment and can serve as a reservoir for 
resistance genes that can be transferred to pathogenic bacteria (Sunde et al., 1998; 
Windfield and Groisman, 2003;Anderson and Sobsey, 2006). However, the actual 
transfer of resistant genes from commensal bacteria to pathogenic bacteria has not been 
thoroughly investigated in vivo (Mathew et al., 2007). One theory suggests that the 
exposure of commensal bacteria to various antimicrobials can lead to an increase in 
prevalence of genes that are associated with resistance by plasmids, integrons, and 
transposons (Lees et al., 2008). 
In the study of antimicrobial resistance in Campylobacter spp. and E. coli 
presented in this dissertation, the microbiological methods used for isolation, 
identification of bacterial isolates and their resistance patterns included several steps. 
First, the bacteria were isolated from the fecal samples based on current microbiological 
methods (see Section 2). Second, the antimicrobial susceptibility was determined. For 
Campylobacter a panel of six antimicrobial drugs was used, and for E. coli, a panel of 14 
antimicrobial drugs was used (Bunner et al., 2007).  
The apparent prevalence of Campylobacter among finishers was approximately 
33% and the prevalence was independent of herd size and production system (ABF vs. 
conventional). The highest apparent prevalence of AMR was to erythromycin, 
azithromycin, and tetracycline. Both macrolides (erythromycin and azithromycin) had 
similar distributions and there were about 70% more resistant isolates among 
conventional farms. Tetracycline resistance was evident on all farms and although there 
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was a significant higher proportion of AMR on conventional farms, the difference 
between the two production systems was less than the macrolides. One interesting result 
in this study was an apparent dose-response effect for the duration of antimicrobial-free 
production.  
There was an association with the length of time a farm was free from 
antimicrobial drug use and the reduced proportion of bacterial antimicrobial resistance. 
In other words, the more years that a farm was managed without antimicrobial drug use, 
the less antimicrobial resistance of Campylobacter spp. was present on the farm. The 
apparent dose-response effect was most apparent for the macrolides (see Figure 3.1). 
Tetracycline resistance had a threshold for decline at approximately 3 years. In other 
words tetracycline resistance did not decline until a farm was antimicrobial free for 3 or 
more years. The large variety of mechanisms of tetracycline resistance (see Figure 3.2) 
among Campylobacter spp. isolates may explain why there was only a 40% decrease in 
tetracycline resistance on farms that were antimicrobial free for ≥ 6 years, compared 
with findings on conventional farms; in contrast, an 80% decrease in erythromycin 
resistance and an 83% decrease in azithromycin resistance was detected between those 
farm types. This is relevant because bacteria resistance of tetracycline on the farm will 
most likely be difficult to eliminate or reduce significantly compared to other 
antimicrobials. 
 In the Campylobacter study described in section two, decreased AMR to 
erythromycin, azithromycin, and tetracycline was observed on antimicrobial-free farms. 
However, this was a cross-sectional study so the rate of decrease in resistance could not 
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be quantified. Furthermore, one inherent assumption was that both types of farms had 
the same amount of AMR prior to the change in production to organic practices. Another 
limitation was that when farms changed to organic production, changes in risk factors 
most likely would have occurred. The results of this study are valuable for generating 
hypotheses and the prospect of a longitudinal study which could further characterize 
potential dose responses that may be associated with the cessation of antimicrobial drug 
use would be intriguing. 
A number of descriptive studies have reported various proportions of 
antimicrobial resistance among Campylobacter spp., Salmonella, and E. coli in animal 
populations (Mathew et al., 2001; Sato et al., 2004a; Gebreyes et al., 2005; Englen et al., 
2007). The measure of susceptibility was presented as minimum inhibitory 
concentrations which were then dichotomized into two categories (susceptible and 
resistant) based on breakpoints for each antimicrobial drug. Using microbiological 
breakpoints to dichotomize bacteria into susceptible and resistant categories may limit 
researchers’ ability to compare susceptibility among bacteria isolated from animals 
reared under different production systems. This is particularly troublesome when few or 
none of the bacteria have MIC values above the breakpoint (i.e. classified as resistant). 
An alternative to comparing proportions is to compare the distribution of MIC values in 
two or more populations. The frequency distribution of MICs in a group of bacterial 
isolates will vary based on the bacteria, the antimicrobial drug, and the proportion of 
isolates that have unique MICs. The distribution can be right or left censored and often 
there is a spike in the highest MIC category. In addition, each test to determine MIC 
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(e.g. Etest® or microbroth dilution) differs in the number of categories available for 
measuring growth inhibition. Comparing MIC distributions allows the researcher to 
account for the variation and the range of MICs in a population. Another characteristic 
of a MIC distribution is that the distribution is not considered continuous; rather, there 
are a set number of categories. The number of categories differs based on the 
susceptibility testing method. From a statistical point of view, this is referred to as 
interval censoring. These inherent characteristics of MIC distributions make the 
statistical analysis a challenge and addressing this issue was the objective of Section 3. 
The objective of the second study reported in Section 3 was to introduce a 
statistical model that accounted for the inherent characteristics of an MIC distribution 
including censoring of the data and discrete intervals. The MIC distribution of E. coli 
and Campylobacter isolates were compared between antimicrobial-free and conventional 
farms. We described a discrete time survival analysis model and its suitability for 
analysis of MIC data. To our knowledge, this model has not been considered and derived 
in detail for use in comparing MIC distributions between populations previously. Section 
3 considers the possibility of using this model. Derivation of this model for this type of 
data required a transformation of the data from a subject-period data into subject-period 
time data, a longitudinal progression. Each isolate was represented in multiple lines 
accounting for time or the lowest concentration of the test to the point where growth 
inhibition occurred. A hazard function describes the conditional probability of event 
occurrence at time (t) given it has not occurred up to time (t) (Dohoo et al., 2003). In 
addition, other assumptions inherent to survival analysis models were also addressed. 
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Using the DTSA framework, there was a significant difference in the 
distributions for all six antimicrobial-bacterial combinations tested among antimicrobial-
free and conventional farms, whereas when comparing the proportion of resistant 
isolates, there was no significant difference for two out of six antimicrobial drugs (see 
Section two). The DTSA model is popular in the social sciences because it allows 
outcome measures to be grouped into discrete outcomes which are common in some 
research settings. Although data transformation was cumbersome, this model could 
provide a framework for assessing subtle differences between two populations when 
MIC distributions are the outcome. One limitation of this model derivation was the 
failure to fully incorporate accountability for clustering among isolates within farms. We 
recommend a more extensive statistical analysis that could incorporate a shared frailty 
into the model (Rabe-Hesketh and Skrondal, 2005). We recommend that this model be 
considered when the objective of the study is to determine if there are differences 
between MIC distributions. The use of a DTSA could potentially be considered when 
examining the usefulness of an intervention. In a longitudinal context, a population of 
bacteria could be monitored over time to see if a proposed intervention caused a very 
subtle change in the MIC frequency distribution. In addition, simulation modeling may 
shed light on what the actual threshold would be to see an actual difference between two 
populations. 
In conclusion, we have considered MIC data in a unique fashion by introducing a 
DTSA model, deriving this model, and applying it in a setting that compares bacterial 
antimicrobial resistance among two production methods. The model seems to 
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appropriately match the inherent characteristics of the data. Using a DTSA model to 
compare population MICs is intriguing. The goal of statisticians is to select a statistical 
model that accurately reflects the nature of the data and the DTSA is the closest model 
available for this type of data. Other statistical considerations that should be accounted 
for in studies incorporating farm populations, are accounting for the hierarchical nature 
of the data. 
The objective of the final project reported in this dissertation (Section 4) was to 
identify the association between farm management practices (other than herd type) and 
antimicrobial resistance. Very few studies have addressed this issue. Risk factors 
including management practices such as biosecurity measures, disease prevention, and 
history of certain diseases have been associated with pathogen apparent prevalence on 
the farm (Funk and Gebreyes, 2004; Zheng et al., 2007). The association of these 
practices with a higher proportion of bacterial antimicrobial resistance is lacking. There 
are several possible reasons for this research gap. First, the association of bacterial 
prevalence with farm-level risk factors may be more directly related based on a causal 
pathway. For example, changes of management practices may directly impact pathogen 
loads which would indirectly impact bacterial antimicrobial resistance. Secondly, the 
additional cost of conducting antimicrobial resistance testing in a study may be 
prohibitive. This question may be better addressed in a controlled environment where 
interventions can be measured and accounted for in the study. However, this project 
serves the purpose of asking the question in a broad context and associations here may 
serve as new hypotheses in a more controlled environment. 
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This study was conducted by collecting herd level risk factors with the use of a 
questionnaire as described in Section 4. A questionnaire was administered to all 
participating farm managers to capture farm practices such as biosecurity measures, 
vaccine usage, and use of preventive measures, and antimicrobials used, as well as 
disease history. The questionnaire included sections for nursery pigs, sows, gilts, and 
boars. However, only data collected specifically on finishers was used in the study 
described here. The questionnaire format was based on data collected for NARMS 
(CDC, 2003). The goal of this study was to identify potential herd-level risk factors 
associated with AMR among Campylobacter and E. coli in pigs from antimicrobial-free 
and conventional swine farms in the Midwest. Farm-level risk factors were analyzed 
using multivariable models (representing each antimicrobial and bacteria combination) 
where the dichotomous outcome represented each individual bacterial isolate as 
susceptible or resistant based on a predetermined breakpoint. Findings in this study 
indicate that the prevalence of isolates with AMR in the Campylobacter and E. coli 
isolates of swine were associated with unique herd-level risk factors among each 
antimicrobial-bacteria combination. This emphasizes the complexity of antimicrobial 
susceptibility on the farm among commensal bacteria. However, the results are 
important for generating new hypothesizes and considerations when designing controlled 
studies in the future. 
Antimicrobial resistance in agricultural systems is an ongoing concern to both 
human and animal health (Molbak, 2004; Mathew et al., 2007). Both commensal and 
pathogenic bacteria obtained from swine farms, including Campylobacter spp. and E. 
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coli (Rollo et al., 2010, Taylor et al., 2009; Bunner et al., 2007; Dunlop et al., 1998), 
may be resistant to a large range of antimicrobials. In many cases, bacterial resistant 
strains are associated with the type of antimicrobial used on the farm (Harada et al., 
2008; Rosengren et al., 2009; Varga et al., 2009); however, there are resistant clones to 
antimicrobial drugs for which there is no history of farm use (Thakur and Gebreyes, 
2005). For example, bacteria that are resistant to fluoroquinolones are apparent on some 
poultry farms that have never used drugs in this group (Taylor et al., 2009). In addition, 
in countries in which some antimicrobials are banned, bacterial antimicrobial resistance 
is still present (Bischoff et al., 2002; Harada et al., 2006). Furthermore, on antimicrobial-
free farms, resistance is present although at lower proportions (Rollo et al., 2010; Bunner 
et al., 2007; Halbert et al., 2007; Sato et al., 2004a; Luangtongkum et al., 2006). A 
number of studies have addressed mechanisms promoting AMR persistence, and the 
complex interaction between antimicrobials and bacterial species further complicates the 
issue (Andersson, 2003). 
There are several strategies to reduce AMR in farming environments in addition 
to converting to an antimicrobial-free farming system. First of all, producers could 
reduce the quantity of antimicrobial drugs used by considering the following changes. 
Producers should attempt to reduce disease; for example, there are farms that are 
certified free of diseases such as Mycoplasma hyopneumoniae (Baker, 2006). Vaccine 
development and usage could also be used for Salmonella, E. coli, and other diseases 
(McEwen and Fedorka-Cray, 2002). Some recent changes in production have increased 
weaning age, which appears to reduce antimicrobial use in young pigs and helps with 
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maternal immunity. Biosecurity is another management tool used for disease prevention 
that would mitigate some AMR that could potentially be spread in the environment (by 
people, other animals, or wildlife). Applying some of these practices may directly 
influence the bacterial prevalence for pathogens such as Salmonella, but indirectly could 
be related to the prevalence of AMR on the farm. Further strategies that mitigate 
resistance selection or persistence in both animal and human populations are warranted. 
Furthermore, farm level practices may be associated with different proportions of 
bacterial antimicrobial resistance, and this dissertation explores this possibility. Based on 
these multivariable models, some new hypotheses should be explored further. Finally, 
based on the limitations of the current published literature on this subject, we 
recommend the following. Sampling variation and variance has been explored by several 
researchers without a clear cut conclusion on the best strategies for sampling farms. This 
subject should be addressed within each prospective project. Furthermore, the research 
community should address products and management strategies that are allowed on 
organic farms, that is, clarify and unify the meaning of ‘organic’ farms. Breakpoints 
need to be clarified between countries and for all species of bacteria in animals and when 
changes occur in breakpoint designations, these should be specified in the literature. The 
CLSI has improved the standards for antimicrobial susceptibility methods since the early 
2000s, but researchers must realize this is a dynamic process and frequently verify any 
changes in the standards on an annual basis.  
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APPENDIX A 
 
DATABASE SEARCH STRATEGY 
A.  Database: FSTA, BIOSIS Previews, AGRIS 
Search Strategy: 
-------------------------------------------------------------------------------- 
1     (antimicrobial$ or antibiotic$).mp. [mp=ti, ab, ao, ea, fa, sa, sh, ec, ei, fc, fi, fm, ie, 
lc, oi, si, sm, bc, bo, bt, cb, cc, ds, ge, gn, mc, mi, mq, or, ps, sq, st, tm, tn, hw] (259026) 
2     limit 1 to english language (205670) 
3     limit 2 to yr="1985 -Current" (182780) 
4     (resistance$ or susceptible$ or minimum inhibitory concentration$ or mic$).mp. 
[mp=ti, ab, ao, ea, fa, sa, sh, ec, ei, fc, fi, fm, ie, lc, oi, si, sm, bc, bo, bt, cb, cc, ds, ge, 
gn, mc, mi, mq, or, ps, sq, st, tm, tn, hw] (5537098) 
5     limit 4 to english language (4381534) 
6     limit 5 to yr="1985 -Current" (3769993) 
7     (organic$ or antibiotic-free$ or antibiotic free$ or antimicrobial-free$ or 
antimicrobial-free$).mp. [mp=ti, ab, ao, ea, fa, sa, sh, ec, ei, fc, fi, fm, ie, lc, oi, si, sm, 
bc, bo, bt, cb, cc, ds, ge, gn, mc, mi, mq, or, ps, sq, st, tm, tn, hw] (387916) 
8     limit 7 to english language (302296) 
9     limit 8 to yr="1985 -Current" (278720) 
10     (swine or pig* or porcine or sow or boar or finisher or cattle or cow$ or heifer$ or 
dairy or poultry$ or layer$ or hen$ or chicken$).mp. [mp=ti, ab, ao, ea, fa, sa, sh, ec, ei, 
fc, fi, fm, ie, lc, oi, si, sm, bc, bo, bt, cb, cc, ds, ge, gn, mc, mi, mq, or, ps, sq, st, tm, tn, 
hw] (1397901) 
11     limit 10 to english language (1038831) 
12     limit 11 to yr="1985 -Current" (892210) 
 
B.  Database: CAB Abstracts <1910 to 2010 Week 26> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1     (antimicrobial$ or antibiotic$).mp. [mp=abstract, title, original title, broad terms, 
heading words] (99422) 
2     limit 1 to (english language and yr="1985 -Current") (48791) 
3     (resistance$ or susceptible$ or minimum inhibitory concentration$ or mic$).mp. 
[mp=abstract, title, original title, broad terms, heading words] (1362705) 
4     limit 3 to (english language and yr="1985 -Current") (722423) 
5     (organic$ or antibiotic-free$ or antibiotic free$ or antimicrobial-free$ or 
antimicrobial-free$).mp. [mp=abstract, title, original title, broad terms, heading words] 
(214556) 
6     limit 5 to (english language and yr="1985 -Current") (121885) 
7     (swine or pig* or porcine or sow or boar or finisher or cattle or cow$ or heifer$ or 
dairy or poultry$ or layer$ or hen$ or chicken$).mp. [mp=abstract, title, original title, 
broad terms, heading words] (1320203) 
8     limit 7 to (english language and yr="1985 -Current") (465989) 
   
184
 
 
APPENDIX B 
SUMMARY OF 25 STUDIES COMPARING PREVALENCE OF RESISTANT ISOLATES IN ANTIMICROBIAL-
FREE AND CONVENTIONAL FARMS 
DAIRY/MILK 
Reference Study location Sample years Sample types Bacterium 
Bennedsgaard et al., 
2006 
Denmark 2000–2003 quarter milk samples on 
farm 
Staphylococcus aureus 
Bombyk et al., 2008 USA (MN) 2004–2005 composite milk samples S. aureus 
Cho et al., 2006 USA (MN) 2001–2002 fecal samples E. coli 0157: H7 
Cho et al., 2007 USA (MN) 2001–2002 fecal samples Shiga toxin-producing E. 
coli 
Garmo et al., 2010 Norway 2006–2007 quarter milk samples on 
farm 
S. aureus 
coagulase-negative 
Staphylococcus 
Halbert et al., 2006 USA (MI, MN, WI, 
NY) 
2000–2001 fecal samples on farms Campylobacter spp. 
Pol and Ruegg, 2007 USA (WI) not specified quarter milk samples on 
farm 
S. aureus 
coagulase-negative 
Staphylococcus 
Streptococcus spp. 
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DAIRY/MILK 
Ray et al., 2006 USA (NY, MI, MN, 
WI) 
2000–2001 fecal samples on farms Salmonella 
Reinstein et al., 2009 USA (KS) not specified not specified E. coli 0157: H7 
Roesch et al., 2006 Bern, Switzerland 2003–2004 quarter milk samples on 
farm 
S. aureus and coagulase-
negative Staphylococcus 
Streptococcus spp. (Strep 
uberis and Strep 
dysgalactiae) 
Sato et al., 2004a USA (WI) 2000 and 2001 fecal samples on farms Campylobacter spp. 
Sato et al., 2004b USA (WI) and 
Denmark 
2000 bulk tank milk samples on 
farm 
S. aureus 
Sato et al., 2005 USA (WI) 2000 and 2001 fecal samples on farms E. coli 
   
186
 
 
POULTRY/CHICKEN 
Reference Study location Sample years Sample types Bacterium 
Heuer et al., 2001 Denmark 1998–2000 abattoir Campylobacter spp. 
Hoogenboom et al., 
2008 
The Netherlands 2003 and 2005 fecal samples on farm E. coli 0157: H7 
E. faecium 
Campylobacter spp. 
Luangtongkum et 
al., 2006 
USA (OH) 2000–2002 gastrointestinal tracts at 
slaughter 
Campylobacter spp. 
Schwaiger et al., 
2008 
Bavaria, Germany 2004–2005 cloacal swabs on farm Campylobacter spp. 
E. coli 
Schwaiger et al., 
2009 
Bavaria, Germany 2004–2005 cloacal swabs on farm Listeria 
Enterococcus spp. 
Siemon et al., 2007 USA (WI, NC, VI, 
SC) 
2004–2005 fecal samples prior to 
slaughter 
Salmonella 
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SWINE/PORK 
Reference Study location Sample years Sample types Bacterium 
Bunner et al., 2007 USA (IO,IL, IN, 
MN, NE, OH, 
WI) 
2002–2003 fecal samples on farms E. coli 
Docic and Bilkei, 
2003 
Hungary, Romania, 
Serbia 
2001 fecal samples on farms E. coli 
Gebreyes et al., 
2006 
USA (NC) 2002–2004 fecal samples from 
extensive and intensive 
systems 
Salmonella 
Hoogenboom et al., 
2008 
The Netherlands 2003 and 2005 fecal samples on farms E. coli 0157: H7 
E. faecium 
Campylobacter spp. 
Mathew et al., 2001 USA (IO, NJ, KY, 
TN, IN) 
prior to 2000 fecal samples on farms E. coli 
Salmonella 
Nulsen et al., 2008 New Zealand 2001 fecal samples on farms E. coli 
Enterococcus spp. 
Thakur and 
Gebreyes, 2005 
USA (NC) 2002–2004 fecal samples from 
extensive and intensive 
systems and three 
stages of slaughter 
Campylobacter coli 
 
a
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APPENDIX C 
 
PCR amplicon size and primers used for identification of Campylobacter spp. by use of 
an m-PCR assay.  
Target gene 
PCR amplicon 
size (base pairs) Primer Sequence (5'-3') 
C. jejuni  
 23S rRNA 650 23SF TATACCGGTAAGGAGTGCTGGAG 
 
 23SR ATCAATTAACCTTCGAGCACCG 
C. jejuni hipO  323 CJF ACTTCTTTATTGCTTGCTGC 
 
 CJR GCCACAACAAGTAAAGAAGC 
C. coli glyA  126 CCF GTAAAACCAAAGCTTATCGTG 
 
 CCR TCCAGCAATGTGTGCAATG 
C. lari glyA  251 CLF TAGAGAGATAGCAAAAGAGA 
  
  CLR TACACATAATAATCCCACCC  
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APPENDIX D 
Life table describing the number of Campylobacter spp. isolates in each MIC category for azithromycin in a sample of 
464  isolates from conventional (n=290) and antimicrobial-free (n=174) production systems 
   Number  Proportion of 
MIC 
Value 
(ug/mL) 
MIC 
category Interval 
Isolates at 
the 
beginning 
of the MIC 
scale (n at 
risk) 
Isolates 
with an 
MIC in 
the 
interval 
(n events) 
Censored 
isolates an 
the end of 
the MIC 
scale (n 
censored)   
Susceptible 
isolates whose 
growth becomes 
inhibited by AB 
(hazard 
function) 
All isolates 
that are still 
susceptible 
(survivor 
function) 
Antimicrobial Free Farms             
0.016 1 1, 2      1.0000 
0.03 2 2, 3      1.0000 
0.064 3 3, 4 174 1 0  0.0058 0.9943 
0.125 4 4, 5 173 34 0  0.2179 0.7989 
0.25 5 5, 6 139 39 0  0.3264 0.5747 
0.5 6 6, 7 100 38 0  0.4691 0.3563 
1 7 7, 8 62 27 0  0.5567 0.2011 
2 8 8, 9 35 2 0  0.0588 0.1897 
4 9 9; 10     - - 
8 10 10; 11     - - 
16 11 11; 12     - - 
32 12 12; 13     - - 
64 13 13; 14     - - 
128 14 14; 15     - - 
256 15  ≥15 33 33 33  1 0 
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MIC 
Value 
(ug/mL) 
MIC 
category Interval 
Isolates at 
the 
beginning 
of the MIC 
scale (n at 
risk) 
Isolates 
with an 
MIC in 
the 
interval 
(n events) 
Censored 
isolates an 
the end of 
the MIC 
scale (n 
censored)   
Susceptible 
isolates whose 
growth becomes 
inhibited by AB 
(hazard 
function) 
All isolates 
that are still 
susceptible 
(survivor 
function) 
Conventional Farms             
0.016 1 1, 2     - 1.000 
0.03 2 2, 3     - 1.000 
0.064 3 3, 4 290 4 0  0.0139 0.9862 
0.125 4 4, 5 286 7 0  0.0248 0.9621 
0.25 5 5, 6 279 39 0  0.1503 0.8276 
0.5 6 6, 7 240 31 0  0.1381 0.7207 
1 7 7, 8 209 9 0  0.044 0.6897 
2 8 8, 9 200 2 0  0.0101 0.6828 
4 9 9; 10     - - 
8 10 10; 11     - - 
16 11 11; 12     - - 
32 12 12; 13     - - 
64 13 13; 14     - - 
128 14 14; 15     - - 
256 15  ≥15 198 198 198   1 0 
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Life table describing the number of Campylobacter spp. isolates in each MIC category for tetracycline in a sample of 
464  isolates from conventional (n=290) and antimicrobial-free (n=174) production systems 
   Number  Proportion of 
MIC 
Value 
(ug/mL) 
MIC 
category Interval 
Isolates at 
the 
beginning 
of the MIC 
scale 
 (n at risk) 
Isolates with 
an MIC in 
the interval 
 (n events) 
Censored 
isolates an 
the end of the 
MIC scale 
 (n censored)   
Susceptible 
isolates whose 
growth becomes 
inhibited by AB  
(hazard 
function) 
All isolates 
that are 
still 
susceptible 
(survivor 
function) 
Antimicrobial Free Farms             
0.016 1 1; 2 174 0   - 1.000 
0.03 2 2; 3 174 1   0.0057 0.9943 
0.064 3 3, 4 173 2 0  0.0116 0.9828 
0.125 4 4, 5 171 12 0  0.0702 0.9138 
0.25 5 5, 6 159 18 0  0.1132 0.8103 
0.5 6 6, 7 141 26 0  0.1844 0.6609 
1 7 7, 8 115 8 0  0.0696 0.6149 
2 8 8, 9 107 6 0  0.0561 0.5805 
4 9 9; 10 101 7   0.0693 0.5402 
8 10 10; 11 94 9   0.0957 0.4885 
16 11 11; 12 85 8   0.0941 0.4425 
32 12 12; 13 77 19   0.2468 0.3333 
64 13 13; 14 58 15   0.2586 0.2471 
128 14 14; 15 43 13   0.3023 0.1724 
256 15 ≥15 30 30 30  1 0.1724 
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MIC 
Value 
(ug/mL) 
MIC 
category Interval 
Isolates at 
the 
beginning 
of the MIC 
scale (n at 
risk) 
Isolates with 
an MIC in 
the interval  
(n events) 
Censored 
isolates an 
the end of the 
MIC scale  
(n censored)   
Susceptible 
isolates whose 
growth becomes 
inhibited by AB 
(hazard 
function) 
All isolates 
that are 
still 
susceptible 
(survivor 
function) 
Conventional Farms             
0.016 1 1; 2 290 0   -  
0.03 2 2; 3 290 0   -  
0.064 3 3, 4 290 1 0  0.0034 0.9966 
0.125 4 4, 5 289 3 0  0.0104 0.9862 
0.25 5 5, 6 286 2 0  0.0070 0.9793 
0.5 6 6, 7 284 7 0  0.0246 0.9552 
1 7 7, 8 277 7 0  0.0253 0.9310 
2 8 8, 9 270 16 0  0.0593 0.8759 
4 9 9; 10 254 19   0.0748 0.8103 
8 10 10; 11 235 19   0.0809 0.7448 
16 11 11; 12 216 21   0.0972 0.6724 
32 12 12; 13 195 40   0.2051 0.5345 
64 13 13; 14 155 29   0.1871 0.4345 
128 14 14; 15 126 27   0.2143 0.3414 
256 15 ≥15 99 99 99   1 0.3414 
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Life table describing the number of Campylobacter spp. isolates in each MIC category for gentamicin in a sample of 
464  isolates from conventional (n=290) and antimicrobial-free (n=174) production systems 
   Number  Proportion of 
MIC 
Value 
(ug/mL) 
MIC 
category Interval 
Isolates at 
the 
beginning 
of the 
MIC scale 
(n at risk) 
Isolates 
with an 
MIC in 
the 
interval 
(n events) 
Censored 
isolates an 
the end of the 
MIC scale  
(n censored)   
Susceptible 
isolates whose 
growth becomes 
inhibited by AB 
(hazard 
function) 
All isolates 
that are 
still 
susceptible 
(survivor 
function) 
Antimicrobial Free Farms             
0.016 1 1; 2     0  
0.03 2 2; 3       
0.064 3 3, 4   0    
0.125 4 4, 5   0    
0.25 5 5, 6 174 1 0  0.0057 0.9943 
0.5 6 6, 7 173 76 0  0.4393 0.5575 
1 7 7, 8 97 91 0  0.9381 0.0345 
2 8 8, 9 6 5 0  0.8333 0.0057 
4 9 9; 10 1 1 0  1 0 
8 10 10; 11       
16 11 11; 12       
32 12 12; 13       
64 13 13; 14       
128 14 14; 15       
256 15 ≥15   0    
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MIC 
Value 
(ug/mL) 
MIC 
category 
Interva
l 
Isolates at 
the 
beginning 
of the MIC 
scale (n at 
risk) 
Isolates 
with an 
MIC in 
the 
interval 
(n events) 
Censored 
isolates an 
the end of the 
MIC scale 
(n censored)   
Susceptible 
isolates whose 
growth becomes 
inhibited by AB 
(hazard 
function) 
All isolates 
that are 
still 
susceptible 
(survivor 
function) 
Conventional Farms             
0.016 1 1; 2       
0.03 2 2; 3       
0.064 3 3, 4       
0.125 4 4, 5       
0.25 5 5, 6 290 8 0  0.0276 0.9724 
0.5 6 6, 7 282 118 0  0.4184 0.5655 
1 7 7, 8 164 153 0  0.9329 0.0379 
2 8 8, 9 11 10 0  0.9091 0.0034 
4 9 9; 10 0 0 0  0.9091 0.0000 
8 10 10; 11 1 1   1.0000 0.0000 
16 11 11; 12       
32 12 12; 13       
64 13 13; 14       
128 14 14; 15       
256 15 ≥15             
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Life table describing the number of E. coli isolates in each MIC category for chloramphenicol in a sample of 1,381  
isolates from conventional (n=883) and antimicrobial-free (n=498) production systems 
   Number  Proportion of 
MIC 
Value 
(ug/mL) 
MIC 
category Interval 
Isolates at 
the 
beginning of 
the MIC 
scale (n at 
risk) 
Isolates 
with an 
MIC in the 
interval  
(n events) 
Censored 
isolates an the 
end of the 
MIC scale 
 (n censored)   
Susceptible 
isolates whose 
growth becomes 
inhibited by AB 
(hazard 
function) 
All isolates 
that are still 
susceptible 
(survivor 
function) 
Antimicrobial Free Farms             
2 1 1,2 498 80 0  0.1606 0.8394 
4 2 2,3 418 294 0  0.7033 0.249 
8 3 3,4 124 105 0  0.8468 0.0382 
16 4 4,5 19 3 0  0.1579 0.0321 
32 5 5,6 16 14 0  0.875 0.004 
>32 6 ≥ 6 2 2 2  0 0.004 
Conventional Farms             
2 1 1,2 883 79 0  0.0895 0.9105 
4 2 2,3 804 502 0  0.6244 0.342 
8 3 3,4 302 197 0  0.6523 0.1189 
16 4 4,5 105 33 0  0.3143 0.0815 
32 5 5,6 72 40 0  0.5556 0.0362 
>32 6 ≥ 6 32 32 32   0 0.0362 
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Life table describing the number of E. coli isolates in each MIC category for ampicillin in a sample of 1,381  isolates from 
conventional (n=883) and antimicrobial-free (n=498) production systems 
   Number  Proportion of 
MIC 
Value 
(ug/mL) 
MIC 
category Interval 
Isolates at the 
beginning of 
the MIC scale 
(n at risk) 
Isolates 
with an 
MIC in the 
interval (n 
events) 
Censored 
isolates an 
the end of the 
MIC scale (n 
censored)   
Susceptible 
isolates whose 
growth becomes 
inhibited by AB 
(hazard function) 
All isolates 
that are still 
susceptible 
(survivor 
function) 
Antimicrobial Free Farms             
1 1 1,2 498 52 0  0.1044 0.8956 
2 2 2,3 446 213 0  0.4776 0.4679 
4 3 3,4 233 152 0  0.6524 0.1627 
8 4 4,5 81 15 0  0.1852 0.1325 
16 5 5,6 66 1 0  0.0152 0.1305 
32 6 6,7 65 2 0  0.0308 0.1265 
>32 7 ≥ 7 63 63 63  0 0.1265 
Conventional Farms             
1 1 1,2 883 102 0  0.1155 0.8845 
2 2 2,3 781 328 0  0.42 0.513 
4 3 3,4 453 220 0  0.4857 0.2639 
8 4 4,5 233 18 0  0.0773 0.2435 
16 5 5,6 215 2 0  0.0093 0.2412 
32 6 6,7 213 3 0  0.0141 0.2378 
>32 7 ≥ 7 210 210 210   0 0.2378 
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Life table describing the number of E. coli isolates in each MIC category for gentamicin in a sample of 1,381  isolates 
from conventional (n=883) and antimicrobial-free (n=498) production systems s 
   Number  Proportion of 
MIC 
Value 
(ug/mL) 
MIC 
category Interval 
Isolates at 
the 
beginning of 
the MIC 
scale (n at 
risk) 
Isolates 
with an 
MIC in the 
interval (n 
events) 
Censored 
isolates at the 
end of the 
MIC scale (n 
censored)   
Susceptible 
isolates whose 
growth becomes 
inhibited by AB 
(hazard 
function) 
All isolates that 
are still 
susceptible 
(survivor 
function) 
Antimicrobial Free Farms             
<=0.25 1  498 74 0  0.1486 0.8514 
0.5 3 3, 4 424 333 0  0.7854 0.1827 
1 4 4, 5 91 84 0  0.9231 0.0141 
2 5 5, 6 7 5 0  0.7143 0.004 
4 6 6, 7 2 0 0  0.5 0.004 
8 7 7, 8 2 1 0  0.5 0.002 
16 8 8, 9 1 0 0  0 0.002 
>16 9 ≥ 9 1 1 1  0 0 
Conventional Farms             
<=0.25 1  883 125 0  0.1416 0.8584 
0.5 3 3, 4 758 598 0  0.7889 0.1812 
1 4 4, 5 160 145 0  0.9063 0.017 
2 5 5, 6 15 3 0  0.2 0.0136 
4 6 6, 7 12 0 0  0.2 0.0079 
8 7 7, 8 12 5 0  0.4167 0.0079 
16 8 8, 9 7 3 0  0.4286 0.0045 
>16 9 ≥ 9 4 4 4   0 0.0045 
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APPENDIX E 
 
Questionnaire: 
 
Antibiotic Usage and Risk Factors for Antimicrobial Resistance in Pork Production 
 
Farm ID Number: _______________  
Type of farm: 1  Antibiotic free, not organic, 2  Antibiotic free, organic, 3  Not 
antibiotic free 
 
Date of interview: _______________________ 
 
Herd Information. 
 
How many years has your farm been antibiotic free: ______years. 
If your farm is organic, how many years has your farm been organic: ______years.  
 
1  Open herd,  2  Closed herd. 
 
If open herd, bring in: 1  breeding stock, 2  nursery pigs, 3  feeder pigs   
  4  finishers,           5  other: ___________________ 
 
Type of operation: 1   farrow to weaning, 2   farrow to finish, 
3   farrow to feeder,       4   grower & finishing 
 
Parents. 
Genetic line:   Sire: ____________________ Dam: 
_____________________ 
Total number of sows: ______________________ 
Total number of boars: ______________________ 
 
Growing pigs. 
Total number of pigs marketed per year: _____________________________ 
 
Months that pigs are marketed/# marketed per incidence: ______________ 
             
Total number of growing pigs at any one time: ____________________ 
 
Environment of pigs. 
 
Housing type for breeding animals: 
____________________________________________________________________ 
 1  total confinement,      2  partial confinement,           3  pasture 
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Breeding barn: ________________________________________________________ 
      1  stalls, 2  pens, 3  both 
Gestation:      
_________________________________________________________ 
      1  stalls, 2  pens, 3  both 
Farrowing:    _________________________________________________________ 
      1  crates, 2  individual pens, 3  
group pens,      4   hutches  
       
Housing type for growing animals: 
Nursery:  1  total confinement,        2  partial confinement,        3  pasture  
Floor type:1  solid floor,     2  slats, 3  partial slats  
Flooring type: 1  concrete,     2  metal,      3  dirt,  4  wood 
 
Grower:  1  total confinement,      2  partial confinement,      3  pasture 
Floor type:       1  solid floor,  2  slats,       3  partial slats 
Flooring type:  1  concrete,      2  metal, 3  dirt,        4  wood 
 
Finisher:   1  total confinement,        2  partial confinement,       3  pasture 
Floor type:    1  solid floor, 2  slats, 3  partial slats 
Flooring type:  1  concrete,      2  metal,       3  dirt,     4  wood 
 
Bedding: 
Breeding stock:  1  none, 2  straw, 3  wood shavings, 4  saw dust,     
   5  rice hulls 6  corn stalks 
Nursery:     1  none, 2  straw, 3  wood shavings, 4  saw dust,      
  5  rice hulls 6  corn stalks 
Grower:     1  none, 2  straw, 3  wood shavings, 4  saw dust,     
   5  rice hulls 6  corn stalks 
Finisher:    1  none, 2  straw, 3  wood shavings, 4  saw dust,      
  5  rice hulls 6  corn stalks 
 
Manure handling: 
Finisher:   
 ____________________________________________________________ 
1  pit holding,  2  mechanical scraper,  3  flush - open gutter,  4  flush - under slats,  
5  hand-cleaned,  6 shallow pig with scraper 
  
Do you spread manure on fields with livestock:1  Yes,     2  No,       3  other 
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Ventilation: 
Breeding/Gestation:
 _________________________________________________________ 
  1  natural,     2  mechanical,       3  both 
Nursery:    
 _________________________________________________________ 
  1  natural,     2  mechanical,  3  both    
Grower:    
 _________________________________________________________ 
  1  natural,     2  mechanical,  3  both 
Finisher:    
 _________________________________________________________ 
  1  natural,     2  mechanical,  3  both 
 
 
Pig Density: 
What is the pig density on your farm:  ______________________________ 
 
Finisher:  __________________________________________ 
 
Niman Ranch requirements:____________________________ 
 
If pig density not known: 
 
Finisher:  1  less 10,     2  11-15,    3  16-20,     4  21-25,    5  26-30,
           6  31-35,  7  36-40, 8  41-45,   9  46-50,  10  50+ 
 
Finisher: pen length (feet): _________  pen width (feet): _________ 
 
Are pigs co-mingled during nursery thru finisher: 1  yes, 2 no,   3 unsure 
If yes, how many times: __________________________________ 
 
 
Feeding of animals: 
   
Finisher: 1  feeders,        2  floor,       3  both 
 
Number of diets: 
Finisher:    
______________________________________________________________ 
  1 ,  2 ,  3 ,  4 ,  5  other 
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Feed: 
 ______________________________________________________________ 
1  mix on farm,  2  by premixed,  3 , buy corn 
 4  buy soybean  5  other 
 
 
Other animals: 
Do you have other livestock besides pigs:   1  yes, 2 no 
 If yes, what other animals: 
_____________________________________________________ 
           
Do pigs interact with other livestock: __________________________ 
           
  1  Yes,  2  No,  3 ,Other 
 
Do you have a confinement operation for pigs on site:    1  yes, 2 no 
 
Do pigs have fence contact with others :   1  Yes,  2  No,  3 
,maybe 
 
 
MEDICATION HISTORY: 
 
Grower/Finishers: 
 _______________________________________________________________ 
1  dewormer,  2  mange/lice,  3  abx in feed, 4  abx in water,  5  abx oral,
  6  abx injection, 7  probiotics 
 
 
List of antibiotics – Grower/finisher pigs: 
Antibiotic  
 
Y        N 
Primar
y 
reason. 
Use 
code 
below 
Days 
in 
feed 
Dose 
(g/ton) 
1- 3 Nitro (Roxarzone)              
2- Ampicillin              
3- Apralan (Apramycin)              
4- ASP 
(chlortetracycline/Sulfamethazine/Penicil
lin) 
             
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5- Aureomycin, CTC (chlortetracycline)              
6- BMD (Bacitracin)              
7- CSP 
(Chlortetracycline/Sulfathiazole/Penicilli
n) 
             
8- Denagard (Tiamulin)              
9- Erythromycin              
10- Flavomycin (Bambermycin)              
11- Gentocin (Gentomycin)              
12- Hygromix (hygromycin)              
13- Lincomix, Safeguard (Lincomycin)              
14- LS 50 (Lincomycin/Spectiniomycin)              
15- Mecadox (Carbadox)              
16- Naxcel (Ceftiofur)              
17- Neomix (neomycin)              
18- NeoTerra (Neomycin Terramycin)              
19- OM-5 premix (Oleandomycin)              
20- Oxytet (oxytetracycline)              
21- Penicillin and Spectomycin,              
22- Penicillin G              
23- Producil (Efromycin)              
24- Pulmotil (Tilmicosin)              
25- Stafac (Virginiamycin)              
26- Sulfachlorpyridazine              
27- Sulfadimethoxine              
28- Tetracycline              
29- Tylan (Tylosin)              
30- Tylan 40 Sulfa-G 
(Tylosin/Sulfamethazine) 
             
31- Other specify              
32- Other specify              
33- Other specify              
  1 = Growth promotion 
2 = Disease prevention 
3 = other treatments (specify in 
column) 
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Preventive medicine. 
Vaccinations in finishers: 
 
Do you vaccinate finishers against one or more of the following diseases: 
Diseases Vaccinate 
 
Y        N 
Name of 
vaccine 
Manufacturer 
of vaccine 
Pseudorabies             
PRRS             
Swine Flu             
Salmonella             
Erysipelas             
Mycoplasma             
Atrophic rhinitis             
E. coli             
Other____________________
______________ 
            
 
Pig flow in Finisher: 
________________________________________________________________ 
1  continual flow,  2  all pigs removed, no cleaning,  3  AIAO by room,  4  AIAO 
by building,  5  AIAO by site  ,  6  all pigs removed and cleaned,  ,  7  other 
 
 
Biosecurity. 
Visitors to farm: 
__________________________________________________________ 
1  take shower,    2  clean boots and coveralls, 3  24 hours or longer “pig 
free” 
 
What type of restroom is available for workers/visitors: 
___________________________ 
1  toilet/septic system       2   toilet/municipal sewage system      3   outhouse         4 
 no facilities 
  
Are rendering trucks allowed on the farm: 1  yes, 2  no,   3 sometimes  
 
Do you control rodents: 
_____________________________________________________  
1  cats,  2  dogs, 3  traps, 4  bait/poison, 5  professional 
exterminator,    6   no 
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Are your buildings bird proof: 1  yes, 2  no, 3  don’t know. 
 
Isolation of new breeding stock: 
______________________________________________ 
 1  all,     2  some,   3  none 
 
Acclimation: 1  feedback of feces,    
2  feedback of mummies, placenta or stillborn piglets,  3  exposure to cull animals, 
4  exposure to sick pigs,  5  administration of vaccines. 
 
Disease history. 
 
Grower/finisher pigs: 
 
In the last 12 months, which of the following disease problems were present in one or 
more grower/finisher pigs. 
  Diagnosed by 
veterinarian. 
APP (Actinobacillus pleuropneumonia) 
(Haemophilus) 
 Yes     No  Yes     No 
PRRS (porcine reproductive and respiratory 
syndrome) 
 Yes     No  Yes     No 
Swine flu  Yes     No  Yes     No 
Salmonella  Yes     No  Yes     No 
Glasser’s disease (Haemophilus parasuis)  Yes     No  Yes     No 
Mycoplasma pneumonia  Yes     No  Yes     No 
Circovirus or PMWS (Post-weaning 
Multisystemic Wasting Syndrome) 
 Yes     No  Yes     No 
Swine dysentery  Yes     No  Yes     No 
Atrophic rhinitis  Yes     No  Yes     No 
Pseudorabies  Yes     No  Yes     No 
Hemorrhagic bowel syndrome  Yes     No  Yes     No 
Ileitis (Lawsonia intracellularis)  Yes     No  Yes     No 
Gastric ulcers  Yes     No  Yes     No 
Erysipelas  Yes     No  Yes     No 
Other 
______________________________________
__ 
 Yes     No  Yes     No 
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APPENDIX F 
Summary of management factors on 35 antimicrobial-free and 60 conventional swine farms in the Midwest U.S. 
Variable Name Description Category No. herds Proportion 
A. Biosecurity risk value   
visitoronfarm_0 
no visitor biosecurity measures 0 6 6.3 
visitoronfarm_1 visitors clean boots 1 61 64.2 
visitoronfarm_2 visitors shower and/or visitor is 24 hours free from 
pig exposure 
2 28 29.5 
 
 
   
toilet_0 no restroom available for workers/visitors 0 38 40 
toilet_1 septic system, municipal sewage or outhouse 1 57 60 
 
 
   
exterm exterminator and/or baits used 0,1 78 82 
 
 
   
rendering allow trucks on farm or not 0,1 21 22.1 
  
   
birdproof are buildings bird proof or not 0,1 41 43.2 
  
   
free_roam are animals allow to free roam on farm or not 0,1 20 21.1 
  
   
chickens are their chickens on farm or not 0,1 17 17.9 
  
   
newlivestock are new breeding stock isolated or not 0,1 31 32.6 
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Variable Name Description Category No. herds Proportion 
animal_contact do animals have fence contact with others or not 0,1 17 17.9 
  
   
acclim_0 acclimation is not used 0 43 45.3 
acclim_1 acclimation by administration of vaccines 1 17 17.9 
acclim_2 use of mummies, cull animals, sick animals or feces 2 35 36.8 
B.  Disease History for the last 12 months   
actino Actinobacillus pleuropneumoniae (Haemophilus) 0,1 5 5.3 
  
   
prrs Porcine reproductive and respiratory syndrome 0,1 24 25.3 
  
   
swineflu Swine Flu (traditional) 0,1 30 31.6 
  
   
salm Salmonella 0,1 6 6.3 
  
   
glassers Glasser's disease (Haemophilus parasuis) 0,1 11 11.6 
  
   
myco_pn Mycoplasma pneumonia 0,1 26 27.4 
     
rhin Atrophic rhinitis 0,1 5 5.3 
  
   
hbs Hemorrhagic bowel syndrome 0,1 28 29.5 
  
   
ili Ileitis (Lawsonia intracellularis) 0,1 31 32.6 
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Variable Name Description Category No. herds Proportion 
ulcer Gastric Ulcers 0,1 15 15.8 
  
   
erysip Erysipelas 0,1 9 9.5 
C.  Vaccine Usage on farm   
vaccine any vaccine usage as a preventive treatment or not 0,1 19 20 
  
   
pseudovx use of Pseudorabies vaccine or not 0,1 9 9.5 
  
   
mycovx use of Mycoplasma or not 0,1 10 10.5 
D. Management Practices on the farm   
mixfarm farms mix own feed on farm or not 0,1 66 69.5 
  
   
premix farms buy premixed feed or not 0,1 39 41.1 
  
   
corn farms buy corn 0,1 14 14.7 
  
   
soybean farms buy soybean product 0,1 31 32.6 
     
manurespread farms spread manure on fields with livestock or not 0,1 12 12.6 
     
house_1 total confinement is referent (also total and hoop) 1 40 42.1 
house_2 partial confinement 2 20 21.1 
house_3 Pasture 3 6 6.3 
house_4 Hoop barn 4 25 26.3 
house_5 Other 5 4 4.2 
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Variable Name Description Category No. herds Proportion 
flooring concrete floor is referent or dirt and other 0,1 16 16.8 
  
   
floor solid floor is referent or slats, weaved, and other 0,1 50 52.6 
  
   
bedding_0 no bedding materials used 0 43 45.3 
bedding_1 Straw 1 38 40 
bedding_2 corn stalks or other 2 14 14.7 
 
    
vent_0 ventilation to outside 0 33 34.7 
vent_1 mechanical or natural and mechanical ventilation 1 31 32.6 
vent_2 only natural ventilation 2 31 32.6 
 
    
aiao 
pig flow was continuous or some form of all in and all 
out (aiao) 0,1 73 76.8 
E.  Medication History   
dewormer use of dewormer or not 0,1 39 41.1 
     
mangelice use of topical products for mange and lice or not 0,1 14 14.7 
     
probiotics use of probiotics or not 0,1 13 13.7 
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APPENDIX G 
 
Appendix G-1. Potential risk factors for azithromycin resistance in Campylobacter 
isolates in finishing pigs from 95 farms in the Midwest, using population averaged 
logistic regression.  Herd type was included in each bivariate analysis. 
Variable Name B (SE) p-value Wald p (df) 
A. Biosecurity risk value     
_visitoronfarm_0 _ _    
_visitoronfarm_1 0.38 (0.89) 0.67  
_visitoronfarm_2 0.91 (0.91) 0.32 0.33 (2) 
_toilet_1 0.48(0.38) 0.21  
exterm 0.31 (0.45) 0.49  
rendering  -0.38 (0.46) 0.41  
birdproof 0.75 (0.09) 0.09  
free_roam 0.28 (0.41) 0.48  
chickens -0.38(0.47) 0.42  
newlivestock -0.41 (0.39) 0.29  
animal_contact -0.80(0.47) 0.09  
_acclim_0 _ _  
_acclim_1 0.68 (0.57) 0.24  
_acclim_2 0.25 (0.40) 0.54 0.49 (2) 
B.  Disease History for the last 12 months     
Action -0.04 (0.90) 0.97  
Prrs -0.69 (0.46) 0.13  
swineflu -0.38 (0.41) 0.34  
salm -0.87 (0.64) 0.17  
glassers -0.12 (0.43) 0.78  
myco_pn -0.38 (0.43) 0.38  
rhin -1.87 (0.55) 0.001  
hbs 0.24(0.40) 0.54  
ili -0.17 (0.41) 0.67  
ulcer 0.05 (0.54) 0.93  
erysip -0.40 (0.44) 0.36  
C.  Vaccine Usage on farm     
vaccine 0.28 (0.42) 0.51  
pseudovx -0.14 (0.67) 0.84  
mycovx -0.09(0.49) 0.86  
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Variable Name B (SE) p-value† Wald p† (df) 
D. Management Practices on the farm     
mixfarm -1.09(0.39) 0.005  
premix 0.24 (0.38) 0.52  
corn 0.73 (0.48) 0.13  
soybean 0.24 (0.38) 0.54  
manurespread -0.01 (0.49) 0.98  
_house_1 _ _  
_house_2 
-0.44(0.52) 0.4  
_house_3 
-0.02 (0.58) 0.97  
_house_4 
-0.79 (0.51) 0.12  
_house_5 
-0.60 (0.70) 0.39 0.52 (4) 
flooring 0.12 (0.42) 0.78  
floor  0.52 (0.44) 0.24  
_Ibedding_0 
_ _  
_Ibedding_1 
-0.28 (0.42) 0.5  
_Ibedding_2 
-0.35 (0.59) 0.55 0.75 (2) 
_Ivent_0 
_ _  
_Ivent_1 
-0.32 (0.53) 0.55  
_Ivent_2 0.74 (0.48) 0.13 0.05 (2) 
Aiao 0.12 (0.44) 0.78  
E.  Medication History     
Dewormer -0.39 (0.38) 0.3  
Mangelice -0.52(0.61) 0.39  
Probiotics -0.91 (0.48) 0.06   
B = Regression coefficient. SE = Standard error.  
†A value of P≤0.05 was considered significant. 
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Appendix G-2. Potential risk factors for tetracycline resistance in 
Campylobacter isolates in finishing pigs from 95 farms in the Midwest 
Variable Name B (SE) p-value† Wald p† (df) 
A. Biosecurity risk value     
_visitoronfarm_0 _ _  
_visitoronfarm_1 
-0.66(0.62) 0.29  
_visitoronfarm_2 
-1.08 (0.68) 0.11 0.25 (2) 
_toilet_0 _ _  
_toilet_1 0.07 (0.36) 0.84  
exterm 
-0.68(0.39) 0.08  
rendering  0.02(0.42) 0.96  
birdproof -0.64(0.51) 0.21  
free_roam -0.66 (0.34) 0.06  
chickens -0.53(0.41) 0.20  
newlivestock 0.25 (0.30) 0.42  
animal_contact -0.06 (0.40) 0.88  
_acclim_0 _ _  
_acclim_1 0.43 (0.41) 0.30  
_acclim_2 
-0.05 (0.35) 0.89 0.49 (2) 
B. Disease History for the last 12 months    
Action 0.46 (0.68) 0.50  
Prrs -0.69 (0.46) 0.13  
Swineflu -0.54 (0.37) 0.14  
Salm -0.41 (0.63) 0.52  
Glassers 1.41 (0.86) 0.10  
myco_pn 0.02 (0.43) 0.96  
rhin -0.20 (0.57) 0.73  
hbs 0.04 (0.39) 0.93  
ili -0.83 (0.35) 0.02  
ulcer 0.11 (0.48) 0.83  
erysip -0.47 (0.56) 0.40   
C.  Vaccine Usage on farm     
Vaccine -0.77 (0.48) 0.11  
Pseudovx -0.18 (0.71) 0.80  
Mycovx -0.81 (0.57) 0.16   
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Variable Name B (SE) p-value† Wald p† (df) 
D. Management Practices on the farm 
  
Mixfarm -0.36 (0.33) 0.28  
Premix -0.33 (0.33) 0.32  
Corn -0.78 (0.41) 0.05  
Soybean -0.45 (0.33) 0.16  
Manurespread 0.12 (0.42) 0.77  
_house_1 _ _  
_house_2 0.18 (0.53) 0.73  
_house_3 1.11 (0.55) 0.04  
_house_4 0.25 (0.44) 0.57  
_house_5 0.79 (0.60) 0.19 0.19 (4) 
_flooring_0 
_ _  
Flooring 0.28 (0.46) 0.54  
_floor_0 _ _  
floor  -1.38 (0.45) 0.00  
_Ibedding_0 _ _  
_Ibedding_1 0.68 (0.42) 0.10  
_Ibedding_2 0.54 (0.57) 0.35 0.26 (2) 
_Ivent_0 
_ _  
_Ivent_1 
-1.03 (0.53) 0.05  
_Ivent_2 
-0.96 (0.53) 0.07 0.12 (2) 
Aiao -0.75 (0.45) 0.10   
E.  Medication History     
Dewormer -0.00 (0.35) 1.00  
Mangelice 0.73 (0.44) 0.10  
Probiotics -0.31 (0.42) 0.45   
See appendix G-1 for key.
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Appendix G-3. Potential risk factors for tetracycline resistance in E. coli isolates from 
finishing pigs from 95 farms in the Midwest 
Variable Name B (SE) p-value† Wald p† (df) 
A. Biosecurity risk value     
_visitoronfarm_0 _ _  
_visitoronfarm_1 0.05 (0.37) 0.88  
_visitoronfarm_2 0.29 (0.50) 0.57 0.81 (2) 
_toilet_0 
_ _  
_toilet_1 
-0.06 (0.28) 0.83  
Exterm 0.02 (0.34) 0.94  
rendering  0.05 (0.28) 0.86  
Birdproof 0.33 (0.34) 0.33  
free_roam -0.28 (0.30) 0.35  
Chickens -0.28 (0.33) 0.39  
Newlivestock -0.31 (0.30) 0.31  
animal_contact -0.55 (0.31) 0.08  
_acclim_0 _ _  
_acclim_1 0.78 (0.39) 0.05  
_acclim_2 0.03 (0.29) 0.93 0.09 
B.  Disease History for the last 12 months     
Action 1.09 (0.72) 0.13  
Prrs 0.13 (0.40) 0.74  
Swineflu 0.33 (0.28) 0.24  
Salm 0.67 (0.65) 0.30  
Glassers 0.39 (0.41) 0.35  
myco_pn 0.93(0.34) 0.01  
Rhin 0.15 (0.44) 0.74  
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Variable Name B (SE) p-value† Wald p† (df) 
Hbs -0.24 (0.31) 0.45  
Ili -0.33 (0.33) 0.31  
Ulcer -0.06 (0.49) 0.90  
Erysip -0.07 (0.46) 0.89  
C.  Vaccine Usage on farm     
Vaccine -0.03 (0.30) 0.93  
Pseudovx 0.33 (0.37) 0.37  
Mycovx 0.59 (0.53) 0.27  
D. Management Practices on the farm     
Mixfarm -0.11(0.38) 0.78  
Premix 0.10 (0.36) 0.77  
Corn -0.45 (0.35) 0.20  
Soybean -0.07 (0.25) 0.77  
Manurespread -0.06 (0.37) 0.87  
_house_1 _ _  
_house_2 
-0.39 (0.35) 0.27  
_house_3 
-1.04 (0.45) 0.02  
_house_4 
-0.19 (0.36) 0.60  
_house_5 0.95 (0.90) 0.29 0.06 (4) 
Flooring -0.39 (0.32) 0.22  
floor  0.56 (0.29) 0.06  
_Ibedding_0 _ _  
_Ibedding_1 
-0.53 (0.30) 0.08  
_Ibedding_2 
-0.29 (0.40) 0.47 0.20 (2) 
_Ivent_0 
_ _  
_Ivent_1 0.69 (0.34) 0.04  
_Ivent_2 0.79 (0.38) 0.04 0.05 (2) 
Aiao -0.29 (0.29) 0.32  
E.  Medication History     
Dewormer 0.12(0.27) 0.67  
Mangelice 0.51 (0.32) 0.11  
Probiotics -0.19 (0.37) 0.61   
See appendix G-1 for key.
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Appendix G-4. Potential risk factors for streptomycin resistance in among 
E. coli isolates from finishing pigs from 95 farms in the Midwest 
Variable Name B (SE) p-value† Wald p† (df) 
A. Biosecurity risk value     
_visitoronfarm_0 _ _   
_visitoronfarm_1 
-0.02 (0.35) 0.96  
_visitoronfarm_2 0.06 (0.37) 0.87 0.91 (2)  
toilet_0 
_ _  
toilet_1 0.07 (0.18) 0.70  
exterm -0.13 (0.25) 0.60  
rendering  -0.07 (0.20) 0.71  
birdproof -0.26 (0.21) 0.21  
free_roam -0.34 (0.20) 0.08  
chickens 0.04 (0.27) 0.89  
newlivestock 0.11 (0.19) 0.57  
animal_contact -0.19 (0.32) 0.55  
_acclim_0 _ _  
_acclim_1 
-0.14 (0.26) 0.57  
_acclim_2 
-0.10 (0.19) 0.61 0.81 (2) 
B.  Disease History for the last 12 months     
Action -0.42 (0.44) 0.33  
Prrs -0.41 (0.22) 0.06  
Swineflu -0.51 (0.21) 0.01  
Salm -0.14 (0.35) 0.69  
Glassers -0.07(0.30) 0.81  
myco_pn 0.01 (0.20) 0.96  
rhin -0.44 (0.44) 0.33  
hbs -0.28 (0.19) 0.14  
ili -0.26 (0.19) 0.17  
ulcer -0.71 (0.24) 0.00  
erysip -0.34 (0.25) 0.17   
C. Vaccine Usage on farm     
Vaccine -0.12 (0.24) 0.60  
Pseudovx 0.42 (0.29) 0.15  
Mycovx -0.14 (0.34) 0.68   
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Variable Name B (SE) p-value† Wald p† (df) 
D. Management Practices on the farm    
 
Mixfarm 0.20 (0.19) 0.28  
Premix -0.23 (0.18) 0.21  
Corn 0.07 (0.18) 0.69  
Soybean -0.01 (0.18) 0.96  
Manurespread -0.24 (0.25) 0.33  
_house_1 _ _  
_house_2 0.09 (0.25) 0.70  
_house_3 
-0.44 (0.41) 0.28  
_house_4 
-0.04 (0.23) 0.87  
_house_5 0.57 (0.18) 0.00 0.00 (4) 
Flooring 0.38 (0.23) 0.10  
floor  -0.04 (0.25)  0.86  
_Ibedding_0 _ _  
_Ibedding_1 
-0.20 (0.22) 0.38  
_Ibedding_2 
-0.09 (0.24) 0.70 0.67 (2) 
_Ivent_0 
_ _  
_Ivent_1 0.14 (0.25) 0.58  
_Ivent_2 
-0.02 (0.25) 0.92 0.69 (2) 
Aiao -0.25 (0.19) 0.18   
E.  Medication History    
Dewormer 0.20 (0.19) 0.30  
Mangelice 0.34 (0.20) 0.09  
Probiotics -0.16 (0.27) 0.56   
See appendix G-1 for key. 
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Appendix G-5. Potential risk factors for ampicillin resistance of among E. coli 
isolates from finishing pigs on 95 farms in the Midwest. 
Variable Name B (SE) p-value† Wald p† (df) 
A. Biosecurity risk value     
_visitoronfarm_0 _ _  
_visitoronfarm_1 
-0.34(0.47) 0.47  
_visitoronfarm_2 
-0.52 (0.49) 0.29 0.50 (2) 
toilet_0 
_ _  
toilet_1 
-0.07 (0.21) 0.74  
Exterm 
-0.24 (0.31) 0.44  
rendering  -0.03 (0.24) 0.91  
Birdproof -0.12 (0.29) 0.67  
free_roam 0.07 (0.26) 0.78  
Chickens -0.11 (0.33) 0.75  
Newlivestock 0.19 (0.27) 0.47  
animal_contact 0.18 (0.36) 0.62  
_acclim_0 _ _  
_acclim_1 
-0.24 (0.30) 0.44  
_acclim_2 0.21 (0.23) 0.36 0.32 (2) 
B.  Disease History for the last 12 months     
Action 0.58 (0.59) 0.32  
Prrs -0.10 (0.26) 0.70  
Swineflu -0.29 (0.25) 0.24  
Salm 0.19 (0.41) 0.65  
Glassers 0.08 (0.40) 0.84  
myco_pn 0.37 (0.26) 0.16 
 
Rhin -1.71 (0.44) 0.00 
 
Hbs 0.36 (0.24) 0.13 
 
Ili 0.18 (0.22) 0.41 
 
Ulcer -0.08(0.33) 0.82 
 
Erysip -0.36 (0.27) 0.18 
 
C.  Vaccine Usage on farm   
 
Vaccine 0.06 (0.21) 0.78 
 
Pseudovx 0.21 (0.28) 0.45 
 
Mycovx -0.06 (0.29) 0.84 
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Variable Name B (SE) p-value† Wald p† (df) 
D. Management Practices on the farm     
Mixfarm 0.39 (0.24) 0.10  
Premix -0.30 (0.22) 0.17  
Corn -0.18(0.29) 0.52  
Soybean 0.05 (0.24) 0.83  
Manurespread -0.41 (0.30) 0.17  
_house_1 _ _  
_house_2 0.04 (0.31) 0.89  
_house_3 
-0.57 (0.52) 0.28  
_house_4 0.27 (0.29) 0.36  
_house_5 
-0.23 (0.85) 0.78 0.51 (4) 
Flooring 0.43 (0.27) 0.11  
floor  -0.34 (0.30) 0.25  
_Ibedding_0 _ _  
_Ibedding_1 
0.07 (0.32) 0.83  
Table 4.7a (continued) 
  
Variable Name B (SE) p-value Wald p (df) 
_Ibedding_2 0.43 (0.34) 0.21 0.43 (2) 
_Ivent_0 
_ _  
_Ivent_1 0.45 (0.42) 0.29  
_Ivent_2 0.10 (0.42) 0.82 0.27 (2) 
Aiao -0.14 (0.26) 0.60  
E.  Medication History     
Dewormer 0.14 (0.25) 0.57  
Mangelice 0.18 (0.31) 0.57  
Probiotics 0.45 (0.37) 0.23   
See appendix G-1 for key. 
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Appendix G-6. Potential risk factors for  ampicillin resistance of 
sulfamethoxazole in E. coli isolates from finishing pigs on 95 farms in the 
Midwest 
Variable Name B (SE) p-value† Wald p† (df) 
A. Biosecurity risk value     
_visitoronfarm_0 _ _  
_visitoronfarm_1 
-0.30 (0.29) 0.30  
_visitoronfarm_2 
-0.25 (0.32) 0.45 0.58 (2) 
toilet_0 
_ _  
toilet_1 
-0.27 (0.18) 0.14  
exterm -0.12 (0.23) 0.60  
rendering  0.04 (0.20) 0.86  
birdproof 0.09 (0.21) 0.67  
free_roam -0.13 (0.22) 0.56  
chickens 0.11 (0.26) 0.69  
newlivestock -0.15 (0.20) 0.45  
animal_contact -0.18 (0.24) 0.44  
_acclim_0 _ _  
_acclim_1 
-0.10 (0.22) 0.64  
_acclim_2 
-0.06 (0.20) 0.77 0.89 (2) 
B.  Disease History for the last 12 months     
Actino -0.13 (0.37) 0.72  
Prrs -0.05(0.22) 0.84  
Swineflu -0.13 (0.20) 0.51  
Salm 0.10 (0.29) 0.72  
Glassers -0.11 (0.29) 0.70  
myco_pn 0.17 (0.20) 0.38  
rhin -0.09 (0.26) 0.73  
hbs -0.16 (0.21) 0.43  
ili 0.10 (0.20) 0.61  
ulcer -0.46 (0.25) 0.07  
erysip -0.25 (0.26) 0.34  
C. Vaccine Usage on farm    
Vaccine 0.11 (0.22) 0.63  
Pseudovx 0.53 (0.29) 0.06  
Mycovx 0.25 (0.28) 0.37  
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Variable Name B (SE) p-value† Wald p† (df) 
D. Management Practices on the farm     
Mixfarm 0.24 (0.21) 0.24  
Premix 0.07 (0.19) 0.73  
Corn -0.15 (0.25) 0.54  
Soybean 0.10 (0.19) 0.61  
Manurespread -0.28 (0.22) 0.20  
_house_1 _ _  
_house_2 0.04 (0.24) 0.86  
_house_3 
-0.73 (0.41) 0.07  
_house_4 
-0.29 (0.23) 0.20  
_house_5 0.52 (0.20) 0.01 0.00 (4) 
Flooring -0.10 (0.27) 0.70  
floor  0.09 (0.22) 0.70  
_Ibedding_0 - _  
_Ibedding_1 
-0.11(0.21) 0.61  
_Ibedding_2 
-0.38 (0.24) 0.11 0.28 (2) 
_Ivent_0 
_ _  
_Ivent_1 0.33 (0.26) 0.22  
_Ivent_2 0.27 (0.27) 0.31 0.45 (2) 
aiao -0.16 (0.19) 0.41  
E. Medication History      
dewormer 0.32 (0.20) 0.10  
mangelice 0.55 (0.23) 0.02  
probiotics 0.01 (0.31) 0.98   
See appendix G-1 for key. 
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Appendix G-7. Potential risk factor for chloramphenicol resistance of in E. 
coli isolates from finishing pigs on 95 farms in the Midwest 
Variable Name B (SE) p-value† Wald p† (df) 
A. Biosecurity risk value     
_visitoronfarm_0 _ _  
_visitoronfarm_1 
-0.60 (0.56) 0.29  
_visitoronfarm_2 
-0.42 (0.59) 0.47 0.54 (2) 
toilet_0 
_ _  
toilet_1 
-0.04 (0.33) 0.90  
exterm 0.62 (0.47) 0.19  
rendering  -1.50 (0.52) 0.00  
birdproof 0.40 (0.42) 0.34  
free_roam 0.16 (0.33) 0.64  
chickens 1.17 (0.33) 0.00  
newlivestock -0.07 (0.36) 0.84  
animal_contact -0.09 (0.60) 0.88  
_acclim_0 _ _  
_acclim_1 
-0.28 (0.44) 0.53  
_acclim_2 0.04 (0.34) 0.91 0.78 (2) 
B.  Disease History for the last 12 
months     
actino 0.00 (0.41) 0.99  
Prrs 0.18 (0.36) 0.62  
Swineflu -0.04 (0.33) 0.91  
Salm -0.78 (0.74) 0.29  
Glassers 0.33 (0.45) 0.46  
myco_pn 0.11 (0.36) 0.75  
Rhin -0.71 (0.74) 0.34  
Hbs 0.23 (0.35) 0.51  
Ili 0.33 (0.32) 0.30  
Ulcer -0.31 (0.43) 0.48  
Erysip -1.09 (0.57) 0.06  
C. Vaccine Usage on farm    
Vaccine 0.08 (0.37) 0.82  
Pseudovx 0.81 (0.40) 0.05  
Mycovx 0.51 (0.40) 0.20  
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Variable Name B (SE) p-value† Wald p† (df) 
D. Management Practices on the farm     
Mixfarm 0.12 (0.33) 0.70  
Premix 0.37 (0.33) 0.25  
Corn -0.16 (0.41) 0.70  
Soybean 0.00 (0.32) 1.0  
Manurespread -0.44 (0.45) 0.34  
_house_1 _ _  
_house_2 0.07 (0.47) 0.88  
_house_3 
-0.10 (0.57) 0.86  
_house_4 
-0.86 (0.48) 0.08  
_house_5 
-0.39 (0.80) 0.71 0.40 (4) 
Flooring -0.47 (0.44) 0.28  
Floor  0.27 (0.44) 0.54  
_Ibedding_0 _ _  
_Ibedding_1 0.05 (0.42) 0.90  
_Ibedding_2 
-1.90 (0.71) 0.01 0.02 (2) 
_Ivent_0 
_ _  
_Ivent_1 1.25 (0.51) 0.02  
_Ivent_2 1.61 (0.47) 0.00 0.00(2) 
Aiao -0.04 (0.42) 0.93  
E.  Medication History     
Dewormer 0.46 (0.34) 0.17  
Mangelice 0.32 (0.34) 0.34  
Probiotics -0.35 (0.51) 0.49   
See appendix G-1 for key. 
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Appendix G-8.  Potential risk factors multidrug resistance in Campylobacter isolates 
from finishing pigs on 95 farms in the Midwest.  Herd type was included in each 
analysis. 
Variable Name B (SE) p-value† Wald p† (df) 
A. Biosecurity risk value     
_visitoronfarm_0 _ _    
_visitoronfarm_1 
-0.32 (0.75) 0.66  
_visitoronfarm_2 0.22 (0.78) 0.77 0.35 (2) 
_toilet_1 0.12 (0.35) 0.74  
Exterm 0.13 (0.43) 0.77  
rendering  -0.59 (0.44) 0.18  
Birdproof 0.58 (0.43) 0.17  
free_roam 0.02 (0.40) 0.96  
Chickens -0.32 (0.44) 0.46  
Newlivestock -0.53 (0.37) 0.16  
animal_contact -0.60 (0.43) 0.17  
_acclim_0 _ _  
_acclim_1 0.55 (0.52) 0.29  
_acclim_2 0.10 (0.38) 0.80 0.57 (2) 
B.  Disease History for the last 12 months     
Action 0.21 (0.95) 0.83  
Prrs -0.56 (0.44) 0.21  
Swineflu -0.21 (0.37) 0.58  
Salm -0.66 (0.58) 0.26  
Glassers -0.02 (0.42) 0.95  
myco_pn -0.41 (0.41) 0.31  
rhin -1.95 (0.55) 0.000  
hbs 0.31 (0.38) 0.73  
ili 0.03 (0.38) 0.94  
ulcer -0.04 (0.53) 0.93  
erysip -0.62 (0.57) 0.28  
C.  Vaccine Usage on farm    
Vaccine 0.12 (0.46) 0.79  
Pseudovx -0.21 (0.66) 0.75  
Mycovx -0.15 (0.48) 0.76  
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Variable Name B (SE) p-value† Wald p† (df) 
D. Management Practices on the farm     
Mixfarm -0.78 (0.36) 0.03  
Premix 0.21 (0.36) 0.56  
Corn 0.60 (0.47) 0.20  
Soybean 0.22 (0.36) 0.55  
Manurespread -0.09 (0.47) 0.84  
_house_1 _ _  
_house_2 
-0.08 (0.42) 0.84  
_house_3 
-0.30 (0.63) 0.64  
_house_4 
-0.56 (0.49) 0.25  
_house_5 
-0.34 (0.69) 0.62 0.68 (4) 
Flooring 0.35 (0.43) 0.41  
floor  0.43 (0.39) 0.27  
_Ibedding_0 
_ _  
_Ibedding_1 
-0.37 (0.38) 0.33  
_Ibedding_2 0.02 (0.62) 0.97 0.51 (2) 
_Ivent_0 
_ _  
_Ivent_1 
-0.38 (0.52) 0.45  
_Ivent_2 0.39 (0.47) 0.42 0.19 (2) 
Aiao 0.26 (0.40) 0.51  
E.  Medication History      
Dewormer -0.26 (0.38) 0.47  
Mangelice -0.36 (0.46) 0.43  
See appendix G-1 for key. 
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Appendix G-9.  Potential risk factor for multidrug resistance in E. coli isolates 
from finishing pigs on 95 farms in the Midwest.  Herd type was included in each 
analysis. 
Variable Name B (SE) p-value† Wald p† (df) 
A. Biosecurity risk value     
_visitoronfarm_0 _ _    
_visitoronfarm_1 
-0.50 (0.33) 0.13  
_visitoronfarm_2 
-0.16 (0.36) 0.66 0.10 (2) 
_toilet_1 
-0.11 (0.18) 0.52  
Exterm 
-0.04 (0.23) 0.88  
rendering  -0.01 (0.19) 0.95  
Birdproof 0.13 (0.25) 0.59  
free_roam -0.28 (0.21) 0.19  
Chickens -0.02 (0.30) 0.94  
Newlivestock -0.15 (0.22) 0.48  
animal_contact -0.30 (0.28) 0.30  
_acclim_0 _ _  
_acclim_1 0.07 (0.25) 0.78  
_acclim_2 0.17 (0.20) 0.40 0.70 (2) 
B.  Disease History for the last 12 months     
Action 0.23 (0.37) 0.54  
Prrs -0.22 (0.24) 0.37  
Swineflu -0.48 (0.21) 0.02  
Salm -0.33 (0.26) 0.21  
Glassers -0.24 (0.36) 0.51  
myco_pn 0.33 (0.22) 0.14  
Rhin -0.45 (0.27) 0.10  
Hbs -0.01 (0.22) 0.96  
Ili 0.10 (0.20) 0.62  
Ulcer -0.47 (0.28) 0.09  
Erysip -0.23 (0.30) 0.43  
C.  Vaccine Usage on farm    
Vaccine 0.19 (0.24) 0.44  
Pseudovx 0.70 (0.35) 0.05  
Mycovx 0.36 (0.33) 0.27  
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Variable Name B (SE) p-value† Wald p† (df) 
D. Management Practices on the farm     
Mixfarm -0.27 (0.22) 0.23  
Premix -0.33 (0.20) 0.10  
Corn 0.04 (0.26) 0.89  
Soybean 0.06 (0.19) 0.76  
Manurespread -0.36 (0.19) 0.06  
_house_1 _ _  
_house_2 
-0.15 (0.26) 0.56  
_house_3 
-0.79 (0.31) 0.01  
_house_4 
-0.18 (0.24) 0.46  
_house_5 
-0.13 (0.19) 0.49 0.01 (4) 
Flooring 0.08 (0.23) 0.71  
floor  -0.01 (0.33) 0.98  
_Ibedding_0 
_ _  
_Ibedding_1 
-0.24 (0.25) 0.34  
_Ibedding_2 
-0.17 (0.22) 0.45 0.61 (2) 
_Ivent_0 
_ _  
_Ivent_1 0.60 (0.23) 0.01  
_Ivent_2 0.45 (0.23) 0.05 0.03 (2) 
Aiao -0.21 (0.20) 0.29  
E.  Medication History      
Dewormer 0.12 (0.22) 0.57  
Mangelice -0.26 (0.21) 0.20  
See appendix G-1 for key. 
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Appendix G-10. Potential risk factors for multi-bacterial-antimicrobial 
resistance in feces samples from finishing pigs on 95 swine farms in the 
Midwest. 
Variable Name B (SE) p-value† Wald p† (df) 
A. Biosecurity risk value     
_visitoronfarm_0 _ _  
_visitoronfarm_1 
-0.80 (0.51) 0.11  
_visitoronfarm_2 
-0.53 (0.58) 0.36 0.24 (2) 
toilet_0 
 _  
toilet_1 
-0.25 (0.31) 0.42  
Exterm -0.11 (0.35) 0.76  
rendering  -0.28 (0.40) 0.48  
Birdproof 0.66 (0.41) 0.11  
free_roam -0.08 (0.33) 0.82  
Chickens -0.33 (0.34) 0.33  
Newlivestock -0.65 (0.30) 0.03  
animal_contact -0.90 (0.36) 0.01  
_acclim_0 _ _ _ 
_acclim_1 0.04 (0.43) 0.93  
_acclim_2 
-0.22 (0.32) 0.49 0.73 (2) 
B.  Disease History for the last 12 months    
Action 0.60 (1.11) 0.59  
Prrs -0.40 (0.45) 0.37  
Swineflu -0.70 (0.34) 0.04  
Salm -0.43 (0.65) 0.50  
Glassers 0.93 (0.63) 0.14  
myco_pn 0.32 (0.41) 0.43  
Rhin -1.30 (0.68) 0.06  
Hbs 0.13 (0.38) 0.73  
Ili -0.37 (0.36) 0.30  
Ulcer -0.36 (0.54) 0.50  
Erysip -0.50 (0.56) 0.37  
C.  Vaccine Usage on farm    
Vaccine -.07 (0.45) 0.88  
Pseudovx 0.57 (0.48) 0.23  
Mycovx 0.08 (0.48) 0.86  
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Variable Name B (SE) p-value† Wald p† (df) 
D. Management Practices on the farm    
Mixfarm -0.52 (0.37) 0.16  
Premix -0.01 (0.34) 0.97  
Corn 0.46 (0.47) 0.33  
Soybean -0.14 (0.31) 0.65  
Manurespread -0.11 (0.41) 0.79  
_house_1 _ _ _ 
_house_2 
-0.55 (0.37) 0.13  
_house_3 
-0.09 (0.42) 0.84  
_house_4 
-0.88 (0.46) 0.05  
_house_5 
-0.17 (0.62) 0.78 0.22 (4) 
Flooring 0.25 (0.33) 0.45  
floor  0.38 (0.43) 0.37  
_Ibedding_0 _ _  
_Ibedding_1 
-0.69 (0.38) 0.07  
_Ibedding_2 
-0.55 (0.45) 0.23 0.19 (2) 
_Ivent_0 
_ _  
_Ivent_1 0.14 (0.41) 0.74  
_Ivent_2 0.64 (0.40) 0.11 0.25 (2) 
Aiao -0.41 (0.31) 0.19  
E.  Medication 
History      
Dewormer -0.38 (0.30) 0.22  
Mangelice -0.15 (0.40) 0.70  
Probiotics -0.67 (0.40) 0.09   
See appendix G-1 for key. 
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